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Prologue
Fertility care through the eyes 
of a patient
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Fertility care through the eyes of a patient
“We will get you pregnant, lady!” These were literally the words a doctor once 
told me. ‘We’ were the all-knowing doctors who would make sure that I got what 
I wanted: a baby. Of course, this doctor could never make me this promise, as 
I already knew that the chance to achieve pregnancy was far from 100%. But 
more important, I did not appreciate the tone my doctor used, as it sounded 
like: “Please, do not think too much yourself, but just listen to me and follow my 
orders. I, ‘Mr. Gynaecology’, will make sure that it will all turn out well.” Maybe 
his intentions were not so bad at all, but patient-centred? No, this was definitely 
not what I expected from a patient-centred approach. 
Do I feel that it is important to provide patient-centred care? I can answer 
this question with a clear ‘Yes!’. I can also support this with many true stories, 
which my husband and I experienced during the five years that we were under 
treatment for our unfulfilled desire to have children. During these years, we went 
through different positive and negative experiences that were quite demanding 
and stressful. To make it more understandable how it is to be a patient suffering 
from infertility, I will walk you through some of my experiences.
Can I make a new appointment?
After I had undergone a laparoscopy to figure out the cause of my fertility problem, 
my doctor told me to make a new appointment within two weeks to start up a 
new treatment cycle. The next day, when I called the secretary, she surprisingly 
answered: ‘This must be a mistake, because it is absolutely not possible to make 
an appointment only two weeks after surgery. Obviously, your body needs more 
time to recover.’ Of course, I was amazed and I tried to convince her that this was 
really what the doctor had told me. But before I could finish my sentence, she 
has already passed me through to her colleague. Again, she only confirmed what 
her colleague had just told me. Who should I believe? The doctor, who told me 
to return within two weeks to continue my treatment (and I had already started 
to take hormones for this new treatment), or the secretaries, who were also firm 
in their statements. I decided to call again the next morning. And guess what? 
Suddenly, it was no problem to see the doctor and there was nothing to worry 
about. However, the previous calls had already made me very insecure and had 
stressed me out, which obviously could have been prevented.
Big bellies
In the waiting room of my hospital, I often had to sit next to patients who were 
already pregnant. Most of these patients were happy women, all discussing the 
progress of their pregnancies together. That’s good for them of course, but very 
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difficult for everyone who suffers from infertility. It was very hard for me to see 
all these big bellies while I wanted to have such a belly for myself. Once, my 
doctor asked me to return to the waiting room for a few more minutes, because 
he wanted to discuss his findings with a colleague. There I was, sitting next to a 
mother with a two-year old and obviously pregnant with her second child. Oh, I 
definitely wanted to put myself in her shoes and felt really miserable!
Different doctors, different stories
Communication between doctors... my experiences in this area are not really 
impressive. For example, it happened several times that a doctor asked me what 
he had to do during the appointment. Obviously, the doctor was not aware of the 
treatment plan my own doctor had composed and had not even read my medical 
record before I entered the room. Also the advice the doctors gave me was not 
always in line or even contradictory. It seemed like all doctors handled our fertility 
problem in their own way. That is strange, isn’t it? It also scared me a little bit, as 
I already felt psychological pressure to deal with my fertility problem. Now I also 
had to take care that my doctors were all pointing in the same direction regarding 
my fertility treatments. A new doctor once told us that our own doctor should 
never have introduced the IVF treatment that quickly. According to him, we had 
several other valid treatment options. Very confusing, as we did not know who 
was right. Also, some discussion was raised when I suggested a new treatment 
I read about in a magazine. Our doctor told me that this treatment option was 
not even possible in our hospital, while exactly the opposite was true according 
to his colleague. It turned out that no previous patient had been eligible for 
this treatment before. Eventually, I was the first patient receiving that specific 
treatment in our clinic and because of the worse communication, my husband 
and I decided to go to another doctor!
Imagine it is about you
One day, when I needed another ultrasound check-up, a lot of small follicles were 
visible on the screen, which didn’t seem good enough for an ovulation. This was 
a huge disappointment to me, but my doctor just said: ‘You have seen this before 
right? Yes, your endometrial layer looks fine, but this is not what you need of 
course!’ Well, that was just the last thing I wanted to hear, such a platitude!
Another example I would like to share, is about my admission to the hospital a 
few years ago. I was admitted because of blood loss during my pregnancy. Yes, 
we finally got pregnant and these periods with recurrent blood loss were very 
frightening and stressful to us. Therefore, it was even more striking that I heard 
a doctor speaking out loud to the nurse before he entered my room: ‘It is very 
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nice and quiet on this section today. Watch me, I will make sure that it will be 
even more quiet.’ Then he entered my room and asked me how I was doing. I told 
him that my blood loss had stopped since that night. Then I was ‘allowed’ to go 
home, he said. He obviously thought that he did me a favor, but he did not even 
ask me what I wanted. Because of my history, I would have preferred to stay 
another day to be sure the blood loss had really stopped. In my opinion, this was 
a perfect example of ‘talking about the patient’, instead of ‘talking to the patient’. 
Patient-centred care
Now it seems like we have only had negative experiences with fertility care, 
which is of course not true. During the five years of fertility treatments, we met 
a doctor who perfectly answered our expectations on how a doctor should be 
and he became our own doctor. What was so special about him? According to 
us, he was always there when we needed him and he took the time to answer 
all our questions. It was always possible to call him or to make an additional 
appointment, if we wanted to. We felt like we were not alone and were treated 
like human beings. This was very important to us, especially in these difficult and 
uncertain times.
The remark this prologue started with, was clearly not a sign of empathy. I hope 
that these examples of my personal experiences have illustrated what patients 
need when they are treated for their fertility problem. When discussing the 
content of patient-centred care, I think that the remark of the doctor should have 
been: “Together, we will do everything that is in our power to fulfill your desire to 
have a child.” In this case, ‘we’ stands for the professional team and the patient 
together, and not the doctors, nurses or secretaries alone. In my opinion, working 
together is the heart of the matter when it comes to patient-centred care.
Ingrid van der Kuil
Do you want to read more?
This prologue was based on the book “Koningskinderen”
Author: Ingrid van der Kuil
ISBN 9789081954006  
www.ingridvanderkuil.nl
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Chapter 1
General Introduction
CHAPTER 116
General Introduction
Story and reality: fertility care in the Netherlands
The patient your read about in the prologue was being treated in a Dutch fertility 
clinic, because she and her partner failed to achieve pregnancy after having at 
least one year of regular unprotected intercourse.1 Unfortunately, they are not the 
only couple dealing with this problem, as infertility is estimated to affect about 80 
million couples of the current global population.2,3 In developed countries, such as 
the Netherlands, one in six couples who have tried to achieve pregnancy suffers 
from infertility.4,5 Approximately 55% of these couples seek medical help and 
start with a diagnostic workup to determine the cause of their fertility problem 
and come to an appropriate treatment.3,6 In the majority of cases, male and/or 
female causes are found, such as low sperm counts and/or ovulation disorders.5 
However, in about 8-28% of cases, the cause of infertility remains unknown.7 
The effectiveness of the different treatment options in fertility care is limited. 
However, due to professionalization and standardization of care in recent years 
about 70% of the couples achieves pregnancy after one or more cycles of 
Medically Assisted Reproduction (MAR) nowadays.8,9 These treatments include 
ovulation induction (OI), intra-uterine insemination (IUI), in vitro fertilization 
(IVF), intra-cytoplasmic sperm injection (ICSI) and surgical sperm retrieval.10 In 
the Netherlands, initial fertility assessment, OI and IUI treatments are offered in 
all clinics, but only the intermediate Dutch clinics can also start up and monitor 
IVF and ICSI treatments (i.e. transport and satellite clinics). A total of thirteen 
Dutch clinics are licensed to perform the laboratory phase and embryo transfers 
of the IVF and ICSI treatments as well. This means that several patients have to 
visit more than one clinic during their treatment period, which is often lengthy. 
However, the presence of the smaller clinics, transport and satellite clinics makes 
Dutch fertility care accessible throughout the entire country. Nowadays, about 
15.000 IVF and ICSI cycles are performed each year in Dutch clinics, resulting 
in 1 in 40 children who are born after fertility treatments involving in vitro 
techniques.11
Financial coverage of all these treatments is mainly organized by public funding 
in which Dutch health insurers have a prominent role. After negotiating about 
prices and quality, they arrange contracts with different healthcare providers.12 
Subsequently, Dutch citizens are required to purchase a basic insurance package 
from a health insurer of their choice. Concerning fertility care, this basic package 
covers treatment and medication costs for OI, IUI, and three cycles of IVF / ICSI 
per episode. 
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The burden of infertility and its treatment
Infertility could be considered a multidimensional stressor for infertile couples, as 
it affects them in a number of ways.13,14 First, patients’ threat of staying childless 
evokes feelings of depression and helplessness and could therefore be considered 
an important stressor.13,15,16 Second, the physical burden of the treatment can 
cause feelings of anxiety among especially infertile women.13,17 Third, infertility 
often influences the couples’ social network or even their own relationship, as 
most patients find it difficult to talk about their problem to their partner, family 
and friends.14,18 Finally, patients’ emotional response to the fertility treatment 
has a cumulative effect on their emotional status, because patients’ levels of 
quality of life (QoL) decreases with a growing number of unsuccessful cycles.19 
This is underlined by the fact that about 17 to 70 percent of couples end their 
treatment prematurely, mainly because of the physical and emotional burden 
they experience.9,17,20-23
Obviously, infertility is associated with many psychosocial factors and a 
significant proportion of the infertile population suffers from these stressors. 
To help professionals within the field of fertility care to detect patients at risk 
of emotional maladjustment and to identify who could benefit from additional 
psychosocial support, two instruments have been developed in recent years.24,25 
The first instrument is the FertiQoL questionnaire, a disease-specific instrument 
measuring infertile patients’ QoL. This questionnaire is also useful in gathering 
specific information about the ‘Mind-Body’, ‘Emotional’, ‘Relational’ and ‘Social’ 
status of the patient.25 The second instrument is the SCREENIVF questionnaire, 
a screening instrument to determine which patients are at risk of emotional 
maladjustment during treatment. The questionnaire includes parts of both generic 
and disease-specific instruments and provides information about patients’ level 
of anxiety, depression, helplessness, lack of acceptance regarding their fertility 
problem, and lack of social support.24 
The FertiQoL and SCREENIVF questionnaires are used in this thesis to determine 
infertile patients’ level of QoL and their emotional status, respectively. However, 
they are not the only relevant outcome measures for patients suffering from 
infertility. 
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What do patients want? 
Not every couple visiting a clinic for their fertility problem has the same needs. 
Obviously, a couple’s primary goal is to achieve pregnancy, but the additional 
needs and expectations might differ across couples. For example, one couple only 
wants to become pregnant, irrespective of the remaining quality of care. However, 
another couple wants to become pregnant, but also wants to receive the most 
recent and comprehensive information. Meanwhile, the third couple wants to be 
optimally involved in all decisions regarding their treatment, next to their wish of 
becoming pregnant. This underlines the uniqueness of each patient as a person. 
Therefore, professionals in fertility care should keep this in mind by providing not 
only effective, but also patient-centred care. Patient-centredness is defined by 
the Institute of Medicine as care that is ‘respectful of and responsive to patients’ 
preferences and needs and that is guided by patients’ values’.26 Alongside safety, 
effectiveness, timeliness, efficiency and accessibility, patient-centredness is one 
of the six dimensions of quality of care.26 Patient-centredness is gaining more 
and more attention in recent years, as shown in figure 1. Especially in the last 
decade, the number of publications about patient-centredness of care increased 
significantly.
Figure 1. 
Number of publications per year regarding patient-centred care
Source: Pubmed, searched for: patient-centred or patient-centered
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Recent studies from primary and secondary care have shown that providing 
patient-centred care has several advantages, as it relates to improved health 
outcomes27-29, increased professionals’ job satisfaction30-32 and reduced healthcare 
costs.28,29,33 Moreover, studies indicate that patient-centred care increases 
patients’ level of QoL.34 
Obviously, all fields of medicine could benefit from patient-centred care, but 
it might be more relevant to healthcare areas which are associated with high 
emotions and intensive treatment periods, like fertility care.27,35,36 Therefore, 
every fertility clinic should optimize its care towards patient-centredness by 
taking into account their patients’ preferences and needs. More concrete, as 
patient-centredness is a multidimensional concept including different elements37, 
professionals should pay attention to these specific elements in daily practice. In 
an international context however, the content of these elements is not explicit 
and varies among the different models of patient-centredness that have been 
developed in recent years.26-29,38-41 
In this thesis, we will determine the level of patient-centred fertility care using the 
recently developed and validated Patient-Centredness Questionnaire – Infertility 
(PCQ-Infertility). The content of this instrument was based on both quantitative 
and qualitative research and includes elements of the patient-centredness models 
of both the Institute of Medicine and the WHO responsiveness model.38,40 The 
PCQ-Infertility is an objective instrument as it asks about 46 specific patients’ 
experiences with fertility care.42 Consequently, the PCQ-Infertility is a more 
objective instrument than many other satisfaction surveys, as they mainly provide 
an overly optimistic picture of patients’ perception of health care.43,44 Next to an 
overall level of patient-centredness, the PCQ-Infertility covers seven different 
dimensions or subscales, namely: Accessibility of care, Information provision, 
Communication, Respect for patients’ values, Continuity and transition of care, 
Patient involvement, and Professionals’ competence.42 
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What we already know about patient-centred fertility care
Many advantages of providing patient-centred care have already been mentioned, 
but we need some more arguments to stress out the urge of improving this kind 
of care. For the first argument, we will modify figure 1 by adding a line that 
represents the number of publications concerning the improvement of patient-
centred care. As can be seen in Figure 2, studies focusing on improving this kind 
of care are definitely behind and need more attention.
Figure 2. 
Differences between the number of publications regarding patient-
centred care and the improvement of patient-centred care
Source: Pubmed, searched for: patient-centred or patient-centered and improve*
Another important argument could be found in the fact that patient-centred 
care is considerably important to infertile patients themselves45-47, even if we 
compare it to pregnancy rates.48 Patients were willing to trade-off up to a third of 
their pregnancy rate for more patient-centred care. Moreover, a lack of patient-
centredness was one of the main reasons for patients to change fertility clinics.48 In 
addition, also physicians found patient-centred care important, but would trade-
off less pregnancy rates for patient-centredness compared to their patients.48
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Obviously, both patients and professionals in Dutch fertility care attach significant 
value to patient-centredness. However, van Empel et al. showed that the actual 
level of patient-centred fertility care is variable.42 In general, Dutch fertility care 
was already on the right track concerning the dimensions ‘Communication’, 
‘Patient involvement’ and ‘Competence’. Considerable improvement, though, 
seemed to be necessary at the dimensions ‘Information provision’, ‘Respect for 
patients’ values’ and ‘Continuity and transition of care’.42 But maybe even more 
important, the 29 participating Dutch fertility clinics significantly differed on their 
individual levels of patient-centred care, making it possible to distinguish between 
‘weak’ and ‘strong’ performing fertility clinics.42 Therefore, the results from the 
PCQ-Infertility could be useful for benchmark purposes, possibly stimulating the 
‘weak’ clinics to improve their level of patient-centredness.49-51 
Following this, we should be aware which patients and clinic characteristics 
are associated with patient-centred care. In different healthcare areas, many 
characteristics have been related to positive experiences with care, such as age, 
gender, race, marital status, health status, hospital size, continuity of care and 
length of stay.52-55 Also in the area of fertility care, some associations have been 
found. For instance, higher female age, a lower level of education, being pregnant, 
undergoing IVF/ICSI treatment, having a serious medical history, having a lead 
physician, and seeing trained fertility nurses were significantly related to more 
patient-centred care.56,57 These characteristics should be taken into account when 
evaluating a fertility clinic’s level of patient-centredness.56,58
Previous studies regarding patient-centred fertility care have not only focused on 
the opinion of patients, but included fertility care professionals as well. A study in 
Dutch fertility care showed that professionals could not adequately evaluate their 
performance regarding the care experiences of their patients, as they significantly 
misjudged 29 of the 46 PCQ-Infertility items.59 As a result, they overestimated 
one out of seven patient-centredness dimensions and underestimated even four 
dimensions.59 This corresponds to findings from other healthcare areas, where 
physicians’ perceptions about the general quality of care and the perception of 
their patients were poorly correlated.60-63 Apparently, professionals have little 
understanding about the level of patient-centred care they provide and might 
need help and information to make them more aware. 
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Gaps in our knowledge regarding patient-centredness
The previous paragraph illustrated that we are moving in the direction of patient-
centred fertility care. However, if we want to continue this process and focus on 
improvement, we should optimize our knowledge regarding this subject first. 
Based on the current literature, we can state that some important knowledge is 
lacking.
First, patient-centredness should be put in a broader perspective and related to 
other patient reported outcome measures, such as QoL, anxiety, and depression. 
Within other healthcare areas, it is already shown that patient-centredness 
corresponds to a higher level of patients’ QoL or patients’ well being.33,64-67 
Remarkably, this relation has never been studied in the area of fertility care, despite 
the existing knowledge about the emotional burden of infertility.13,14 A strong 
association between patients’ well-being and patient-centred care might indicate 
that we should take patients’ well being into account when measuring patient-
centred fertility care and could underline the importance of improving patient-
centred care. Moreover, it would be valuable to determine the role of patient-
centred care in patients’ decision to drop out treatment. A significant proportion 
of couples do not achieve pregnancy, because they decide to discontinue their 
treatment prematurely.9,17,20-23 In case of a strong association between patient-
centred care and dropout, professionals could be motivated even more to focus 
on the improvement of patient-centred care as it will positively influence their 
dropout rates. 
Further, we noticed that partners of infertile couples are only rarely involved in 
research69-71, while infertility is the perfect example of a condition involving both 
the woman and her partner. Especially, if we want to aim at the improvement of 
patient-centred fertility care, we should be aware of the emotional status, the 
ideas and preferences of both members of the infertile couple. 
Finally, we already showed some study results about the preferences of patients 
and professionals regarding patient-centredness.48 Because these results were 
highly interesting, we should go one step further now and determine the relative 
value of patient-centred fertility care by calculating its monetary value. This is 
especially valuable in the current economic situation where costs are becoming 
more and more important. Moreover, because of the unique Dutch healthcare 
system, which is based on managed competition between health insurers and 
providers, we should be aware of insurers’ preferences regarding fertility care. 
The value patients and health insurers place on patient-centred fertility care might 
be stimulating for policy makers, clinicians and clinics to improve these aspects of 
care and increase the overall value patients derive from their treatment.
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Towards improving patient-centred fertility care
“Es ist nicht genug, zu wissen, man muβ auch anwenden;
es ist nicht genug, zu wollen, man muβ auch tun.”
(Knowing is not enough, we must apply; willing is not enough, we must do.)
Johann Wolfgang von Goethe
This citation illustrates that we have to do more than just gaining knowledge 
about patient-centred fertility care. If we want to come to improvement, 
additional steps are needed. Within the area of fertility care, only a few studies 
focused on the improvement of fertility care aspects that were related to patient-
centredness.74,75 As the number of these studies is scarce and the results are 
variable, we should consider the results from studies in other healthcare areas to 
find out how an optimal improvement strategy should look like. 
In the literature, a growing number of interventions to promote patient-centred 
care are present, but the understanding of the effects of these interventions is 
still relatively poor.34 Interventions that are mentioned most often are: audit and 
feedback, reminders, educational outreach visits, patient-directed interventions, 
and patient-centred training for professionals.34 However, the effects of these 
single interventions were only small to moderate in most studies.76-78 Because the 
implementation of a change in professionals’ performance or clinics’ organization 
is a complex process, many studies combine two or more single interventions34,76, 
resulting in a potentially more effective multifaceted approach.43,79,80 Unfortunately, 
only a few studies evaluated the effect of a multifaceted intervention on patient-
centred care against a control group (i.e. no intervention)76, making it difficult 
to analyze and interpret the effect of multifaceted interventions. Moreover, most 
studies vary considerably in their methodological quality and intensity.34,76 
In this light, it seems not only important to come to an optimal improvement 
strategy, but to create optimal circumstances for improvement as well. 
Studies have shown that for example the culture of a clinic, the organizational 
‘readiness for change’ and organizational commitment could influence a clinic’s 
performance.81-84 Whether there are any effective and generalisable strategies to 
change these characteristics of a clinic is still debatable, and more evidence is 
therefore needed.85 
In conclusion, paying attention to patient-centredness of care is gaining more 
and more attention in daily practice nowadays. Especially patients suffering from 
infertility could benefit from patient-centred care, as fertility treatments are a 
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physical and psychological burden to them. Previous studies have shown that 
the level of patient-centred fertility care varies considerably among clinics and 
improvement is needed. However, no golden standard is available on how to 
promote and improve patient-centred fertility care. 
Aim and outline of the thesis
The aim of this thesis was to improve patient-centredness in fertility care. 
However, to come to an optimal improvement design, we needed to put the 
concept of ‘patient-centred fertility care’ in a broader perspective first. This thesis 
is therefore divided into two parts.
In the first part, we created a proper basis to come to an optimal intervention 
for improving patient-centred fertility care. Therefore, we explored the relation 
between patient-centredness and other patient related outcomes, such as QoL. 
Moreover, we studied whether patients’ experiences with fertility care and their 
emotional status differed between women and their partners. Also the relation 
between patient-centred fertility care and patients’ decision to discontinue 
treatment prematurely (i.e. dropout) was subject of this thesis. Finally, we 
determined the monetary value of patient-centredness, by studying what both 
patients and health insurers were willing to pay for more patient-centred fertility 
care. 
In the second part, we studied the effect of audit and feedback on the level of 
patient-centredness in Dutch fertility care. Subsequently, using the input of both 
patients and professionals, we composed a multifaceted approach aiming at the 
improvement of patient-centred fertility care and studied the effectiveness of this 
intervention. Moreover, we examined the costs, explored determinants at the 
patient and clinic level of an improvement in patient-centred care and performed 
an in-depth process evaluation of the multifaceted strategy.
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The main questions of this thesis are:
Part I. Patient-centred fertility care in a broader perspective
1. How do patient-centred care, quality of life and distress relate to each other 
in fertility care? (Chapter 2)
2. Do infertile women and their partners differ regarding their fertility care 
experiences, quality of life and risk factors for emotional problems? (Chapter 
3 and 4)
3. Can we use the level of patient-centredness as a predictor for dropout in 
fertility care? (Chapter 5)
4. What is the monetary value of patient-centred fertility care? (Chapter 6)
Part II. Improving patient-centred fertility care
5. What is the effect of audit and feedback on the improvement of patient-
centred fertility care? (Chapter 7)
6. Which aspects should be included into an optimal improvement design for 
patient-centred fertility care according to professionals? (Chapter 7 and 8)
7. What is the (cost-)effectiveness of a multifaceted approach on the improvement 
of patient-centred fertility care? (Chapter 9 and 10)
8. Which determinants at the patient and clinic level are associated with an 
increase in the level of patient-centredness? (Chapter 9 and 10)
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Abstract
Background
The aim of this study was to investigate to what extent patients’ experiences with 
fertility care are associated with their quality of life (QoL), and levels of anxiety 
and depression.
Methods
We performed a cross-sectional questionnaire study within 29 Dutch fertility 
clinics, including women with fertility problems. Through multilevel regression 
analyses, associations between patients’ QoL (FertiQoL) and distress [anxiety and 
depression; Hospital Anxiety and Depression Scale (HADS)] and their experiences 
with fertility care [Patient-centredness Questionnaire (PCQ)-Infertility] were 
determined. For all multilevel models, R2 and intra-cluster correlation coefficients 
were calculated.
Results 
This study included 427 non-pregnant patients who filled out the FertiQoL, HADS 
and PCQ-Infertility (response rate 76%). Multilevel regression analysis showed 
significant associations between the PCQ total scale, the total FertiQoL scale (B 
= 0.25), and HADS subscales (B = 20.22 and 20.18). Of the variance in patients’ 
experiences, 13% (=R2) could be explained by their perceived QoL, 12% by their 
level of anxiety and 10% by their level of depression.
Conclusions
Patient-centredness in fertility care and the patients’ QoL and anxiety and 
depression scores are related. Paying attention to these variables could lead 
to positive care experiences and improved patient-centredness of care. Future 
research should focus on identifying causal relationships among these variables.
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Introduction
Traditionally, quality of fertility care focuses on outcome measures, such as 
effectiveness and safety.1,2 However, in the last decade, patient-centredness has 
increasingly been recognized as an important component of high-quality fertility 
care.3-5 Patient-centred care is one of the six quality-of-care dimensions and 
is defined as ‘providing care respectful of and responsive to individual patient 
preferences, needs and values, and ensuring that patient values guide all clinical 
decisions’.3 The patient-centredness questionnaire-infertility (PCQ-Infertility) 
was developed and validated as a reliable instrument to measure patient-
centredness of fertility care by asking patients about their experiences with care.5 
By measuring the level of patient-centredness, clinics will have detailed insight 
into their performance according to patients, and this will allow tailored quality 
improvement and benchmarking.5
The delivery of patient-centred care could bring patients many benefits, especially 
when it comes to their perceived well-being. Tailoring care in a patient-centred 
way could remove some of the emotional burden of infertility, often seen in terms 
of poorer quality of life (QoL) and higher anxiety and depression.5-8 This potentially 
beneficial relationship between patient-centredness and a patient’s well-being 
has often been discussed, but has not yet been investigated in reproductive 
medicine.4,5 
A methodological problem of using patient self-report measures such as the PCQ-
Infertility as indicators for quality of fertility care is that patients’ experiences may 
be influenced by their well-being. It is known that performance on different types 
of cognitive tasks, including completing questionnaires, can be influenced by 
the patient’s mood.9 A positive mood can enhance recall of happy memories10,11, 
whereas negative affect can result in negative memory biases in patients’ self-
report measures.12 This influence might especially apply to infertile patients 
because infertility is associated with a high emotional burden.6,13 Because of this 
emotional impact6,14, it would not be surprising if a patient’s well-being impacted 
on their reports about experiences with care. It is thus important to know to 
what extent patient negative or positive mood influences their evaluation of the 
patient-centred performance of their fertility clinic. A strong association between 
these would indicate the need to take well-being into account when we measure 
patient-centredness using the PCQ-Infertility. 
To gain more insight into these associations, the objective of this cross-sectional 
study was to determine how patients’ reported experiences with fertility care are 
related to their well-being (i.e. QoL, anxiety and depression).
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Materials and Methods
Setting and study design
This cross-sectional study was nested in another study which aimed primarily at 
collecting couples’ care experiences and validating the PCQ-Infertility.5 In order 
to address secondary research questions7, present study during this large multicentre 
study, data were also collected on QoL and levels of distress from a subset of the 
female partners of the participating couples. A total of 29 Dutch fertility clinics 
from three regions in the Netherlands approved participation in data collection.
Recruitment of patients and inclusion and exclusion criteria
In the Netherlands, every patient visiting a Dutch hospital is assigned a code for 
insurance purposes according to the patient’s diagnosis and treatment. Using 
this diagnosis treatment combination (DBC) coding system, participating fertility 
clinics were able to extract from their system the addresses of all patients who 
underwent medically assisted reproduction in their clinic between April and 
June 2009, varying from IVF and ICSI to ovulation induction and intrauterine 
insemination. From these lists of patients (n = 3061 individual women), we 
selected a random sample of 1200 to participate in the total study, and 1189 
actually received the questionnaires. The number of sampled patients per clinic 
depended on the size of their infertility outpatient clinic, ranging from 25 patients 
for smaller clinics to 75 for the largest IVF centres. For the study described in 
this paper, we randomly selected two-thirds of patients per clinic because of 
practical reasons (n = 785). Per fertility clinic, we alternately allocated patients to 
participation in the study. The time interval between the last treatment date and 
the date of filling out the questionnaire could vary between one month (June–July 
2009) and five months (April–September 2009). The full selection procedure is 
depicted in figure 1. When completing the questionnaires, most women were 
expecting or undergoing another fertility treatment; others were awaiting the 
outcome of the previous fertility treatment or had recently achieved pregnancy. 
Those who had become pregnant during the study were excluded from the 
analyses, as most questions of FertiQoL are no longer applicable (e.g. ‘Do your 
fertility problems interfere with your day-to-day work or obligations?’).
Ethical approval
The institutional ethics committee of Radboud University Medical Centre Nijmegen 
reviewed and provided ethical approval for this research project to proceed.
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Figure 1 
Overview of patient selection of the multicentre study in which 
the present study was nested. 
3061 patients were treated in 29 Dutch fertility clinics 
between April and June 2009
Random sample taken of 1200 patients:
     - 75 patients for the largest IVF centres (n=3)
     - 50 patients for average fertility clinics (n=10)
     - 25-35 patients for the smallest fertility clinics (n=16)
All 1189 patients received a questionnaire package 
between July and September 2009 including:
     - Questions on background characteristics (21 items)a,b,c
     - PCQ-Infertility (46 items)a,b,c
     - FertiQoL (24 items)b,c
Two-thrids (n=785) received additionally:
- Hospital Anxiety and Depression Scale – HADS (14 items)b,c
One-third (n=404) received addtionally:
- Questions on importance of care aspects (53 items)a
11 questionnaires returend 
unopened because of 
wrong addresses
a Validation study PCQ-Infertility5
b Validation study Dutch FertiQoL7
c Present study
Data collection
We sent patients the survey and they received a reminder card 3 weeks after 
the initial mailing. After another 2 weeks, non-responders received an additional 
reminder with a new copy of the questionnaire.
Measurement instruments
In fertility care, we can reliably assess well-being by QoL and distress (i.e. anxiety 
and depression), using the FertiQoL questionnaire and the Hospital Anxiety and 
Depression Scale (HADS).7 The internationally developed and validated FertiQoL 
questionnaire consists of 26 questions. Besides two general items, it contains 24 
specific items covering four subscales of QoL: Mind–Body (e.g. ‘Do your fertility 
problems interfere with your day-to-day work or obligations?), Relational (e.g. 
‘Have fertility problems strengthened your commitment to your partner?’), Social 
(e.g. ‘Are you socially isolated because of fertility problems?’) and Emotional 
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(e.g. ‘Do you feel able to cope with your fertility problems?’). The optional 
FertiQoL treatment module was not used in this study. A higher score on one of 
the subscales means a better QoL with subscale scores ranging from 0 to 100 
(see Boivin et al., 2011, and Aarts et al., 2011, for further information on FertiQoL 
development and validity). The Dutch FertiQoL has shown good reliability in a 
previous study: Cronbach’s a varied between 0.72 and 0.91.7
The HADS was used to measure anxiety and depression in our study population. 
This questionnaire comprises 14 items: a 7-item anxiety subscale and a 7-item 
depression subscale. Cronbach’s α of these subscales was 0.82 and 0.83, 
respectively, in the same sample of Dutch patients experiencing infertility.7 
Subscale scores range from 0 to 21: a higher score means higher levels of anxiety 
and depression, respectively.15,16 A score of 8 is set as a cut-off value suggestive 
of a psychiatric condition.15,16 
Finally, we used the PCQ-Infertility (46 items), a validated instrument measuring 
the level of patient-centredness in fertility care, to assess patients’ experiences with 
care. This questionnaire is subdivided into seven different domains: accessibility 
(e.g. ‘Was it a problem for you to contact staff if you had any questions?’), 
information (e.g. ‘Did you receive an overview of your treatment plan with a 
time schedule?’), communication (e.g. ‘How often did your physician take you 
seriously?’), respect for patients’ values (e.g. ‘How often did your physician show 
an interest in your personal situation?’), continuity and transition (e.g. ‘How often 
did you have an appointment with the same physician?’), patient involvement 
(e.g. ‘Was decision-making shared with you, if preferred?’) and competence (e.g. 
‘How often was your physician well-prepared for an appointment?’). Cronbach’s 
a was high among across these domains (range 0.64–0.83).5 Higher scores on 
the total PCQ scale or one of these subscales (range 0–3) means a higher level 
of patient-centredness (see Van Empel et al. for details of the PCQ-Infertility)5.
Data analyses
We entered data into an SPSS database (version 16.0 for Windows, SPSS Inc., 
Chicago, IL, USA). As mentioned above, we excluded pregnant women from the 
analyses. We performed a multilevel regression analysis to adjust for clustering 
of patients within the same clinics. Additionally, the validation study of the PCQ-
Infertility had shown that the level of patient-centredness differed significantly 
between clinics (Van Empel et al., 2010a). We standardized variables to the unit 
of measurement which differed between the three instruments (i.e. 0–3, 0–21, 
and 0–100, respectively). We therefore converted the scores of the PCQ variables 
and the HADS variables to the same unit of measurement as the FertiQoL scores 
(0–100) by multiplying these by 33.33 and 4.76, respectively. In the analyses, 
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we applied these standardized scores, but for the descriptive statistics, we used 
original units of measurement. We chose to use the level of patient-centredness 
as the dependent variable and patient’s QoL and level of anxiety and depression as 
the independent variables, because this way we emphasized patient-centredness 
as an important outcome measure of quality of fertility care. 
We thus considered the total scale of the PCQ-Infertility the dependent outcome 
variable. Per patient, a mean PCQ total score was calculated by summing up 
the responses to the individual items and dividing these scores by the number 
of items completed.5 Patients who filled out half or less of the items within a 
subscale were to be excluded from further analyses. However, this was never the 
case in this study. 
We used the patient’s QoL, and levels of anxiety and depression as potential 
correlates for the level of patient-centredness. Consequently, we considered 
the total scale and all subscales of the FertiQoL, and HADS-anxiety and HADS-
depression scales as independent variables. For the total scale and subscales of the 
FertiQoL, we calculated a mean score per patient (range 0–100).8 HADS subscale 
scores were calculated by summing up the responses to the individual items. 
Additionally, as the patient characteristics ‘type of treatment’ and ‘women’s level 
of education’ were found to be associated with the level of patient-centredness in 
the validation study of the PCQ-Infertility5, we used these variables as additional 
case-mix adjusters. 
We computed multilevel regression models to determine the effects of the 
independent variables on the level of patient-centredness. The first model 
contained no covariates (model 0) and was the reference to which we compared 
seven other models with adjustment for three independent variables, which 
were: type of treatment, women’s education and one of QoL, anxiety or 
depression. Models 1, 2 and 3 contained the total FertiQoL, HADS-anxiety and 
HADS-depression scores, respectively. Models 4–7 adjusted for the FertiQoL 
subscales ‘Emotional’, ‘Mind–Body’, ‘Relational’ and ‘Social’, respectively. In the 
eighth model, we entered HADS scales and the total FertiQoL all together to 
determine what independent variable, taking into account the others, would be 
the most important predictor in this model for patient-centredness of care. In 
this last model, we did not exclude non significant variables, because we aimed 
with this particular analysis to elicit what independent variable had the strongest 
association with the dependent variable, when including the others. 
Furthermore, we calculated intra-cluster correlation coefficients (ICCs) to 
evaluate which part of the variance in patient-centredness is related to differences 
between fertility clinics. We determined this level of relatedness of clustered data 
42 CHAPTER 2
by comparing the variance within clusters with the variance between clusters 
(range 0–1). In this study’s analyses, a cluster was set at the level of fertility 
clinics. We calculated the ICCs using the 0-model as described before. 
Finally, we determined explained variance by calculating R2, indicating what 
percentage of variance in patient-centredness is attributable to the level of 
patient’s QoL, anxiety and depression. Significance for all analyses was set at P 
<0.05.
Results
Respondents
In total, 594 patients filled out the PCQ-Infertility, the FertiQoL questionnaire and 
the HADS (response rate 76%). Of these, 167 women (19%) were pregnant and 
were therefore excluded from further analyses. The median age of the remaining 
participants (n = 427) was 33 years (range 20–45). Of these women, 8% had a 
non-Dutch ethnicity and 42% of them had a high educational level (i.e. higher 
professional education or university according Dutch standardized definitions). 
Their median duration of infertility was 34 months and 72% of women were 
childless. Infertility was due to a male or female factor in 26 and 27% of cases, 
respectively. In 10%, both male and female factors were reported, and 37% of 
patients suffered from unexplained infertility. Half of participants underwent IVF 
and/or ICSI treatment. Table 1 presents their mean scores on the total scale and 
subscales of all three measurement instruments.
Table 1
Total scores and subscale scores of all three measurement instruments 
(n=427)
PCQ-Infertility =  Patient Centredness Questionnaire-Infertility; SD = Standard Deviation  
HADS = Hospital Anxiety and Depression Scale
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Table 1
Total scores and subscale scores of all three measurement instruments (n=427)
PCQ-Infertility = Patient Centredness Questionnaire-Infertility 
SD = Standard Deviation 
HADS = Hospital Anxiety and Depression Scale
Multilevel regression model
Table 2 describes the results of the multilevel regression analyses. When adjusted for ‘type of 
treatment’ and ‘women’s level of education’, Models 1, 2 and 3 showed that lower levels of 
anxiety, lower levels of depression and a higher QoL are significantly associated with 
perceptions of more patient-centred care (B = 20.22, 20.18 and 0.25, respectively). In 
Models 4–7, the analysis showed significant associations between the PCQ total scale and 
every FertiQoL subscale (B = 0.148–0.239), when adjusted for the aforementioned patient 
characteristics, indicating that better QoL in the Social, Emotional, Relational and Mind–Body 
domains is associated with a higher level of patient-centredness of care. The eighth model 
showed that higher scores on the FertiQoL total scale was significantly associated with higher 
levels of patient-centredness, when anxiety and depression were taking into account, 
suggesting that this is the most important variable of those three, when predicting patient-
centredness of care. In four additional models, containing both HADS scales and each of the 
four FertiQoL subscales separately, it showed that the Social subscale added the most, when 
corrected for anxiety and depression (B = 0.137; P = 0.001). 
Table 2 also lists the ICC’s, indicating that the variance in patient-centredness of participating 
clinics appeared to be 12–15%. 
Finally, the 8–13% of the variance in patient-centredness described in this study was 
attributable to the patient’s level of QoL, anxiety and depression (R2, last row).
PCQ-Infertility 
(range 0-3)
Mean (SD) FertiQoL 
(range 1-100)
Mean (SD) HADS 
(range 0-21)
Mean (SD)
Total 2.2 (0.4) Total 70.8 (13.9) Anxiety 5.6 (3.9)
Accessibility 2.1 (0.8) Emotional 59.8 (18.7) Depression 3.5 (3.3)
Information 2.0 (0.6) Mind-body 70.8 (19.5)
Communication 2.5 (0.5) Relational 78.2 (14.5)
Respect for patients’ value 2.1 (0.8) Social 74.0 (16.6)
Patient involvement 2.4 (0.6)
Continuity and transition 2.0 (0.6)
Competence 2.5 (0.4)
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Multilevel regression model
Table 2 describes the results of the multilevel regression analyses. When adjusted 
for ‘type of treatment’ and ‘women’s level of education’, Models 1, 2 and 3 showed 
that lower levels of anxiety, lower levels of depression and a higher QoL are 
significantly associated with perceptions of more patient-centred care (B = 20.22, 
20.18 and 0.25, respectively). In Models 4–7, the analysis showed significant 
associations between the PCQ total scale and every FertiQoL subscale (B = 0.148–
0.239), when adjusted for the aforementioned patient characteristics, indicating 
that better QoL in the Social, Emotional, Relational and Mind–Body domains is 
associated with a higher level of patient-centredness of care. The eighth model 
showed that higher scores on the FertiQoL total scale was significantly associated 
with higher levels of patient-centredness, when anxiety and depression were 
taking into account, suggesting that this is the most important variable of those 
three, when predicting patient-centredness of care. In four additional models, 
containing both HADS scales and each of the four FertiQoL subscales separately, 
it showed that the Social subscale added the most, when corrected for anxiety 
and depression (B = 0.137; P = 0.001). Table 2 also lists the ICC’s, indicating 
that the variance in patient-centredness of participating clinics appeared to be 
12–15%. 
Finally, the 8–13% of the variance in patient-centredness described in this study 
was attributable to the patient’s level of QoL, anxiety and depression (R2, last 
row).
Discussion
Patient-centredness of fertility care and patients’ well-being are related. Patients 
with a better QoL or lower levels of anxiety and depression report higher levels 
of patient-centred fertility care. However, as this is a cross-sectional study, 
associations could also be presented the other way around: more patient-centred 
care is related to a higher QoL and lower levels of anxiety and depression. We 
discuss both directions in more detail below. 
First, we look into the association between patient-centredness and patients’ 
QoL. To the best of our knowledge, this has never been studied before in a 
fertility care setting. QoL involves a reflection of patients’ functioning in relation 
to their health status in a broad sense7 and links merely to a holistic view on care. 
Between 8 and 13% of the variance in patients’ experiences could be explained 
by their perceived QoL, indicating that these two concepts are related but distinct 
as also shown by the relatively weak correlation between the total PCQ-Infertility 
and total FertiQoL (B = 0.250). 
44 CHAPTER 2
 Ta
b
le
 2
M
u
lt
ile
ve
l 
re
g
re
ss
io
n
 a
n
al
ys
es
; 
as
so
ci
at
io
n
s 
b
et
w
ee
n
 p
at
ie
n
t 
ce
n
tr
ed
n
es
s 
an
d
 Q
o
L,
 a
n
xi
et
y 
an
d
 d
ep
re
ss
io
n
C
oe
ff
ic
ie
nt
s 
(B
) 
w
ith
 9
5%
 c
on
fid
en
ce
 in
te
rv
al
s 
ar
e 
de
m
on
st
ra
te
d 
he
re
. 
Th
is
 c
oe
ff
ic
ie
nt
 d
es
cr
ib
es
 t
he
 d
iff
er
en
ce
 in
 P
C
Q
 w
he
n 
Fe
rt
iQ
oL
 o
r 
H
A
D
S
 le
ve
ls
 in
cr
ea
se
 w
ith
 1
. 
  
  
  
  
  
  
  
  
  
  
It
 a
ls
o 
in
di
ca
te
s 
th
e 
di
re
ct
io
ns
 o
f 
th
e 
m
en
tio
ne
d 
as
so
ci
at
io
n.
 F
or
 e
xa
m
pl
e,
 t
he
 P
C
Q
-I
nf
er
til
ity
 is
 p
os
iti
ve
ly
 r
el
at
ed
 t
o 
th
e 
Fe
rt
iQ
oL
 t
ot
al
 (
B
 =
0.
25
),
 b
ut
 t
he
 H
A
D
S 
an
xi
et
y 
is
ne
ga
tiv
el
y 
re
la
te
d 
to
 t
he
 P
C
Q
-I
nf
er
til
ity
 (
B
 =
20
.2
2)
. 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
IC
C
, 
in
tr
a-
cl
us
te
r 
co
rr
el
at
io
n 
co
ef
fic
ie
nt
; 
va
ri
an
ce
 a
t 
ho
sp
ita
l l
ev
el
/t
ot
al
 v
ar
ia
nc
e.
 T
he
am
ou
nt
 o
f 
va
ri
an
ce
 in
 p
at
ie
nt
-c
en
tr
ed
ne
ss
 a
tt
ri
bu
te
d 
to
 d
iff
er
en
ce
s 
be
tw
ee
n 
ho
sp
ita
ls
. 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 
R
2,
 e
xp
la
in
ed
 v
ar
ia
nc
e;
 t
hi
s 
re
pr
es
en
ts
 t
he
 p
er
ce
nt
ag
e 
of
 v
ar
ia
nc
e 
in
 t
he
 c
lin
ic
s 
le
ve
l o
f 
pa
tie
nt
-c
en
tr
ed
ne
ss
 a
tt
ri
bu
ta
bl
e 
to
 p
at
ie
nt
’s
 Q
oL
, 
an
xi
et
y 
an
d 
de
pr
es
si
on
.
*P
 <
 0
.0
5
M
od
el
 0
M
od
el
 1
(F
er
ti
Q
oL
To
ta
l)
M
od
el
 2
(H
A
D
S
A
n
xi
et
y)
M
od
el
 3
(H
A
D
S
 
D
ep
re
ss
io
n
)
M
od
el
 4
(F
er
ti
Q
oL
 
Em
ot
io
n
al
)
M
od
el
 5
(F
er
ti
Q
oL
 
M
in
d
-B
od
y)
M
od
el
 6
(F
er
ti
Q
oL
 
R
el
at
io
n
al
)
M
od
el
 7
(F
er
ti
Q
oL
S
oc
ia
l)
(n
u
l)
In
te
rc
ep
t
-0
.1
6
(-
0.
36
-0
.0
3)
-0
.2
5*
(-
0.
45
-
-0
.0
5)
-0
.2
5*
(-
0.
45
-
-0
.0
4)
-0
.2
4*
(-
0.
44
-
-0
.0
3)
-0
.2
5*
(-
0.
45
-
-0
.0
5)
-0
.2
4*
(-
0.
44
-
-0
.0
4)
-0
.2
5*
(-
0.
45
-
-0
.0
4)
-0
.2
5*
(-
0.
45
-
-0
.0
6)
Fe
rt
iQ
oL
 t
ot
al
0.
25
*
(0
.1
6-
0.
34
)
H
A
D
S
 A
nx
ie
ty
-0
.2
2*
(-
0.
30
-
-0
.1
3)
H
A
D
S
 D
ep
re
ss
io
n
-0
.1
8*
(-
0.
27
-
-0
.1
0)
Fe
rt
iQ
oL
 s
ub
sc
al
es
:
  
  
 E
m
ot
io
na
l
0.
18
*
(0
.0
9-
0.
27
)
  
  
 M
in
d-
B
od
y
0.
22
*
(0
.1
3-
0.
30
)
  
  
 R
el
at
io
na
l
0.
15
*
(0
.0
6-
0.
23
)
  
  
 S
oc
ia
l
0.
24
*
(0
.1
5-
0.
33
)
W
om
en
’s
 le
ve
l o
f 
ed
uc
at
io
n
-0
.2
3*
(-
0.
40
-
-0
.0
6)
-0
.2
2*
(-
0.
39
-
-0
.0
5)
-0
.2
4*
(-
0.
42
-
-0
.0
6)
-0
.2
2*
(-
0.
40
-
-0
.0
5)
-0
.2
3*
(-
0.
41
-
-0
.0
6)
-0
.2
2*
(-
0.
39
-
-0
.0
4)
-0
.2
2*
(-
0.
39
-
-0
.0
4)
Ty
pe
 o
f 
tr
ea
tm
en
t
0.
43
*
(0
.2
3-
0.
64
)
0.
41
*
(0
.2
1-
0.
62
)
0.
42
*
(0
.2
1-
0.
63
)
0.
42
*
(0
.2
1-
0.
63
)
0.
41
*
(0
.2
1-
0.
62
)
0.
41
*
(0
.1
9-
0.
62
)
0.
43
*
(0
.2
2-
0.
64
)
IC
C
0.
17
0.
12
0.
15
0.
14
0.
13
0.
13
0.
14
0.
12
R
2
0.
00
0.
13
0.
12
0.
10
0.
09
0.
11
0.
08
0.
13
45HOW PATIENT-CENTRED CARE RELATES TO PATIENTS’ QUALITY OF LIFE AND DISTRESS
2
However, our results might point at the importance of integrating QoL aspects 
into care delivery and paying attention to anxiety and depression symptoms to 
improve patient-centredness and quality of care. For instance, when adjusted for 
patient characteristics, the Social subscale of the FertiQoL appeared to be related 
the most to patient-centredness of care. This might imply that patients without 
social support from family rely more heavily on the support provided at the fertility 
clinic. There are some studies supporting this hypothesis: less family problems 
were encountered and less psychosocial support was needed when patients’ 
satisfaction with care was high.17,18 These findings stress the importance of a 
comprehensive approach when providing care to patients experiencing infertility. 
This can also be underlined by our findings that only 12–15% of the variance 
in patient-centredness was attributable to differences between the participating 
fertility clinics. Apparently, more than 80% of the variance in patient-centredness 
is attributable to other elements, which emphasizes the comprehensiveness of 
this concept. 
Another more practical implication to these results involves the question of 
whether we should adjust fertility clinic’s patient-centredness levels for QoL and 
distress when reporting. In literature, it is not always recommended to do so, 
as adjustment has a small effect on hospital comparisons mostly.19-21 However, 
if comparisons on the PCQ-Infertility involve groups known to differ on QoL and/
or anxiety and depression, then adjustment for these variables will be required. 
Second, interpretation of the association the other way around (i.e. more 
patient centred care is related to a higher QoL and lower levels of anxiety and 
depression) suggests that a holistic approach to care, including patient-centred 
care, could potentially reduce short-term effects of treatment on concentration 
and interference with day-to-day activities (items in Mind–Body domain) or 
feelings of isolation (items in Social domain). In other health-care areas, 
researchers showed the beneficial effect of patient-centred care on several 
clinical, psychological and even economical outcome measures22-25, for instance, 
improved well-being and reduced costs.25,26 Within a fertility care setting, it would 
be valuable to investigate if more patient-centred care would lead to lower drop-
out from treatment rates, which are often substantial.27-30 By tailoring care more 
specifically to the individual patient and taking into account the patient’s wishes 
and needs, we might take away some of the emotional burden of infertility and 
accompanying treatments.5,6,31
The results of this study are in line with previous studies on the relationship 
between patients’ evaluations of care and their mental health status in fertility 
care in terms of anxiety and depression.21,32 Also in other health-care areas (e.g. 
medical psychology), researchers described interactions between affect and the 
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ability of patients to evaluate different situations in care. Affective states play 
an important role in people’s interpersonal behaviours and ability to disclose 
personal information.9,12 On the one hand, this takes place by priming access to 
only mood-consistent information in memory (e.g. happy mood primes access 
to happy memories). On the other hand, this occurs by influencing the kind of 
processing strategies people use: patients suffering from a sad mood are more 
influenced by external social norms and behaviour of, for example, their partner. 
This results in a more cautious and reciprocal disclosure of personal information.9 
For fertility care, this could mean that more anxious and depressive patients 
might remember more bad experiences with care, underpinning our results, and 
will also be more cautious in sharing their experiences with care providers.33 One 
important difference between previous studies and ours should also be noted: 
the PCQ-Infertility is a validated measurement instrument assessing experiences 
with care instead of satisfaction.5 Patients’ experiences are believed to map the 
quality of care from a patient’s perspective more accurately.34,35
This study has several strengths. First, the large, randomly sampled and diverse 
study population, together with the high response rate (74%), ensures the 
representativeness of the Dutch population experiencing infertility. Second, 
we conducted a multilevel regression analysis. The clustered nature of our 
data on patients’ experiences makes multilevel analysis the preferred method 
for identifying determinants.20 Some potential weaknesses are also worth 
considering. First, due to the cross-sectional study design, we cannot draw any 
conclusions on causality. To evaluate the actual effect that patients’ QoL has 
on the level of patient-centredness would be an interesting subject for future 
prospective research. Second, the PCQ-Infertility was filled out by the patient 
couple, whereas the FertiQoL and HADS were completed by the woman only. This 
discrepancy has to be taken into account when interpreting our results. Several 
authors reported that men feel marginalized and overlooked in fertility care36,37, 
although their QoL is mostly higher than that of women.38-40 The present study 
was nested in another, because we wanted to reduce the burden for couples of 
filling out such an amount of questionnaires. However, for future research, it is 
desirable to include men as well, as knowledge on men’s care experiences are 
also needed to design and develop interventions to improve fertility care services. 
Third, in this study, we adjusted our results for two patient characteristics, 
known to be associated with patient-centred fertility care. It would have been 
valuable if we had also included organizational determinants into the multilevel 
model, as previous research showed that patients’ experiences with care are 
associated with clinic factors.21,41 For instance, providing patients support from a 
nurse specializing in infertility or granting patients access to their own medical 
records is a proven practical way of improving patient-centredness of fertility 
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care services.41 The interaction between these types of possible determinants and 
patients’ well-being could therefore provide us with valuable information on how 
to improve our fertility care services. However, these organizational aspects were 
not available in the present study.
In conclusion, associations exist between the level of patient-centredness in 
fertility care and patients’ QoL and their levels of anxiety and depression. This 
reflects that paying attention to these patient-related variables and more tailored 
care could lead to positive well-being and care experiences and improved patient-
centredness of care.
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Abstract
Objectives
To study the possible differences between women and their partners’ experiences 
with patient-centred fertility care.
Methods
We performed this cross-sectional study within 32 Dutch fertility clinics. A 
total of 1620 infertile women and their partners, under treatment in one of the 
participating clinics, were randomly selected to participate in this study. Main 
outcome measure was the level of patient-centredness, measured with the 
validated Patient-centredness Questionnaire-Infertility (PCQ-Infertility). 
Results
Questionnaires from 696 women and 520 partners could be analyzed. No 
significant difference in PCQ-Infertility total score was found between women and 
their partners. The partners scored significantly higher on the subscales ‘Respect 
for patients values’ and ‘Staff’s competence’ compared to their women.
Conclusions
Patients’ experiences with fertility care are only slightly different between women 
and their partners. This can be valuable in the process of improvement of patient-
centred fertility care, one of the core dimensions of quality of care.
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Introduction
Infertility has a great impact on the infertile couple.1-4 In general, patients have 
to undergo a long lasting period of fertility work up and treatment, which can be 
a physical and psychological burden to them.1,5 Therefore, every fertility clinic 
should focus more on their patients’ preferences and needs.6 Providing patient-
centred care, being one of the core dimensions of quality of care6, can improve 
patients’ experiences with fertility care by building caring relationships between 
patients and professionals7,8, increase patients’ quality of life (QoL)9,10 and possibly 
decrease dropout rates.11
Only a few studies explored specific patients’ fertility care experiences, by 
measuring the level of patient-centredness.12-16 All studies showed remarkable 
room for improvement within fertility care.12-16 For example, patients expressed a 
need for more written information about the treatment13,15, and more emotional 
advice and support.12,13,16 Moreover, infertile women expressed the wish for a 
more couple-centred approach.15 Providing care to both members of the infertile 
couple seems obvious, as infertility is the perfect example of a shared condition 
concerning both partners.17-19 Therefore, it is remarkable that available fertility 
care research typically includes infertile couples as a whole20-22 or women 
alone.10,15,16,23-25 Partners seems to be a forgotten party.17-19 Especially if we aim at 
improving the level of patient-centred fertility care, we should primarily identify 
possible differences in preferences and needs between women and partners. This 
is underlined by the results of Malik et al., showing a clear wish of partners also 
to discuss their feelings and concerns regarding their experiences with fertility 
care.19 
Gender differences in patients’ experiences with care are rarely evaluated in 
a fertility care setting. Only a few studies have explored gender differences in 
patients’ satisfaction in a fertility care setting.12,13,26 Unfortunately, satisfaction 
surveys often provide an overoptimistic picture of patients’ perception of 
healthcare.27,28 Getting insight into more objective patients’ experiences with care 
by measuring the level of patient-centredness would provide more useful and 
meaningful information. An appropriate and reliable instrument to achieve this 
goal is the Patient-centredness Questionnaire-Infertility (PCQ-Infertility), which 
was recently developed and validated.29 
Therefore, the main aim of the current study is to compare experiences of women 
and their partners with patient-centred fertility care using the PCQ-Infertility. 
Results of this study will provide more insight into the possible different preferences 
and needs of infertile women and their partners. Moreover, our results can guide 
the development of an improvement strategy for more patient-centred fertility 
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care, with accurate adjustment for both members of the infertile couple.
Materials and Methods
Study design
This cross-sectional study was nested within the before measurement of a 
randomized controlled trial, which aims to improve the level of patient-centredness 
of Dutch fertility care using a multifaceted approach. For more information on this 
study, we refer the reader to Huppelschoten, et al.30
Setting
In the Netherlands, fertility care is provided by three different types of clinics 
based on the kind of treatment they offer. Almost all clinics are part of a hospital 
and carry out initial fertility assessment, ovulation induction (OI) and intra-uterine 
insemination (IUI). A limited number of clinics can also start and monitor the In 
Vitro Fertilization (IVF) and Intra-cytoplasmic Sperm Injection (ICSI) treatment, 
including the ovum pickup. The laboratory phase of IVF and embryo transfers 
has to occur in one of the thirteen licensed clinics; eight university hospitals, 
four general hospitals, and one private clinic. Almost all Dutch fertility clinics 
are national health services funded. Every Dutch citizen has a basic insurance 
coverage, which covers treatment and medication costs for OI, IUI, and three 
cycles of IVF/ICSI per episode. 
Study population
The study was performed in a Dutch infertile patient group, being under treatment 
in one of 32 Dutch clinics. To include a representative patient group, clinics were 
asked to extract the address files of all patients who underwent at least one 
cycle of Medically Assisted Reproduction (MAR) (e.g., OI, IUI, IVF, and ICSI) in 
their clinics in the past three months (spring-summer 2011) from their diagnosis 
treatment combination coding system. From this list of patients, we took a 
computerized random sample of patients which was stratified according to the 
clinic size, ranging from 25 couples for smaller clinics to 75 couples for the largest 
IVF centres. As a result, 1620 couples were selected to participate in our study. 
Both members of the couple were invited to participate in the study individually. 
Couples of which the woman was pregnant while completing the questionnaire 
were excluded from analyses, due to a risk of confounding.29 
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Data collection
Data collection was performed using a questionnaire to measure the level of 
patient-centred fertility care. Selected women and their partners received a letter 
in which they were invited to complete an online questionnaire set, accessible by 
a personal code. Both the women and partners were asked explicitly to complete 
the questionnaire separately. Participation was voluntary and anonymous. Patients 
received a reminder card two weeks after the initial mailing. Another three weeks 
later, non-responders received a reminder with the additional option to complete 
a paper version of the questionnaire.31
Questionnaire
The questionnaire consisted of two parts; the first part was the Patient-centredness 
Questionnaire – Infertility (PCQ-Infertility), a validated instrument to assess 
clinic’s level of patient-centredness by measuring patients’ experiences with 
fertility care.29 Development of this questionnaire was based on the models of 
patient-centred care of both the Picker Institute and the Institute of Medicine.6,32 
The questionnaire consists of 46 items, covering seven subscales: 1) Accessibility 
of care (e.g. ‘Was it a problem for you to contact staff if you had any questions?’); 
2) Information provision (e.g. ‘Did you receive an overview of your treatment 
plan with a time schedule?’); 3) Communication (e.g. ‘How often did your 
physician listened to you?’); 4) Respect for patients’ values (e.g. ‘How often did 
your physician show an interest in your personal situation?’); 5) Continuity and 
transition of care (e.g. ‘How often did you have an appointment with the same 
physician?’); 6) Patient involvement (e.g. ‘Was decision-making shared with you, 
if preferred?’); and 7) Staff’s competence (e.g. ‘How often was your physician 
well-prepared for an appointment?’). A higher score on the total PCQ scale or on 
one of the subscales (range 0-3) implicates a higher level of patient-centredness. 
Further details on the validation study of the PCQ-Infertility are described in Van 
Empel et al.29
The second part of the questionnaire consisted of eighteen additional individual 
and couple background questions. These questions were selected as potential 
case-mix adjusters, based on general and fertility care literature as possibly being 
associated with patient-centred care.21,29,33-35 Background questions included 
general questions (e.g. age, ethnicity), questions about patients’ emotional 
status (e.g. consumption of emotional support in the last three months, recently 
experienced life-time events) and questions about past and current treatments 
(e.g. duration of infertility, diagnosis). Only the women answered the questions 
about the couple characteristics to prevent incompatible answers from women 
and their partners. We assumed that the women were most capable of answering 
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these couple questions as most questions were about the diagnosis and history 
of fertility treatments. 
Ethical approval
The institutional ethics committee of Radboud University Nijmegen Medical Centre 
provided ethical approval for this research (CMO nr 2011/034).
Data analyses
First, we tested whether responding and non-responding partners in our study 
differed significantly on the couple characteristics that were gathered in our study 
(i.e. being a lesbian couple; frequency of visiting the clinic as a couple; median 
duration of relationship, infertility and experience in fertility care; net monthly 
family income; diagnosis and treatment type). Chi-square tests and independent 
t-tests were used for categorical and continuous variables, respectively to 
compare women with a partner as responder (‘complete couples’) to women with 
a partner as non-responder (‘incomplete couples’). 
Data analyses of the levels of patient-centredness within the infertile couple started 
with a three-step evaluation to determine if case-mix adjustment was necessary. 
First, a series of univariate regression analyses were performed with the PCQ-
Infertility total score as dependent variable. All background characteristics acted 
as the independent variables. Variables with P<0.15 in the univariate analysis 
were selected as potential case-mix adjusters. Second, it was tested if the 
interaction between these background characteristics and gender significantly 
related to the PCQ-Infertility score. If so, also these interactions were selected 
as potential case-mix adjusters. Third, correlation analyses with Spearman’s ρ 
were performed to evaluate collinearity between the selected characteristics. In 
case of two strongly correlating variables (ρ>0.60), the clinically most relevant 
characteristic was kept.
Subsequently, the main analysis was performed to investigate differences in 
experiences with patient-centred fertility care within the infertile couple. As both 
members of the infertile couple will be affected by the unfulfilled child wish, it is 
more powerful to investigate intra-couple experiences with fertility care instead 
of comparing a group of infertile women and partners separately.17,18 Therefore, 
analysis was performed with the infertile couple as the unit of analyses. Data 
were structured so that each line contained data for one individual, with a variable 
included that defined the couple. Multilevel multivariate regression analyses with 
manual backward elimination was carried out with the individual (level 1) nested 
within the couple (level 2). The total scores and corresponding subscale scores of 
the PCQ-Infertility acted as the dependent variable. Being a women or a partner 
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acted as the independent variable. Significance for multivariate analyses was set 
at P<0.05. Analyses were performed using SPSS (version 18.0 for Windows®, SPSS 
Inc., Chicago, IL, USA). 
Results
In total, 946 women (response rate 58%) and 670 partners (response rate 
41%) of the 1620 invited couples completed the questionnaires. A total of 250 
women and 150 partners (25%) were already pregnant while completing the 
questionnaire. As a result, 1216 questionnaires were eligible for analyses, 696 
from the women and 520 from the partners. Due to the possibility to correct for 
incomplete couples, it is legitimate that the final sample contained less partners 
than women. 
Table 1 presents the patient and couple characteristics. Non-responder analyses 
showed significant differences for only one couple characteristic: couples of which 
both members participated in the study visited the clinic significantly more often 
as a couple, than couples of which only the women participated in the study (74% 
vs. 26%, respectively; p-value=0.01). 
Table 2 presents the PCQ-Infertility total and subscale scores, stratified by women 
and partners. The median total score on the PCQ-Infertility was 2.23 (range 
0.50-2.98) for women and 2.30 (range 0.56 – 2.98) for partners. Of the initial 
eighteen background characteristics, twelve were associated (P<0.15) with the 
PCQ-Infertility total score. Moreover, the interactions between three background 
characteristics (ethnicity, duration of relationship and treatment type) and gender 
were associated with the PCQ-Infertility total score. These results from univariate 
analysis are shown in table I, column 3. Due to collinearity (p=0.818), the couple 
characteristic ‘median duration of infertility’ was selected at the expense of the 
couple characteristic ‘median duration of fertility care experience’. As a result, 
eleven background characteristics and three interactions were selected as case-
mix adjusters in the final multivariate analysis. 
Table 3 describes the results of the multilevel multivariate regression analysis 
with manual backward elimination. The background characteristics ‘professional 
emotional support’, ‘number of hospital visits per month’ and ‘visiting the hospital 
as a couple’ had no statistically significant impact on any outcome variable and 
are therefore not presented (p>0.05). Table 3 shows no significant difference in 
PCQ-Infertility total scores between women and their partners, when adjusted 
for age, ethnicity, actual life-time events, duration of relationship and treatment 
type. Furthermore, in two out of seven subscales significant differences within 
the infertile couple were found: the PCQ-Infertility subscale ‘respect for patients 
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values’ (B = 0.133; 95% CI = 0.066 – 0.201) and the subscale ‘staff’s competence’ 
(B = 0.266; 95% CI = 0.072 – 0.460) were significantly higher scored by partners 
than by women.
Table 1
Patient and couple characteristics and their association with PCQ-
Infertility total score in univariate analysis
8 | CHAPTER 3
Table 1
Patien d couple characteristics and their assoc ation with PCQ-Infertility total 
sco e in univariate analysis
a High level of education = higher professional education or university.
b Recent experienced (last three months) life time event, e.g. financial, work or relational problems.
c Couples visiting the fertility clinic most of the time as a couple instead of the woman alone.
d Low semen quality.
e Irregular ovulation, polycystic ovary syndrome, tubal factor, endometriosis, mucus hostility
f E.g. both male and female infertility diagnosis found, or unexplained infertility. 
g Non-ART included ovulation induction and intrauterine insemination with or without controlled ovarian 
stimulation.
h Assisted reproductive technology (ART), encompassed IVF, IVM, ICSI, cryopreservation and testicular sperm 
extraction.
* Characteristics associated with PCQ-Infertility total score (p<0.15) and therefore allowed in multivariate 
analysis.
^ Interactions between these characteristics and gender were significantly associated (p<0.15) with the PCQ-
Infertility total score. 
Patient characteristics Women 
n=696
Men 
n=520
Univariate 
analysis
Median age (years, range) 33.0 (21-44) 35.0 (25-57) <0.01*
Dutch ethnic background (%) 86.8 91.3 <0.01*/^
High level of educationa (%) 50.0 48.9 0.346
Professional emotional support (%) 12.8 5.2 <0.01*
Medical history (%) 14.0 11.6 0.10*
Life-time eventsb (%) 10.7 9.2 0.10*
Being unemployed (%) 10.1 3.2 0.34
Reported ill at work last 3 months (%) 34.4 15.5 0.18
Median hospital visits per month (nr, range) 4.0 (0-17) 2.0 (0-21) 0.05*
Median travel time (minutes, range) 20.0 (2-161) 20.0 (2-120) 0.57
Couple characteristics
Lesbian couples (%) 1.4 0.81
Mostly visiting hospital as couplec (%) 54.7 0.01*
Median duration of: 
     relationship (months, range) 113.0 (14-358) <0.01*/^
     infertility (months, range) 34.0 (1-151) <0.01*
     fertility care experience (months, range) 18.0 (1 -131) 0.01*
Net monthly family income (Euros, range) 3500 (300-21.677) 0.18
Diagnosis (%)
     Male factord / Female factore / Otherf     21.6 / 31.2 / 47.2 <0.01*
Treatment type (%)
     Non-ARTg – ARTh     48.7 / 51.3 <0.01*/^
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Table 2 
Median (range) scores PCQ-Infertility stratified by women and partners
Discussion
This study shows that infertile women and their partners evaluate their overall 
experiences with patient-centred fertility care comparable, with only small 
differences. This is an important finding as patient-centredness of fertility care is 
a significant dimension of quality of care and needs improvement.2,12 Previously, 
studies often focused on the women of the infertile couple only or included the 
infertile couple as a whole. In our research, we have given a separate voice to 
the infertile partner as well.
It is interesting how these comparable experiences within the infertile couple can 
be more understood. Of course, both women and partners are in fact equally 
affected by the unfulfilled desire for a child.19 This is supported by similar overall 
levels of QoL found in both partners of the infertile couple.17 The relation between 
the findings about QoL and patients’ experiences with fertility care was studied 
by Aarts et al.10, showing a significant association between patient-centredness in 
fertility care and the patients’ QoL, anxiety and depression.10 Apparently, women 
and partners having equal levels of QoL, report similar experiences with patient-
centred fertility care. As we are discussing cross-sectional studies10,17, associations 
can also be shown the other way around: women and their partners reporting 
similar experiences with patient-centred fertility care, have equal levels of QoL. 
Most importantly for our study is the understanding that next to equal levels of 
QoL, also comparable levels of patient-centred fertility care are reported within 
the infertile couple. This is especially interesting in the area of fertility care, as it 
has been shown that couple’s agreement increases the ability to manage stressful 
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Table 2 presents the PCQ-Infertility total and subscale scores, stratified by women and 
partners. The median total score on the PCQ-Infertility was 2.23 (range 0.50-2.98) for women 
and 2.30 (range 0.56 – 2.98) for partners. Of the initial eighteen background characteristics, 
twelve were associated (P<0.15) with the PCQ-Infertility total score. Moreover, the 
interactions between three background characteristics (ethnicity, duration of relationship and 
treatment type) and gender were associated with the PCQ-Infertility total score. These results 
from univariate analysis are shown in table I, column 3. Due to collinearity (p=0.818), the 
couple characteristic ‘median duration of infertility’ was selected at the expense of the couple 
characteristic ‘median duration of fertility care experience’. As a result, eleven background 
characteristics and three interactions were selected as case-mix adjusters in the final 
multivariate analysis. 
Table 2 
Median (range) scores PCQ-Infertility stratified by women and partners
Table 3 describes the results of the multilevel multivariate regression analysis with manual 
backward elimination. The background characteristics ‘professional emotional support’, 
‘number of hospital visits per month’ and ‘visiting the hospital as a couple’ had no statistically 
significant impact on any outcome variable and are therefore not presented (p>0.05). Table 3 
shows no significant difference in PCQ-Infertility total scores between women and their 
partners, when adjusted for age, ethnicity, actual life-time events, duration of relationship 
and treatment type. Furthermore, in two out of seven subscales significant differences within 
the infertile couple were found: the PCQ-Infertility subscale ‘respect for patients values’ (B = 
0.133; 95% CI = 0.066 – 0.201) and the subscale ‘staff’s competence’ (B = 0.266; 95% CI = 
0.072 – 0.460) were significantly higher scored by partners than by women.
Women Partners
PCQ- Infertility total (0-3) 2.23 (0.50 – 2.98) 2.30 (0.56 – 2.98)
Accessibility of care 2.50 (0.00 – 3.00) 3.00 (0.00 – 3.00)
Information provision 2.18 (0.00 – 3.00) 2.27 (0.00 – 3.00)
Communication 2.67 (0.14 – 3.00) 2.71 (0.14 – 3.00)
Respect for patients’ values 2.00 (0.00 – 3.00) 2.17 (0.00 – 3.00)
Continuity and transition of care 2.33 (0.00 – 3.00) 2.42 (0.00 – 3.00)
Patient involvement 1.79 (0.14 – 3.00) 1.86 (0.14 – 3.00)
Staff’s competence 2.50 (0.67 – 3.00) 2.50 (0.50 – 3.00)
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events, including the experience of infertility.36 Moreover, our results can be of 
use in future studies about patients’ experiences with fertility care. Including 
only one member of the infertile couple in these studies might be sufficient, 
as experiences within the couple are nominally comparable. Finally, our results 
should be taken into consideration when developing an improvement strategy for 
more patient-centred fertility care. 
Although the results mentioned before count for the overall level of patient-
centredness, differences were found on two subscales of patient-centred care. 
Partners reported significantly better experiences at the subscales ‘Respect for 
patients’ values’ and ‘Staff’s competence’ (4.4% and 7.5% better, respectively). 
Whether these differences are clinically relevant is debatable, as methods to 
determine the minimal clinically important difference (MCID) are never studied 
at the level of patient-centred care at all.37,38 However, if we do consider its 
relevance for daily practice, we should put these results in a broader perspective. 
In contrast to our study, no differences in patients satisfaction were found 
between infertile women and partners in two other studies14,26, and one study 
reported even higher satisfaction rates of women compared to partners.21 As 
these studies used the more subjective and general outcome measure ‘patient 
satisfaction’27,28 and did not determine differences within the infertile couple17, 
these results are scarcely comparable to our research. Based on our results, we 
can state that both members of an infertile couple are merely in agreement about 
their experiences with fertility care, but the small differences within the couples 
underline the uniqueness of a person and should always be taken into account in 
daily practice.
The main strengths of our study are the large randomly sampled diverse study 
population, the inclusion of infertile partners as a whole and the presentation 
of paired results. This methodology enables us to draw conclusions about the 
couples’ experiences instead of only individual experiences, being very important 
in a fertility care setting.17,18 In addition, it is shown that patient-centredness 
relates to different background variables.21,29,33-35 Therefore, controlling for more 
than ten different, related patient en couple characteristics enhances our study 
results. To the best of our knowledge, this is the first study evaluating the level 
of patient-centred fertility care within the infertile couple.
Some potential weaknesses of our study should also be mentioned. First, the 
response rate differed substantially between women and partners. Because only 
41% of all partners completed the questionnaire, our results will be partially 
influenced by selection bias. This is unfortunate, but conform the trend of the last 
25 years, showing declining response rates of especially men in all health-care 
areas.39-41 As the response of our study still included more than 500 Dutch partners 
64 CHAPTER 3
from all regions in the Netherlands, we assume that representativeness of Dutch 
infertile partners is ensured. Moreover, additional analysis showed that couples of 
which only the woman participated in the study (‘incomplete couples’), only rarely 
visited the clinic as a couple. Partners who did complete the PCQ-Infertility are 
especially those capable to evaluate fertility care, because they visited the clinic 
more frequently. Second, now that we have the knowledge that both members of 
the infertile couple report their care experiences equally, does not mean they also 
experience it equally. It is plausible that men experience fertility care somewhat 
different than their women as they do not undergo the treatment physically and 
most often do not attend all meetings in the clinic. Nevertheless, the way they 
report these experiences is equal to their women’s reporting. This should be 
taken into account when interpreting the results of our study. Third, as validation 
of the PCQ-Infertility questionnaire was performed on the infertile couple as a 
whole, our PCQ-Infertility scores could not be compared to those determined in 
the validation study.29 To achieve this, additional validation of the PCQ-Infertility 
in women and partners separately is warranted. It would even be a suggestion 
for further research to develop an additional instrument focused only on partners 
in which gender-specific questions could be incorporated. It is shown in both 
fertility and general literature that the content of such a questionnaire differs 
from a questionnaire that focuses on women only.42,43 Fourth, because the PCQ-
Infertility questionnaire has been validated in the Netherlands, our results are only 
applicable to the Dutch infertile population. As it is already suggested by Dancet 
et al. that patients across Europe have similar views on patient-centred care22, an 
international questionnaire is expected not to differ considerably from the PCQ-
Infertility. Nevertheless, further research is essential before this statement can 
be underlined or rejected. 
In summary, this study stressed out that not only infertile women, but also their 
partners are important care consumers, capable of evaluating their experiences 
with fertility care. Our results showed that infertile women and their partners 
evaluate their overall experiences with patient-centred fertility care equally, but 
small differences at the subscale levels exist. These results can be used when 
we aim at the improvement of patient-centred fertility care, one of the core 
dimensions of quality of care. 
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Abstract
Background 
The psychological impact of infertility in patients negatively affects their quality of 
life (QoL) and is also related to increased discontinuation of treatment. Moreover, 
psychological factors might positively affect pregnancy rates. However, it is still 
unclear if differences in QoL and emotional status exist between infertile women and 
their partners. So far, research mainly focused on generic instruments to measure 
patients’ QoL in the area of fertility care. The main aim of this study is to explore 
whether QoL and the risk factors for emotional problems during and after treatment 
of infertile women differ from their partners.
Methods
A cross-sectional study of infertile couples within 32 Dutch fertility clinics. We included 
infertile women and their partners under any treatment and at any stage of treatment. 
Per clinic, 25–75 patients were randomly selected depending on clinic size. In total, 
1620 women and their partners were invited separately to complete the FertiQoL and 
SCREENIVF questionnaires to measure their level of QoL and risk factors for emotional 
problems during and after treatment, respectively. 
Results
A total of 946 women (response rate 58%) and 670 partners (response rate 41%) 
completed the questionnaire set. As 250 women and 150 partners were already 
pregnant, questionnaires from 696 women and 520 partners could be analysed. Women 
scored significantly lower on the FertiQoL total scores (B = -6.31; 95% confidence 
interval (CI) = -7.63-4.98) and three of the FertiQoL subscales (Emotional, Mind–
Body and Social) than their partners, indicating lower QoL. Scores on the SCREENIVF 
questionnaire were significantly higher for women (B = 0.22; 95% CI = 0.06-0.38), 
indicating that women are more at risk for developing emotional problems (and these 
factors differed from those of their partners) during and after fertility treatment than 
their partners. 
Discussion
Women have lower levels of fertility-related QoL, and more and differing risk factors 
for emotional problems during and after treatment than their partners. Although the 
number of participants is high (n=1216), the relatively low response rate, especially for 
partners (41%), may have influenced the results through selection bias. An analysis of 
non-responders could not be performed. The FertiQoL and SCREENIVF questionnaires, 
which have been validated only in women starting a first IVF cycle, should also be 
validated by studying partners. In addition, the SCREENIVF questionnaire has been 
validated in Dutch women only and further research in an international setting is 
71
4
DIFFERENCES IN QUALITY OF LIFE AND EMOTIONAL STATUS BETWEEN INFERTILE WOMEN AND THEIR PARTNERS
required. Our study results represent the Dutch infertile population as more than 
one-third of all Dutch clinics participated in the study. As the FertiQoL questionnaire is 
an internationally validated questionnaire already, these results can be put in a more 
broader and international perspective. 
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Introduction
Paying attention to the emotional burden of infertility is increasingly recognized in 
recent years.1,2 To understand the seriousness of patients’ emotional problems in 
fertility care, the emotional status of infertile patients has been studied frequently. 
As a result, being infertile and undergoing fertility treatments have been found to 
affect patients’ quality of life (QoL)1,3, which may be seen in terms of impairment in 
psychosocial well-being, sexual satisfaction and marital relationship.1,4-6 Moreover, 
the stigmatizing character of infertility hinders patients talking about their 
problem, resulting in a lack of social support.7,8 Further, unsuccessful treatment 
cycles raise patients’ levels of anxiety and depression1 and even increase a 
woman’s risk of suicide.9 All these psychological factors associated with infertility 
may influence patients’ decisions to discontinue treatment prematurely2,10,11 and 
might lower their chances to achieve pregnancy.12-14 Obviously, psychological 
interventions are important for infertile patients in order to improve their mental 
health, decrease drop-out rates and possibly increase pregnancy rates. 
Infertility is a shared condition, including a woman and her partner, therefore both 
members of the infertile couple should be studied individually before an accurate 
design for psychological interventions can be developed. Many studies that 
included both members of the infertile couple found differences in psychological 
responses to infertility, in which women appeared to experience more distress 
than partners.3,6,15-19 However, several other studies reported similar levels of 
QoL and distress in both infertile partners.20-23 Considering these mixed findings, 
more specific and clear research is needed to explore the emotional status of 
both members of the infertile couple. Moreover, most studies exploring gender 
differences in fertility care used generic instruments to measure patients’ 
QoL or levels of distress.24-26 It is suggested that these standardized generic 
instruments are unable to easily detect differences between infertile women 
and their partners, as they do not represent all the unique problems of patients 
experiencing infertility.26,27 The use of a disease-specific instrument, such as the 
FertiQoL questionnaire (measuring patient QoL)28 would be more valuable for this 
study purpose. Also the SCREENIVF questionnaire (identifying risk factors for 
emotional problems during and after treatment) could be of use, as it combines 
parts of both generic and disease-specific instruments.27 
The aim of this study is to explore the level of QoL and risk factors for emotional 
problems during and after treatment for both members of the infertile couple, 
using the FertiQoL and SCREENIVF questionnaires, respectively. A significant 
correlation between the results of both questionnaires for women has already 
been suggested by Aarts et al.29 Because it is known that women and their partners 
use different coping strategies during fertility care22, we wanted to determine 
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these correlations in our study as well as provide more insight into the possible 
differences between women and partners. Therefore, we had three different 
study questions: (i) What is the difference in QoL between infertile women and 
their partners, measured with the FertiQoL questionnaire? (ii) Do infertile women 
and their partners have different risk factors for emotional problems during and 
after treatment, as measured with the SCREENIVF questionnaire? (iii) What is the 
correlation between the results of the FertiQoL and SCREENIVF questionnaires for 
infertile women and partners separately? 
Materials and Methods
Setting and study design
This cross-sectional study was nested within of a large RCT (Clinicaltrials.gov 
NCT01481064), aimed at improving the level of patient-centredness of Dutch 
fertility care.30 During the baseline measurement of this trial, we collected data on 
patients’ QoL and risk factors for emotional problems during and after treatment. 
More than one-third of all Dutch clinics (i.e. 32 clinics) participated in the study. 
Patient population
This study was performed in a patient group under treatment in 1 of 32 participating 
Dutch clinics. Clinics extracted the address files of all patients (i.e. both 
heterosexual and lesbian couples) who underwent at least one cycle of assisted 
reproduction treatment (e.g. ovulation induction, intrauterine insemination, 
IVF and ICSI treatment) in their clinics in the last 3 months (spring–summer 
2011) from the Dutch coding system for medical diagnosis and treatment.31 All 
patient data were entered in a database and duplicate entries were removed. 
Subsequently, a computerized random sample was taken, including 25 patients 
for small clinics, 50 patients for medium sized clinics and 75 patients for large 
IVF clinics. Both members of the couple were invited to participate in the study 
individually. A total of 1620 questionnaires were sent to couples: one to the 
woman, one to her partner. Pregnant women and partners (n=400) were excluded 
from analyses, as most questions were no longer applicable then. 
Ethical approval
The institutional ethics committee of Radboud University Nijmegen Medical 
Centre provided ethical approval for this research to proceed (CMO nr 2011/034). 
Informed consent was not necessary for this study. 
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Data collection
We sent an invitation letter to the women and partners of the selected couples in 
which they were invited to complete their own online questionnaire set, accessible 
by a personal code. Participation was voluntary and anonymous. A reminder was 
sent after two weeks and non-responders had an additional option to complete a 
paper version of the questionnaire sent another three weeks later. 
Questionnaires
The first part of the questionnaire set consisted of 17 background questions. 
These questions were selected as potential case-mix adjusters, based on the 
literature as possibly being associated with patients’ QoL or distress.1,3,6,11 
Background questions included general questions (e.g. age, ethnicity), questions 
about patients’ emotional status (e.g. seeking professional emotional support in 
the last 3 months, adverse life-time events) and questions regarding past and 
current fertility treatments (e.g. duration of infertility, diagnostics category, type 
of treatment). The second and third part of the questionnaire set consisted of the 
FertiQoL and SCREENIVF questionnaires. 
FertiQoL
The internationally developed and validated FertiQoL questionnaire consists of two 
general items (i.e. ‘How would you rate your health?’ and ‘Are you satisfied with 
your quality of life?’) and two modules measuring QoL (the Core module and the 
optional Treatment module). In the validation study, the questionnaire has shown 
to be reliable with Cronbach reliability statistics ranging from 0.72 to 0.92.28 The 
Core module involves 24 fertility-specific items covering four subscales (i.e. six 
items per subscale); Mind–Body (e.g. ‘Do you feel drained or worn out because 
of fertility problems?’), Emotional (e.g. ‘Do your fertility problems cause feelings 
of jealousy and resentment?’), Relational (e.g. ‘Have fertility problems had a 
negative impact on your relationship with your partner’) and Social (e.g. ‘Are you 
satisfied with the support you receive from friends with regard to your fertility 
problems?’). The optional Treatment module assesses QoL related to the fertility 
treatment itself. In this study, the Dutch version of the FertiQoL Core module was 
used. A higher score on the total FertiQoL scale or one of the subscales (range 
0–100) indicates better QoL.28 
SCREENIVF
The recently developed SCREENIVF questionnaire is a screening instrument and 
consists of 31 questions covering five emotional maladjustment scales (i.e. five 
predefined risk factors for increased emotional problems during and after fertility 
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treatment). These scales include: Anxiety (seven items, e.g. ‘Worrying thoughts 
go through my mind’), Depression (seven items, e.g. ‘I have lost interest in my 
appearance’), Helplessness (six items, e.g. ‘My infertility problem limits me in 
everything that is important to me’), Acceptance regarding fertility problems (six 
items, e.g. ‘I can cope effectively with my infertility problems’) and perceived 
social support (five items, e.g. ‘When I feel sad, there is someone I can share 
my grief with’).27 The assessments of anxiety, depression and perceived social 
support are based on generic instruments [i.e. Hospital Anxiety and Depression 
Scale32 and Inventory of Social Involvement]33; the assessments of helplessness 
and acceptance are based on a fertility-specific instrument (i.e. Illness Cognition 
Questionnaire.16,34 In previous studies, all scales showed good Cronbach reliability 
scores, ranging from 0.82 to 0.92.27 The five scales have individual cut-off values 
to determine whether a patient is at risk at this specific domain. For anxiety and 
depression, the cut-off value is 9 and above. The cut-off score for helplessness is 
14 and above, it is 11 and less for acceptance and 15 and less for social support 
(based on 1 SD above or below the mean scores of IVF patients in a previous 
study.27 Based on these five subscales, total SCREENIVF scores range from 0 to 
5, indicating how many risk factors for increased emotional problems during and 
after fertility treatment are present.27 Moreover, a SCREENIVF at risk score (%) 
can be calculated, indicating the percentage of patients having at least one risk 
factor for emotional maladjustment during and after treatment. 
Statistical analysis
We described all median FertiQoL and SCREENIVF scores of women and partners 
and compared them using the t-test for independent samples (FertiQoL total and 
subscale scores and SCREENIVF total scores) and chi-quadrate tests (SCREENIVF 
at risk scores). 
Subsequently, we performed multiple univariate linear regression analyses to 
identify potential case-mix adjusters for our main analysis. All 17 background 
characteristics were included separately and characteristics with P < 0.15 in the 
univariate analyses were selected as case-mix adjusters and incorporated within 
the multivariate analyses. 
We performed our main analysis from a dyadic perspective with the infertile 
couple as the unit of analyses. By performing this kind of analyses, we were able 
to evaluate intra-couple differences, which is a more powerful methodology than 
comparing a group of infertile women and partners separately.22,23 We structured 
the database so that each line contained data for one individual, with a variable 
included that defined the couple. Then, a multilevel multivariate regression 
analysis with manual backward elimination was carried out with the individual 
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(level 1) nested within the couple (level 2). The FertiQoL total and subscale scores 
and the SCREENIVF scores acted as the dependent variables, being a women or a 
partner acted as the independent variable. Also the selected case-mix adjusters 
were included in this final analysis. Furthermore, we determined the explained 
variance by calculating R2, indicating the percentage of variance in FertiQoL and 
SCREENIVF scores that is attributable to patients’ gender (women and partners). 
Finally, we explored the correlation between the FertiQoL and SCREENIVF 
questionnaires by first calculating mean FertiQoL scores for both women and 
partners who had at least one risk factor in the SCREENIVF questionnaire (i.e. being 
‘at risk’) and comparing them using an independent samples t-test. Moreover, 
we performed correlation analyses with Spearman’s rho using the FertiQoL and 
SCREENIVF total scores for both women and partners separately. Significance for 
all multilevel analyses was set at P < 0.05. Analyses were performed using the 
Statistical Package for the Social Sciences (version 18.0 for Windows®, SPSS 
Inc., Chicago, IL, USA). 
Results
A total of 946 women (response rate 58%) and 670 partners (response rate 
41%) completed the questionnaire set. After removing the questionnaires 
from pregnant women and their partners (n = 400), 1216 questionnaires were 
eligible for analyses: 696 from the women and 520 from the partners. Our final 
sample therefore contained fewer partners than women, but we corrected for the 
incomplete couples in our analysis. 
Table 1 shows the background characteristics stratified by women and partners, 
including the results from the univariate analyses. All patient characteristics (n = 
10) and the couple characteristic ‘Diagnosis’ (i.e. male infertility, female infertility, 
both male and female infertility, unexplained infertility and other) were associated 
(P < 0.15) with both the FertiQoL total scores and the SCREENIVF scores. Because 
only the diagnostic category ‘unexplained infertility’ was significantly related 
to both questionnaires, we dichotomized this characteristic into ‘unexplained 
infertility’ versus ‘no unexplained infertility’, as shown in Table 1. Furthermore, 
the couple characteristics ‘Treatment’ was also related to the FertiQoL scores.
Table 2 presents the questionnaires’ total and subscale scores. At the SCREENIVF 
questionnaire, 63.8% of women (n = 385) and 45.6% of partners (n = 191) 
had at least one risk factor for emotional problems (P < 0.01). Women were 
significantly more at risk on the subscales ‘Anxiety’, ‘Depression’, ‘Helplessness’ 
and ‘Acceptance’ than their partners. About one-third of all women and partners 
were at risk at the subscale ‘Lack of social support’, but no significant differences 
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were found within the infertile couple. 
The results from the multilevel multivariate regression analysis are presented in 
Table 3. After case-mix adjustment, partners had a significantly higher score on 
the FertiQoL total scale and the subscales ‘Emotional’, ‘Mind–Body’ and ‘Social’ 
than the women (i.e. better QoL). On the ‘Relational’ subscale, no differences 
were found within the couple. Scores on the SCREENIVF questionnaire were 
significantly higher for women after case-mix adjustment, indicating that women 
had more risk factors for emotional problems during and after fertility treatment 
than their partners. Table 3 shows that 28% of the variance in FertiQoL total 
scores was attributable to patient gender. For the SCREENIVF scores, this variance 
was 16%. 
Further, when focusing only on women and partners having at least one risk 
factor on the SCREENIVF questionnaire, women had a lower FertiQoL total score 
than partners, which was a statistically significant difference (mean score for 
women: 63.3, SD 12.6; and partners: 71.6, SD 12.0; P-value ≤0.001). Finally, 
the Spearman’s rho correlation between FertiQoL and SCREENIVF scores was 
-0.73 for women and -0.60 for partners. 
Discussion
The present study showed that infertile women had significantly lower levels 
of QoL than their partners. Also three of the four FertiQoL subscales were 
significantly different within the infertile couple, with women having lower 
scores on all subscales. Moreover, women had more and different risk factors for 
developing emotional problems during and after treatment than their partners. 
Obviously, infertility impacts differently on women than on partners, which is 
an important finding, as previous studies showed incompatible results about 
the emotional status of infertile women and their partners. With the use of two 
recently developed, validated and disease-specific instruments, we have provided 
more insight into the impact of infertility on QoL and the emotional burden of 
infertility within the couple. 
Only one other study examined infertile couples’ QoL from a dyadic perspective, 
finding no differences within the infertile couple.23 A plausible explanation for 
this difference is the use of a fertility-specific questionnaire (i.e. FertiQoL) in our 
study, instead of the generic QoL assessment instrument (i.e. WHOQOL-BREF) 
used by Chachamovich et al.23 As we aimed at detecting QoL differences between 
women and partners in the setting of fertility care, the results of our study may 
seem more relevant to this specific area of health care. The R2 values that we 
found in our study underline this, as a significant proportion of variance in
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Table 2 
Unadjusted total and subscale scores of the FertiQoL and SCREENIVF 
questionnaires
FertiQoL and SCREENIVF scores was attributable to differences between women 
and their partners. 
We found several interesting differences within the infertile couple that are worth 
discussing. First, partners reported higher scores on the FertiQoL ‘Mind–body’ 
subscale. This could be understood, knowing that most partners do not attend all 
visits, and in most of the cases do not have to undergo the treatments physically. 
By including more partners undergoing Percutaneous Epididymal Sperm Aspiration 
(PESA) or Testicular Sperm Extraction (TESE) in further research, this hypothesis 
could be supported or rejected. Secondly, differences at the ‘Emotional’ and 
‘Social’ subscales might imply that women are affected emotionally in different 
ways by the stress of infertility compared with their partners. This corresponds to 
our findings on the SCREENIVF questionnaire, as women were vulnerable to more 
and other risk factors for emotional problems than their partners. Also other 
studies found similar results showing, for example, higher levels of anxiety and 
more depressive symptoms in women compared with men.18,35 
It would be valuable to understand why infertility impacts differently on women 
and partners. Peterson et al.22,36 mentioned the use of different coping strategies as 
a possible explanation. Women appeared to use greater amounts of confrontative 
coping, accepting responsibility and escape or avoidance coping, while partners 
tend to use more coping techniques, such as distancing, self-controlling and 
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Table 2
Unadjusted total and subscale scores of the FertiQoL and SCREENIVF questionnaires
Questionnaires
Women
(n = 696)
Partners
(n = 520) P-value 
Median (Range) Median (Range)
FertiQoL total score, median (range) 70.8 (14.6–96.9) 80.2 (35.4–100.0) <0.01
Emotional 52.5 (0.0–100.0) 79.2 (8.3–100.0) <0.01
Mind–Body 66.7 (0.0–100.0) 83.3 (29.2–100.0) <0.01
Relational 79.2 (2.5–100.0) 79.2 (25.0–100.0) n.s.
Social 75.0 (4.2–100.0) 83.3 (29.2–100.0) <0.01
SCREENIVF total score, median (range) 1.0 (0.0–5.0) 0.0 (0.0–5.0) <0.01
SCREENIVF patients at riska, % 63.8 45.6 <0.01
Anxiety 27.4 11.1 <0.01
Depression 9.9 5.3 <0.01
Helplessness regarding infertility 34.2 12.6 <0.01
Lack of acceptance regarding fertility problems 31.2 12.8 <0.01
Lack of social support 33.0 36.0 n.s.
Differences were calculated using t-tests for independent samples and χ2 tests for continuous and categorical 
variables. 
a Patients were identified as ‘at risk’ in case they were at risk on at least one of the five subscales.
Discussion
The present study showed that infertile women had significantly lower levels of QoL than their 
partners. Also three of the four FertiQoL subscales were significantly different within the 
infertile couple, with women having lower scores on all subscales. Moreover, women had more 
and different risk factors for developing emotional problems during and after treatment than 
their partners. Obviously, infertility impacts differently on women than on partners, which is 
an important finding, as previous studies showed incompatible results about the emotional 
status of infertile women and their partners. With the use of two recently developed, validated 
and disease-specific instruments, we have provided more insight into the impact of infertility 
on QoL and the emotional burden of infertility within the couple. 
Only one other tudy examined infertile couples' QoL from a dyadic perspective, f ding no 
differences within the infertile couple.23 A plausible explanation for this difference is the use of 
a fertility-specific questionnaire (i.e. FertiQoL) in our study, instead of the generic QoL 
assessment instrument (i.e. WHOQOL-BREF) used by Chachamovich et al.23 As we aimed at 
detecting QoL differences between women and partners in the setting of fertility care, the 
results of our study may seem more relevant to this specific area of health care. The R2
values that we found in our study underline this, as a significant proportion of variance in 
FertiQoL and SCREENIVF scores was attributable to differences between women and their 
partners. 
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planful problem-solving. Moreover, a partner’s coping pattern influences the 
woman’s ability to cope with the infertility and vice versa.22,36,37 In our study, 
we showed different correlations between the FertiQoL and SCREENIVF scores 
for women and partners, which could also indicate why women and partners 
differ. Because this correlation was slightly stronger in women than in partners, 
we might conclude that more risk factors for emotional problems in women (i.e. 
being at risk in the SCREENIVF) are related to the high impact of their infertility 
problem (i.e. low FertiQoL scores), while partners might be influenced by several 
other factors that were not included in the questionnaires (e.g. work-related 
problems, sexual problems). This is underlined by our additional analysis, showing 
lower FertiQoL scores in women having at least one risk factor on the SCREENIVF 
questionnaire, compared with partners being at risk for emotional problems. Also 
Wischmann et al.19 found similar results, as infertile women mainly suffered from 
childlessness and depression. However, distress in partners was mainly indicated 
by dissatisfaction with the partnership and sexuality.19 Based on our results, we 
might state that infertile women experience higher levels of distress than their 
partners. Moreover, women’s distress could be linked more to fertility-related 
problems than distress in partners, which should be taken into account in daily 
practice. 
In fertility care, the professionals’ decision as to whether a patient could benefit 
from additional psychosocial support is mainly based on ‘gut feeling’.27 To help 
them in this process, cut-off values of instruments such as the FertiQoL and 
SCREENIVF questionnaires are necessary to select especially those patients 
that are emotionally more affected by their fertility problem. The results of our 
study show that these cut-off values would differ remarkably between women 
and partners, underlining the necessity of validating both questionnaires for 
infertile partners as well. It would even be more valuable to develop an additional 
instrument for partners. It is shown in both the fertility and general literature that 
the content of such a questionnaire differs from a questionnaire that focuses on 
women only.26,38 For example, the content of a questionnaire for men experiencing 
infertility due to a male factor consisted of many questions about ‘sexual 
relationship’ and ‘gender identity’.26 Hence, the risk of developing emotional 
problems during and after treatment can be determined for both members of the 
infertile couple appropriately. This enables fertility care professionals to identify 
women and partners who could benefit from additional psychosocial support and 
to provide a more tailored psychosocial support. 
This study has several strengths. First, the large randomly sampled diverse 
study population ensures representativeness of the Dutch infertile population. 
Secondly, the presentation of paired results enables us to draw conclusions about 
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the differences in emotional status within the infertile couple.22,23 This is especially 
important in a fertility care setting, as infertility is a shared condition involving 
both members of the couple. Thirdly, we included two measuring methods by 
using an entire disease-specific questionnaire (i.e. FertiQoL questionnaire) and a 
combined questionnaire of disease-specific and generic elements (i.e. SCREENIVF 
questionnaire). The disease-specific elements are necessary to include all the 
unique problems of patients experiencing infertility. The generic elements of the 
SCREENIVF questionnaire enable us to generalize our results to a broader patient 
population as well. In addition, it should be noted that the two questionnaires 
also have some overlap and could measure some comparable concepts, such as 
emotional or social problems. Aarts et al.  already showed that the subscales of 
the FertiQoL questionnaire have a weak to moderate correlation with the anxiety 
and depression scales of the SCREENIVF questionnaire.28 
Some potential weaknesses of this study are also worth considering. First, the 
response rate differed substantially between women and partners. Because only 
41% of all partners completed the questionnaire, our results may be partially 
influenced by selection bias. This is unfortunate but confirms the trend of the last 
25 years, showing declining response rates, especially of men, in all healthcare 
areas.39-41 As the response of our study still included more than 500 Dutch 
partners from all regions in the Netherlands, we assume that representativeness 
of Dutch infertile partners is ensured. Non-responder analyses would have 
provided additional information about the level and direction of the potential 
bias. Unfortunately, we did not have the data to perform this kind of analysis. 
Secondly, we used the FertiQoL and SCREENIVF questionnaire to study women 
and partners, while both instruments are only validated in women starting their 
first IVF treatment. Moreover, as we aimed to explore possible differences within 
the infertile couple, instead of determining ‘cut-off values’, the use of these 
questionnaires is justified for our research question. However, we still suggest 
validating these questionnaires for partners as well in further research. Thirdly, 
the percentages of patients at risk at the SCREENIVF questionnaire differed 
substantially from the results of van Dongen et al.42 We found 64% of the women 
and 46% of the partners to be at risk, compared with one-third of all patients (i.e. 
women and partners) in the previous study.42 The different patient populations 
may explain these differences, as Van Dongen et al. included patients who were 
about to start their first IVF/ICSI cycle, while our patients received different 
treatments in all different phases.42 It is already known that a woman’s emotional 
response to IVF differs across the course of the treatment.16 Our results might 
point to a change, or even increase, on both women’s and partners’ emotional 
problems during treatment, which underlines the high psychosocial impact of 
infertility and its treatment as well as the need for adequate psychosocial support 
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in all treatment phases. In summary, infertile women have lower fertility-related 
levels of QoL than their partners. Moreover, women seem to be more at risk and 
have different risk factors for developing emotional problems during and after 
fertility treatment than their partners. This study showed that both members of 
the infertile couple are vulnerable to different sources of psychological stress, 
which underlines the importance of identifying risk factors for emotional problems 
for both members of the couple separately. Only then can infertile women and 
partners receive the tailored psychosocial support they need. 
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Abstract
Background
In fertility care, a significant proportion of patients do not achieve pregnancy 
because they discontinue treatment prematurely. Many studies have tried to 
identify factors predicting dropout, showing incompatible results. However, these 
studies mainly focus on factors at the treatment and patient level, while clinic 
factors have received little attention. Therefore, our main aim was to study 
whether clinic factors, including patients’ experiences with patient-centred care, 
are associated with dropout in fertility care.
Methods
This prospective, longitudinal study was nested within a large RCT, which aims 
to improve the level of patient-centredness of Dutch fertility care. Of the 1620 
infertile women who were invited to participate, the baseline measurement of 
the study (T0) included 693 women who completed a questionnaire about their 
experiences with patient-centred fertility care. The follow-up of the patients was 
1 year (T1). All included women suffered from infertility and were undergoing 
treatment in one of the 32 Dutch clinics involved in the trial. Levels of patient-
centredness were determined using the Patient-Centredness Questionnaire-
Infertility (PCQ-Infertility) at T0. Meanwhile, a professionals’ questionnaire was 
used to gather additional information on characteristics of the clinic (e.g. the 
number of patients per year or the presence of a fertility nurse). After one year, 
at T1 measurement, patients completed a questionnaire on their current status in 
fertility care, including their main reason for discontinuation if applicable. 
Results
A total of 693 non-pregnant women completed the questionnaire set at T0 and 
534 women (77.1%) provided consent for follow-up. At T1 measurement, 434 
women (81.3%) completed the questionnaire and 153 of these women (35.2%) 
continued treatment while 76 women (17.5%) dropped out. Another 175 women 
(40.3%) had achieved pregnancy and 30 patients (7.9%) were advised to 
discontinue treatment for medical reasons. Neither levels of patient-centredness 
nor the additional clinic characteristics differed significantly between dropouts 
and compliers. However, patients who did not receive assisted reproduction 
treatments (ART; e.g. underwent intrauterine inseminations) before they dropped 
out had significantly lower scores on the PCQ-Infertility subscale ‘Respect for 
patients’ values’ than patients who continued their treatment [odds ratio (OR) 
0.57; 95% confidence interval (CI) 0.34–0.95]. Patients who received ART and, 
subsequently, dropped out had higher scores on the PCQ-Infertility subscale 
‘Patient involvement’ than those who continued treatment (OR 2.39; 95% CI 
1.02–5.59).
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Conclusions
The results of this study provide a better insight into those factors influencing 
dropout from the perspective of factors in the clinic itself. Although most clinic 
factors were not related to dropout, clinic factors might be of use when predicting 
dropout for specific patient groups, such as patients receiving ART and non-
ART. Future research should involve an exploration of more specific predictors of 
dropout at the patient, treatment and clinic levels.
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Introduction
A successful fertility treatment is something every infertile couple is striving 
for. Unfortunately, a significant proportion of couples do not achieve pregnancy 
because of medical factors, but also because they discontinue treatment 
prematurely. The exact number of patients dropping out of fertility treatment 
varies across European studies and ranges from 17 to 70%.1-7 This wide range 
might be due to the conceptual issues around the definition of dropout and the 
methodological differences between studies.7,8 However, it still indicates that 
treatment dropout concerns many infertile patients. It is worrisome that these 
couples decide to give up their dream of becoming parents, because of the 
physical or psychological burden they encounter during treatment. Therefore, 
prognostic factors for dropping out should be identified to develop interventions, 
which target specifically those burdensome aspects of treatment.7-8
When considering the reasons why patients discontinue treatment, one could 
think of reasons related to the patients themselves (e.g. their well-being) 
or the kind of treatments they receive.8 Moreover, it might be expected that 
reasons related to the clinic itself, such as inadequate organization of care or 
poor communication skills of staff, influences patients’ decisions to discontinue 
fertility treatment prematurely. This is supported by the literature where, for 
example, inadequate information provision and coordination of care have been 
identified as reasons for dropout.9 Also a lack of empathy by the staff, poor 
listening skills1 and negative interactions with staff3 have been cited as reasons to 
discontinue treatment. Apparently, numerous clinic factors have been reported in 
connection with discontinuation8, but whether they could be used as a predictor 
of dropout has never been studied. It would be interesting to investigate this 
possible relationship through longitudinal research, as it shows us to what extent 
professionals could account for these factors in daily practice to prevent dropout. 
To identify clinic factors as potential predictors of dropout, standard clinic 
characteristics could be studied (e.g. clinic size and presence of specialized 
fertility nurses). Furthermore, it would be valuable to ask infertile patients 
themselves about their experiences with fertility care in a clinic to identify relevant 
and predictive clinic factors for dropout. The recently developed and validated 
Patient-Centredness Questionnaire-Infertility (PCQ-Infertility) could be used for 
this goal, as it measures patient-centredness from the patients’ perspective in 
seven different and concrete dimensions (e.g. accessibility of care, continuity and 
transition and professionals’ competence.10  Van Empel et al. already showed that 
patients change clinics because they experience a lack of patient-centred care. 
Whether patients dropout treatment because of a lower level of patient-centred 
fertility care is unknown.11 
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Therefore, the main aim of this study was to identify clinic factors, including 
patients’ experiences with patient-centredness in their clinic, as potential 
predictors of dropout in fertility care, in a prospective manner. Furthermore, 
previous studies have shown that barriers to the uptake of treatment for dropout 
are common to all types of treatment, while others are type-specific.6-7 Because 
van Empel et al. found a significant association between treatment type [i.e. 
assisted reproduction treatment (ART) and non-ART] and patient-centred care12, 
we wanted to study the relation between dropout and patient-centred care for 
these subgroups of patients as well. 
Materials and Methods
Study design
This prospective longitudinal study was nested within a large RCT (Trial registration 
number: Clinicaltrails.gov NCT01481064), which aims to improve the level of 
patient centredness of Dutch fertility care.13 During the baseline measurement 
of this study (T0), patients completed a questionnaire on their experiences 
with patient-centred care. We used a questionnaire for professionals to gather 
additional clinic characteristics as potential predictors of dropout. One year later 
(T1), patients who gave consent for follow-up received a questionnaire on their 
current status in fertility care. 
Setting
In the Netherlands, fertility care is provided by three different types of clinic 
based on the kind of treatment they offer. Almost all clinics carry out initial 
fertility assessment, ovulation induction (OI) and intrauterine insemination (IUI). 
A limited number of clinics can also start and monitor IVF and ICSI treatments, 
including the ovum retrieval. The laboratory phase of IVF and embryo transfers 
has to occur in one of the thirteen licensed fertility clinics. Almost all Dutch 
fertility clinics are funded by the National Health Service. Every Dutch citizen has 
a basic insurance coverage, which covers treatment and medication costs for OI, 
IUI and a maximum of three cycles of IVF/ICSI until couples achieve an ongoing 
pregnancy. 
Study population
We performed this study in infertile patients receiving treatment in one of 32 
participating Dutch clinics. All patients who participated underwent at least one 
cycle of medically assisted reproduction (MAR; e.g. OI, IUIs, IVF and ICSI). We 
only invited the women of the infertile couples to participate in our study as 
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a previous study has shown that patients’ experiences with fertility care are 
comparable between infertile women and their partners.14 Patients who were 
already pregnant at T0 were excluded from follow-up, as our research question 
did not concern this patient group. 
Data collection
T0 measurement
To include a representative patient group for T0 measurement, clinics were 
asked to extract from their medical records, the address files of all patients who 
underwent at least one cycle of MAR in their clinic in the previous 3 months 
(spring–summer 2011). From this list of patients, 25–75 patients per clinic were 
randomly selected depending on the clinic size. Selected women received a letter 
in which they were invited to complete an online questionnaire set, accessible by 
a personal code. Participation was voluntary and anonymous. Patients received 
a reminder card 2 weeks after the initial mailing. Another 3 weeks later, non-
responders received a reminder with the additional option to complete a paper 
version of the questionnaire.15 
Per clinic, one gynaecologist (i.e. our contact) received an online questionnaire 
for professionals by e-mail. All 32 gynaecologists received a standard reminder 
after 2 weeks, and we sent the non-responders an additional reminder 3 weeks 
later. 
T1 measurement
Only the patients who gave consent to follow-up were invited for the T1 
measurement (summer 2012). The first steps of questionnaire distribution were 
performed in the same way as at T0 measurement. Subsequently, an additional 
reminder was sent to the final non-responders to achieve as high a response 
rate as possible. The questionnaire at T1 consisted of questions about patients’ 
current status in fertility care. In cases of dropout, we asked for patients’ most 
important reason for discontinuation. To do so, we provided them with a list of 
10 different options for dropout, which was based on the literature (e.g. poor 
response, emotional reasons, ethical reasons or women’s age.6,7 In case of no 
valid options, patients had the possibility to add their personal most important 
reason for discontinuation. Only those patients who discontinued their treatment 
prematurely were identified as dropouts. However, patients who ended treatment 
because they have had the maximum of three IVF/ICSI cycles or had no more 
treatment options were not considered as dropouts. The compliers group consisted 
of patients who were still under treatment in their own clinic, or patients who had 
no more treatment options in their own clinic and, therefore, went to another 
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clinic. Patients who went to another clinic because they were unsatisfied with 
their clinic were excluded from analysis. 
Questionnaires at T0 measurement
Patients’ questionnaire
The questionnaire set for patients consisted of several background questions 
for case-mix adjustment and the PCQ-Infertility questionnaire. The background 
questions were based on both general and fertility care related issues described 
in the literature as possibly being linked to dropout and/or patient-centred 
care12,16-19, including issues related to the quality of life (FertiQoL questionnaire20) 
and risk factors for emotional maladjustment during treatment (SCREENIVF 
questionnaire21). 
The PCQ-Infertility is a validated instrument measuring patient-centredness 
of fertility care by asking patients about their experiences with care. This 
questionnaire is composed of 46 questions and contains 7 subscales, namely: 
accessibility (two items, Cronbach’s α = 0.64, e.g. ‘Was it a problem for you to 
contact staff if you had any questions?’); information (11 items, Cronbach’s α 
= 0.73, e.g. ‘Did you receive an overview of your treatment plan with a time 
schedule?’); communication (seven items, Cronbach’s α = 0.78, e.g. ‘How often 
did your physician take you seriously?’); respect for patients’ values (seven 
items, Cronbach’s α = 0.85, e.g. ‘How often did your physician show an interest 
in your personal situation?’); continuity and transition (seven items, Cronbach’s α 
= 0.66, e.g. ‘How often did you have an appointment with the same physician?’); 
patient involvement (three items, Cronbach’s α = 0.75, e.g. ‘Was decision-making 
shared with you, if preferred?’) and competence (six items, Cronbach’s α = 0.72, 
e.g. ‘How often was your physician well-prepared for an appointment?’). A higher 
score on the total PCQ scale or one of the subscales (range 0–3) indicates a 
higher level of experienced patient-centredness.10 
Professionals’ questionnaire
We used a questionnaire for professionals to gather the remaining clinic 
characteristics as potential predictors of dropout. The representative 
gynaecologists of all 32 participating clinics received a short online questionnaire 
with eight questions about their clinic. The selection of the clinic characteristics 
was based on the literature as possibly being related to patient-centred care12,16,17, 
and included the number of gynaecologists, the number of new fertility patients 
per year, presence of a separate waiting room for infertile patients (yes/no), a 
separate room for semen production (yes/no), specialized fertility nurse(s) (yes/
no), having a psychologist as part of the fertility team (yes/no), structured (e.g. 
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weekly) meetings to discuss all (new) patients within the team (yes/no) and 
execution of structured (e.g. yearly) quality measurements before the start of 
this study (yes/no). 
Ethical approval
The institutional ethics committee of Radboud University Nijmegen Medical Centre 
provided ethical approval for this research to proceed (CMO nr 2011/034). A 
written informed consent had been obtained at T0 from all participants. 
Data analysis
We first performed a power analysis using the model of Tosteson.22 We considered 
an odds ratio (OR) of 1.5–2.0 for 1 SD increase in exposure as clinically relevant, 
resulting in a minimum required number of 115 to 317 patients (α = 0.05, β = 
0.8). 
We categorized all patients into five groups depending on their current status in 
fertility care and compared all background characteristics between these groups. 
The five groups included (i) patients who had achieved pregnancy between T0 
and T1; (ii) patients who were still under treatment (i.e. compliers); (iii) patients 
who dropped out of treatment; (iv) patients who ended treatment for medical 
reasons (e.g. having the maximum of three IVF cycles, or poor prognosis) and 
(v) patients who were lost to follow-up. We used one-way analysis of variance 
and chi-quadrate tests to compare these groups on continuous and categorical 
patient characteristics, respectively. 
For further analyses, we used the data of groups 2 (i.e. compliers) and 3 (i.e. 
dropouts), as our research question concerned these patients only. Patient 
characteristics that showed significant differences between these two groups 
were taken up as case-mix adjusters in the final analysis. Subsequently, all clinic 
characteristics were included in multiple binary logistic regression analyses to 
evaluate them as a potential predictor of dropout. Compliers and dropouts acted 
as the dependent variable. 
For our additional analysis, we divided our patient group into patients undergoing 
ART and patients undergoing non-ART at T0. Then, we determined to what 
extent the treatment type and PCQ-Infertility total scores were related to each 
other, using linear regression analyses. In case of a significant correlation, we 
performed our previous analyses on these two groups separately. Significance for 
all analyses was set at P < 0.05. Analyses were performed using the Statistical 
Package for the Social Sciences (version 18.0 for Windows®, SPSS Inc., Chicago, 
IL, USA). 
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Results
At T0 measurement, 1620 women were invited to participate, of which 946 
completed the questionnaire (response rate 58.4%). After excluding 253 
pregnant women, 693 women were eligible for participation in the follow-up 
study. Of this group, 534 women (77.1%) provided consent for the follow-up. 
At T1 measurement, 434 women completed the questionnaire (response rate 
81.3%). Of these women, 175 (40.3%) had achieved pregnancy and 153 women 
(35.2%) continued treatment since T1 measurement. Of these women, 12 (7.8%) 
changed clinics because they were unsatisfied with the care they received in 
their clinic and were, therefore, excluded, leaving 141 patients in the compliers 
group. Further, a total of 76 women (17.5%) dropped out treatment and 30 
women (6.9%) had stopped because of medical reasons. Figure 1 presents the 
flowchart of this study. From the 76 women, who dropped out, 31 women (40.8%) 
mentioned emotional problems as their most important reason and 10 patients 
(13.2%) stated that they had relational problems. Also, female age increased the 
risk of birth defects (n = 10; 13.2%) and fundamental reasons (e.g. considering 
IVF as a step to far; n = 5; 6.6%) were mentioned as reasons for dropping out. In 
addition, as we included 217 patients in our main analysis, it seems we have no 
remarkable limitations in sample size considering our previous power calculation. 
All patient characteristics are presented in table 1, divided according to their 
current status in fertility care. Patients who ended treatment because of medical 
reasons were significantly older and less well educated, had longer experiences 
in fertility care and had undergone ART more often than patients in the other 
groups. Furthermore, patients who dropped out of treatment were significantly 
older than the patients who became pregnant, the compliers or the patients lost 
to follow-up. Female age was, therefore, taken up as a case-mix adjuster. 
Table 2 presents the results from the PCQ-Infertility, including all median PCQ-
Infertility total and subscale scores. Logistic regression analyses with adjustment 
for age showed that women’s PCQ-Infertility total and subscale scores do not 
differ significantly between dropouts and compliers. Additional analyses on the 
subgroup of patients who went to another clinic because they were unsatisfied 
(n = 12) did not show any differences with the compliers group on the PCQ-
Infertility total and subscales (data not shown). Table 3 shows the results from 
the additional clinic characteristics, which also do not differ between dropouts 
and compliers.
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Figure 1 
Flowchart of the longitudinal study of patient-centredness to identify 
factors, which predict dropout in fertility care
The results from the analyses of the non-ART and ART subgroups are presented 
in table 4. It was appropriate to perform these analyses as the PCQ-Infertility 
total scores were significantly related to the treatment type [β = -0.231; 95% 
confidence interval (CI) = -0.302 to -0.160; P = <0.001]. In the non-ART subgroup, 
a lower score on the PCQ subscale ‘Respect for patients’ values’ was significantly 
related to higher dropout (OR 0.57; 95% CI 0.34–0.95). In the ART subgroup, 
a higher score on the PCQ subscale ‘Patient Involvement’ was associated with 
higher dropout (OR 2.39; 95% CI 1.02–5.59). We found no significant differences 
within both subgroups for the additional clinic characteristics. 
Patients invited at T0
(n=1620)
Completed T0 
questionnaire
(n=946, 54.4%)
Pregnant women
(n=253, 26.7%)
Non-pregnant women
(n=693, 73.3%)
Consent T1
(n=534, 77.1%)
No consent T1
(n=159, 22.9%)
Status after one year
Dropouts
(n=76, 17.5%)
Medical reasons
(n=30, 6.9%)
Compliers
(n=153, 36.2%)
Pregnant
(n=175, 40.3%)
Lost to follow-up
(n=100, 18.7%)
Excluded 
Changing clinics because 
of dissatisfaction
(n=12, 7.8%)
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Table 2
The relation between the level of patient-centredness and dropout
Data presented as OR’s and 95% CI. Binomial logistic regression analysis was used to compare patients under 
treatment with patients who dropped out treatment. The results are adjusted for age.
Table 3
The relation between additional clinic characteristics and dropouts
Data presented as OR’s and 95% CI. Binomial logistic regression analysis was used to compare patients under 
treatment with patients who dropped out treatment. The results are adjusted for age.
Compliers
(n=141)
Dropout
(n=76)
Compliers versus
dropout
Median (range) Median (range) OR 95% CI
PCQ-Infertility (0-3) 2.24 (1.04-2.93) 2.18 (0.67-2.95) 0.73 (0.37 – 1.46)
Accessibility of care 2.50 (0.00-3.00) 2.50 (0.50-3.00) 1.07 (0.71 – 1.61)
Information provision 2.09 (0.60-3.00) 2.00 (0.00-3.00) 0.79 (0.49 – 1.30)
Communication 2.57 (0.57-3.00) 2.57 (0.14-3.00) 0.82 (0.47 – 1.43)
Respect for patients’ values 2.00 (0.14-3.00) 1.80 (0.00-3.00) 0.72 (0.49 – 1.05)
Continuity and transition 1.86 (0.67-3.00) 1.79 (0.43-3.00) 0.87 (0.52 – 1.46)
Patient involvement 2.33 (0.00-3.00) 2.67 (0.33-3.00) 1.24 (0.78 – 1.97)
Staff’s competence 2.50 (1.17-3.00) 2.50 (0.67-3.00) 0.80 (0.40 – 1.62)
Clinic characteristics
Compliers Dropout Compliers vs. dropout
(n=141) (n=76) OR (95% CI)
Number of patients per clinic
     Median (range) 444 (110–2600) 500 (110–2600) 1.00 (1.00 – 1.01)
Separate waiting room for infertile patients
     Number (%) 55 (39.0) 23 (30.3) 0.65 (0.35 – 1.19)
Specialized fertility nurses
     Number (%) 96 (68.1) 57 (75.0) 1.57 (0.82 – 3.02)
Regularly measuring clinic’s quality levels
     Number (%) 77 (54.6) 39 (51.3) 0.88 (0.50 – 1.56)
Structured meetings to discuss all patients
     Number (%) 116 (82.3) 67 (88.2) 1.80 (0.78 – 4.18)
Number of gynaecologists
     Median (range) 3 (1–7) 2 (1 –7) 0.81 (0.67 – 1.00)
Separate semen production room
    Number (%) 89 (63.1) 47 (61.8) 1.11 (0.61 – 2.02)
Presence of clinic psychologist(s)
     Number (%) 116 (82.3) 62 (81.8) 0.96 (0.46 – 2.03)
Table 2
The relation between the level of patient-centredness and dropout
Table 3
The relation between additional clinic characteristics and dropouts
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Discussion
This study shows that patients’ experiences with patient-centred fertility care 
are not related to dropout, as the PCQ-Infertility scores did not differ between 
patients who continue and patients who discontinue their fertility treatment. 
Also the additional clinic characteristics were not related to dropout. However, 
when focusing on subgroups of patients, the PCQ-Infertility subscale ‘Respect 
for patients’ values’ negatively predicted dropout in patients receiving non-ART. 
Moreover, the subscale ‘Patient involvement’ was a positive predictor of dropout 
in patients undergoing ART treatments. These are important findings as clinic 
factors have rarely been studied as potential predictors of dropout. Therefore, 
the results of this study provide more insights into fertility clinics’ characteristics 
that do and do not predict dropout and the direction (i.e. positive or negative) in 
which this prediction might be. 
It is remarkable that the level of patient-centredness that patients assign to their 
clinic was not related to dropout, since both qualitative and quantitative studies 
showed that infertile patients consider their clinic’s level of patient-centredness 
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The results from the analyses of the non-ART and ART subgroups are presented in table 4. It
was appropriate to perform these analyses as the PCQ-Infertility total scores were 
significantly related to the treatment type [β = -0.231; 95% confidence interval (CI) = -0.302 
to -0.160; P = <0.001]. In the non-ART subgroup, a lower score on the PCQ subscale 
‘Respect for patients’ values’ was significantly related to higher dropout (OR 0.57; 95% CI 
0.34–0.95). In the ART subgroup, a higher score on the PCQ subscale ‘Patient Involvement’ 
was associated with higher dropout (OR 2.39; 95% CI 1.02–5.59). We found no significant 
differences within both subgroups for the additional clinic characteristics. 
Table 4
Clinic characteristics and dropouts; differences between patients who received ART 
and non-ART
Data presented as OR’s and 95% CI. Binomial logistic regression analysis was used to compare patients under 
treatment with patients who dropped out treatment for both the ART treatment and non-ART treatment groups. 
The results are adjusted for age.
Compliers vs. dropout Compliers vs. dropout
Clinic 
characteristics
ART
(n=96)
Non-ART
(n=115) Clinic 
characteristics
ART
(n=96)
Non-ART
(n=115)
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
PCQ-Infertility (0-3) 1.51 (0.48-4.79) 0.52 (0.20-1.38) Number of patients per clinic 1.00 (0.99-1.00) 1.00 (0.99-1.00)
Accessibility of care 0.91 (0.50-1.67) 1.27 (0.71-2.26)
Separate waiting 
room for infertile 
patients
0.75 (0.31-1.82) 0.57 (0.23-1.41)
Information provision 1.32 (0.53-3.26) 0.59 (0.28-1.25) Specialized fertility nurses 1.93 (0.53-7.07) 1.66 (0.73-3.76)
Communication 1.25 (0.46-3.38) 0.77 (0.38-1.56) Regularly measuring clinic’s quality levels 1.08 (0.43-2.68) 0.70 (0.31-1.56)
Respect for patients’
values 1.17 (0.60-2.27) 0.57 (0.34-0.95)*
Structured meetings 
to discuss all patients 2.45 (0.46-13.00) 1.64 (0.59-4.55)
Continuity and 
transition 0.89 (0.40-1.98) 0.96 (0.48-1.95)
Number of 
gynaecologists 0.71 (0.47-1.10) 0.85 (0.67-1.08)
Patient involvement 2.39 (1.02-5.59)* 0.99 (0.55-1.77) Separate semen production room 1.50 (0.54-4.18) 1.10 (0.49-2.45)
Staff’s competence 1.83 (0.56-5.93) 0.52 (0.20-1.32) Presence of clinic psychologist(s) 1.21 (0.35-4.12) 0.89 (0.34-2.30)
Table 4
Clinic characteristics and dropouts; differences between patients 
who received ART and non-ART
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very important.11,12,23 A study of van Empel et al. also demonstrated that patients 
were willing to trade of up to a third of their pregnancy rate for more patient-
centred care.11 Moreover, a lack of patient-centredness was found as the most 
common reason for patients to change clinics.11,24 These findings notwithstanding, 
we can now conclude that, in our study setting, patients’ experiences with patient-
centred care seem to be no optimal predictor of dropout. Still, it might be too 
restrictive to state that clinic factor could never be used as a predictor of dropout. 
Our study was performed within one European country, while it is known that 
the quality of care varies according to cultural and social settings.25-27 Extending 
our study to a more international setting might, therefore, influence the results. 
Moreover, dropout in relation to patient-centred care could be more relevant for 
specific treatment types7, as we have shown in our study. First, patients who 
received non-ART had more chance of dropping out when they scored lower on 
the ‘respect for patients’ values’ subscale (i.e. a negative predictor). It is already 
known from the literature that non-ART patients are generally more dissatisfied 
with their care than patients receiving ART.10,16,17 This can be better understood, 
knowing that non-ART procedures are generally performed in less specialized 
fertility clinics, by more general gynaecologists compared with the more 
specialized gynaecologists and nurses in fertility centres. Our study showed that 
especially patients undergoing non-ART are sensitive to the respect they receive 
from the professional team. As a result, paying less attention to patients’ values 
led to more dropouts, which can be considered a negative effect in fertility care. 
Therefore, professionals treating non-ART patients should give these patients the 
personal attention they need and respect them in their values and needs. 
The second possible predictor of dropout in our additional analyses was ‘Patient 
involvement’. Patients receiving ART were more likely to dropout when the level 
of patient involvement was higher (i.e. a positive predictor). Patients do not 
always know that they also have the option to withdraw from treatment. Achieving 
awareness of this and involving patients in the decision process could make this 
clear to them.28 Apparently, patients’ decision to discontinue treatment is taken 
more easily when they are well informed and involved in all treatment phases, as 
we have shown in our study. Other studies in fertility care illustrate this as well. 
For example, van Peperstraten et al. found that empowering infertile patients 
by giving them a decision aid made them choose to replace fewer embryos in 
IVF.29 Also, studies from other health care areas have shown the relation between 
patient empowerment and a reduction in care consuming.30,31 From this point of 
view, dropping out or discontinuing treatment might be considered a positive 
choice in fertility care as it is well informed and without decisional conflict. 
This line of thought could shed light on the complex issue of dropout. Dropping 
out of treatment could be a positive, well-informed choice. This decisional process 
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seems to be supported by involving patients in their care and by respecting their 
values regarding treatment options. On the other hand, a negative choice to 
dropout could be explained by an inability to continue because of emotional or 
other personal reasons. This is supported by studies indicating stress or emotional 
strain as reasons for dropout. In previous research, dropout is mainly considered 
as a negative decision as patients were unsatisfied with the organization of 
care or mentioned poor communicating skills of the staff as their reason for 
discontinuation.1,9 The results of our study might indicate that patients’ decision 
to dropout of fertility care is more heterogeneous, as their decision was related 
to negative evaluations of patient-centred care (i.e. less respect of patients’ 
values), but also to positive evaluations (i.e. more patient involvement). We 
might, therefore, speak about dropouts as following a positive or after a negative 
choice.32 To underline or reject this hypothesis, more research is obviously 
needed, for example, regarding the process underlying the decisions that infertile 
patients make. The results of our study could be helpful in the initiation of future 
research about this topic. 
This study has several strengths. First, we included more than 500 infertile 
women from all areas across the Netherlands, ensuring representativeness of the 
Dutch infertile population. Second, we included patients in different treatment 
phases, while previous studies mainly focused on patients undergoing IVF and/
or ICSI treatments. By including such a varied group of patients, we were able 
to evaluate predictors of dropout in almost the entire setting of fertility care. 
Moreover, we performed additional analyses, enabling us to draw conclusions on 
the different treatment phases as well. Third, we explored all different elements 
of ‘clinic factors’ by including both ‘standard clinic characteristics’ (e.g. clinic size) 
and clinic factors evaluated by the patients themselves. By including the PCQ-
Infertility questionnaire, we were able to evaluate clinics from the perspective of 
the patients. Finally, we compared various patient characteristics between the 
dropouts and compliers, including patients’ quality of life, and corrected them if 
necessary. We also added the non-responders to this comparison, showing that 
their background characteristics did not differ significantly from the patients we 
included in the analysis. 
Some limitations of this study should also be discussed. First, we were not able 
to follow-up all 534 patients who provided consent for this study at T0, which 
might have biased our results. However, due to the effort of sending additional 
reminders, we managed to reach a response rate of >80% at the T1 measurement. 
It should, however, be noticed that the response rate of T0 was 58.4% and, 
subsequently, we lost 22.9% of patients between T0 and T1, because they were 
not willing to participate in our prospective study. Bias of our results is, therefore, 
more likely and should be taken into account when interpreting our results. 
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Second, we only included patients who already started treatment for their fertility 
problem and, consequently, left out those patients who dropped out during or 
even before diagnostic fertility work-up. Brandes et al. showed that already at 
this stage, patients drop out.6 However, the PCQ-Infertility was not validated 
for this group of patients, as they have not visited their clinic often enough to 
evaluate it appropriately. Consequently, we decided not to include these patients 
in our study. Third, we used a definition for dropout that might be somewhat 
different from the definition used in several other studies. Generally, dropout 
is defined as every premature discontinuation of treatment in that particular 
clinic. As we included patients from different clinics across the Netherlands and 
from all different treatment types, our study setting was somewhat different. 
Consequently, patients also ended treatment in their clinic, because they needed 
a treatment in another clinic or simply had no more treatment options. Because 
of this specific situation, we decided to exclude these patients from the dropout 
group. Following the literature, these patients can be considered as ‘active 
censored’ or ‘physician-recommended dropouts’. Consequently, we included 
patients who were ‘passive censored’ or ‘patient-initiated dropouts’.33,34 We also 
excluded patients who went to another clinic because they were unsatisfied with 
their current clinic, as they did not fit our definitions of ‘dropouts’ or ‘compliers’. 
However, we considered this an interesting subgroup of patient and performed 
additional analyses on this group. We found no relation to dropout, but this could 
very well be due to the small sample size (n = 12). 
The results of our study led to some recommendations for daily practice and 
future research. The fact that we did not find any association between clinic 
factors and dropouts in our entire patient group could imply that this association 
does not exist at all. If this is true, dropouts might be more related to factors 
at the patient and the treatment level and further research should concentrate 
on these elements. Another explanation for the lack of relationship between 
patient-centredness and dropout is the heterogeneity of the sample regarding 
the centre, phase of treatment and treatment type. Despite the fact that we 
controlled for clinical characteristics and that we performed separate analyses 
for patients undergoing ART and non-ART, the patients relate their scores on 
patient-centredness to their experience with their own clinic, which could explain 
the lack of significant relationships. In addition, dropout might be explained 
by a complex interplay of clinical, personal and treatment-related factors.8 It 
is possible that clinical factors play a role in patients who experience a lot of 
distress. This means that the results of this study do not justify the exclusion of 
clinical factors as possible contributors to dropout. More in-depth analyses are 
warranted to control for clinical differences, which will require large samples. 
Obviously, predicting dropout in fertility care is complicated given the number of 
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studies on this subject and their conflicting outcomes.4,35-40 We have made a first 
initiative to show the relation between clinic factors and dropouts in a prospective 
setting. Future research should concentrate on more different patient, treatment 
and clinic factors and their possible interactions in order to identify appropriate 
predictors of dropout in fertility care. 
In conclusion, patients’ experiences with patient-centred fertility care are not 
related to dropout. However, within two subgroups of patients (i.e. receiving non-
ART and ART), we have collected some clues that clinic factors could be used as 
a predictor of dropout in specific patient groups. In future research, it would be 
interesting to find more predictors of dropout at the patient, treatment and clinic 
levels and explore their possible interactions. Only then, will we gain an optimal 
insight into those factors influencing dropout, making it possible to account for 
them in daily clinical practice. 
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Abstract
Background
The benefit patients derive from treatment arise from a number of aspects of 
their care, such as their safety, medical outcome, but also patient-centred factors. 
Understanding the values patients place on these care dimensions is important 
if professionals are to improve the overall benefits they provide for their patients 
and if health insurers are to contract with those clinics that best meet the needs 
of their members. This study assesses the value patients and insurers place on 
different aspects of treatment in the area of fertility care, with a particular focus 
on patient-centredness.
Methods 
A discrete choice experiment (DCE) was constructed to assess both patients’ 
and health insurers’ hypothetical choices of fertility clinics based on clinics’ 
performance on: the pregnancy rate, patient-centredness levels (i.e. information 
provision, patient involvement, and continuity of care) and additional costs per 
treatment cycle. 996 patients and 84 healthcare insurers received the DCE-
questionnaire. With logistic regression analysis, we calculated the willingness-to-
pay values for more effective and patient-centred fertility care.
Results
550 patients (55.4%) and 45 healthcare insurers (53.6%) completed the DCE 
questionnaire. Patients were willing to pay a medium amount of €463 for a 
relevant one-step increase in patient-centred care and €107 for one percent 
increase in pregnancy rates. Healthcare insurers’ valuations were lower: €191 for 
more patient-centred care and €60 for one percent increase pregnancy rates. The 
willingness-to-pay values depended on patients’ age, patients’ ethnicity, income, 
and treatment type and on health insurers’ age.
Conclusions
This study emphasises the importance of patient-centredness for both patients 
and their insurers. Therefore, efforts by policymakers and clinicians to improve 
these aspects of care would increase the overall value patients derive from 
their treatment. Although insurers placed a lower monetary value on patient-
centredness aspects than patients, insurers’ purchasing decisions should be 
guided by patient rather than insurer preferences.
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Background
Providing patient-centred care has become an important and central aim in current 
healthcare.1 This is reflected in the numerous studies exploring the concept of 
‘patient-centredness’ in recent years.2-5 In general, patient-centredness is defined 
by respectfulness of and responsiveness to patients’ preferences, values and 
needs.2 Moreover, it is recognized as a multidimensional concept2,3,5, including 
domains on the organizational and the human level.6 For example, patients want 
shorter waiting times and optimal continuation of care, but patients also want to 
trust their doctor by receiving clear and customized information, they want to be 
treated as a person, and be involved in decision making.7,8 
So far, it seems like the content of ‘patient-centredness’ is diverse, but clearly 
studied. However, its integration in daily care is more complicated as the benefits 
patients derive from treatment arise from several aspects of care, including 
not only patient-centred factors but also for example their safety and medical 
outcome. If professionals want to improve the overall benefits they provide 
for their patients, including the patient-centred aspects of care, they should 
understand the values patients place on the different dimensions of care first. 
This information would also guide policy makers to assign public resources to 
care elements most relevant to the healthcare consumer.9 Furthermore, it could 
stimulate health insurers to contract with those clinics that best meet the needs 
of their members. An increasingly popular method to determine the relative 
importance of outcome measures is by assigning it a monetary value.10 
Therefore, the main aim of this study is to estimate the monetary value both 
patients and health insurers place on different aspects of healthcare, with a 
particular focus on the patient-centredness of care. We performed our study in 
the area of fertility care, as it is known that infertile patients suffer from a high 
physical and psychological burden during treatment and could therefore especially 
benefit from patient-centred care.11 Moreover, the concept of patient-centred 
fertility care is explored extensively and leaves room for improvement.6,12,13
Methods
Study design
We used a discrete choice experiment (DCE) design, to estimate the monetary 
value both patients and health insurers place on different aspects of fertility 
care. We examined the relative weight patients and health insurers place on 
relevant aspects of fertility care with respect to costs through a questionnaire 
with choice sets representing hypothetical but realistic fertility clinics. We asked 
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patients which fertility clinic they would choose for their treatment and health 
insurers which clinic they would prefer to purchase healthcare for their insurance 
company. The institutional ethics committee of Radboud University Nijmegen 
Medical Centre provided ethical approval for this research to proceed (CMO nr 
2011/034). Our study was registered with ClinicalTrials.gov (NCT01834313) and 
we reported our results according to the STROBE statement for observational 
studies. 
Setting and study population
Due to the unique Dutch health system, which is based on managed competition14, 
we included both a group of infertile patients and a group of Dutch health 
insurers. Dutch health insurers can be considered as the patients’ representatives 
in healthcare as they are the prudent purchasers of care for their customers 
(i.e. patients). Health insurers negotiate with care suppliers about the quality 
and costs of care and have the freedom to selectively contract care suppliers 
based on adherence to quality standards and price levels. Furthermore, Dutch 
citizens are forced to purchase a basic insurance package from a health insurer 
of their choice and have the option to purchase supplementary insurance for 
additional healthcare.14 Concerning fertility care, the basic insurance package 
covers treatment and medication costs for ovulation induction (OI), intra-uterine 
inseminations (IUI), and three cycles of IVF/ICSI per episode. Supplementary 
insurance could cover the costs for the fourth or fifth IVF/ICSI cycle or annual 
subscription costs for the Dutch Patients’ Association of Infertility.
We selected patients from ten Dutch fertility clinics throughout the country, 
consisting of four large IVF centres and six medium-sized clinics. The IVF centres 
are licensed to perform all phases of all different fertility treatments, while the 
medium-sized clinics refer their patients to a larger centre for the laboratory 
phase and embryo transfer of the In Vitro Fertilization (IVF) and Intra-cytoplasmic 
Sperm Injection (ICSI) treatments. To include a representative patient group, 
clinics were asked to extract the address files of all patients who underwent at 
least one cycle of a fertility treatment in their clinics in the past three months 
(summer 2012) from their national coding system for diagnosis and treatment. We 
randomly selected 50 couples per clinic, of whom the women and their partners 
were invited to participate individually. Finally, we asked all Dutch health insurers 
responsible for purchasing healthcare (n=84) from the five largest Dutch health 
insurer companies to participate in our study.
Development of the DCE-questionnaire
The first step in questionnaire development was the selection of care elements 
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most relevant for patients and health insurers in a fertility care setting. We 
based this selection on the existing literature about patients’ preferences in 
fertility care13,15-17 and an interview with the Chief of the ‘Healthcare purchasing 
department’ of one of the largest Dutch health insurer companies. We discussed 
it within an expert panel of clinicians and methodologists and determined 
both the effectiveness and patient-centredness as pivotal factors for decision 
making in fertility care.6,12,15 The panel selected the four most relevant attributes 
covering these two care aspects and divided each attribute into three levels 
covering a ‘realistic range’ (Table 1). The levels of ‘ongoing pregnancy rate’ (i.e. 
effectiveness of fertility care) ranged from 20% to 35%, corresponding the actual 
mean ongoing pregnancy rates in Dutch fertility clinics.18 Three attributes were 
selected to represent patient-centredness (i.e. information provision, patient 
involvement and continuity of physicians), which was based on previous studies 
about patient-centred fertility care in the Netherlands.12,13 We performed a pilot 
study among 13 patients and a health insurer to determine the levels of the fifth 
attribute ‘additional costs per IVF cycle’. For both parties a range from zero to 
€500 seemed suitable. 
The combination of five attributes, each consisting of three levels, resulted in 243 
(35) hypothetical scenarios for fertility care. To create a more functional sample, 
we used a fractional factorial design which was based on an 81 array orthogonal 
main effects plan.19 This guarantees an optimal balance of attributes and levels 
with a minimal correlation.20 Subsequently, we created choice sets existing of 
two scenarios by means of a fold over technique (22222), ensuring maximum 
differentiation between attribute levels within each scenario.21 As a result, 162 (2 
* 81) of the 243 possible scenarios were included. The efficiency of this design 
was considered most optimally (i.e. 100%).19
Clearly, a respondent would not be able to complete all 81 choice sets, although 
studies have shown that the amount of choice sets only slightly influences the 
error of variance20,22 For this study, we created five different questionnaire 
versions for the patients: four with 16 choice sets and one with 17 choice sets. 
For healthcare purchasers, we composed four different questionnaires (four 
questionnaires with 20 choice sets and one with 21 choice sets). All questionnaires 
versions were tested for level balance and consisted of two dominant choices to 
assess the understanding of the attributes by the participants. These choices 
were characterized by logically preferable levels on all attributes. Respondents 
who “failed” at both tests were defined as “irrational” and dropped from the 
analyses.21 Finally, all questionnaires consisted of additional background 
questions to account for heterogeneity of our study population, such as gender, 
age, ethnicity, education and income.
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Data collection
The questionnaires were randomly divided over a total of 993 patients (497 
women and 496 partners) and 84 Dutch healthcare purchasers. Participation was 
voluntary and anonymous. All participants received a reminder card two weeks 
after the initial mailing. Another three weeks later, non-responders received a 
second reminder.
Data analyses
Participants’ preferences regarding fertility care were analysed using generalized 
estimating equations, an optimal method in cases of correlated responses (i.e. 
multiple choices per individual).23 Within this model, we performed binary logistic 
regression analysis to calculate coefficients for all five attributes, representing the 
change in benefit for a one-unit change in the attribute level.20,21 This was defined 
by a one percent higher pregnancy rate, one hundred Euros higher costs per IVF 
cycle, and one level up for the attributes concerning patient-centredness (e.g. 
from contradictory information to general information). We included interaction 
terms to account for heterogeneity between subgroups of respondents by using 
all collected background characteristics. We excluded the statistically insignificant 
variables via manual backward elimination to come to our final model.
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‘additional costs per IVF cycle’. For both parties a range from zero to €500 seemed suitable. 
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hypothetical scenarios for fertility care. To create a more functional sample, we used a 
fractional factorial design which was based on an 81 array orthogonal main effects plan.19 This 
guarantees an optimal balance of attributes and levels with a minimal correlation.20
Subsequently, we created choice sets existing of two scenarios by means of a fold over 
technique (22222), ensuring maximum differentiation between attribute levels within each 
scenario.21 As a result, 162 (2 * 81) of the 243 possible scenarios were included. The 
efficiency of this design was considered most optimally (i.e. 100%).19
Clearly, a respondent would not be able to complete all 81 choice sets, although studies have 
shown that the amount of choice sets only slightly influences the error of variance20,22 For this 
study, we created five different questionnaire versions for the patients: four with 16 choice 
sets and one with 17 choice sets. For healthcare purchasers, we composed four different 
questionnaires (four questionnaires with 20 choice sets and one with 21 choice sets). All 
questionnaires versions were tested for level balance and consisted of two dominant choices 
to assess the understanding of the attributes by the participants. These choices were 
characterized by logically preferable levels on all attributes. Respondents who “failed” at both 
tests were defined as “irrational” and dropped from the analyses.21 Finally, all questionnaires 
consisted of additional background questions to account for heterogeneity of our study 
population, such as gender, age, ethnicity, education and income.
Table 1
Attributes and corresponding levels
Attributes Levels
Clinic’s mean ongoing pregnancy rate
20%
30%
35%
Information provision
Contradictory information
Only general information
Clear and customized information
Patient involvement
Never
Sometimes
Always
Continuity of physicians
Seeing a different physician almost 
every visit
Having one lead physician
Always seeing your own physician
Additional costs per IVF cycle
€0,-
€200,-
€500,-
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The willingness-to-pay for more effective fertility care was calculated by the ratio 
of the coefficients ‘pregnancy rates’ and ‘additional costs’ for both patients and 
health insurers. To calculate the willingness-to-pay for more patient-centred 
care, we aggregated the attribute coefficients of ‘Information provision’, ‘Patient 
involvement’ and ‘Continuity of care’ to one score. We categorized the sum of 
the coefficients of the 27 (33) possible combinations into three equally large 
improvement steps (i.e. step 1: from 0 to 9, step 2: from 9 to 18, and step 3: 
from 18 to 27). For example, step 1 means the improvement from no aspects of 
patient-centred care to the provision of some aspects of patient-centred care. We 
calculated the willingness-to-pay of all three improvement steps for both patients 
and health insurers separately. However, we considered the second improvement 
step (i.e. from some aspects to several aspects of patient-centred care) as most 
relevant for clinical practice.6,12 Significance for multivariate analyses was set at 
P<0.05. Analyses were performed using SPSS (version 20.0 for Windows®, SPSS Inc., 
Chicago, IL, USA). 
Results
In total, 282 women (response rate 56.7%) and 268 partners (response rate 
54.0%) completed the questionnaire. The healthcare purchasers returned a total 
of 45 questionnaires (response rate 53.6%). None of the participants failed at the 
rationality tests. The background characteristics of the patients and healthcare 
purchasers are presented in table 2. 
Table 3 shows the results from the logistic regression analysis. All five attributes 
had a significant impact on both patients’ and health insurers’ choice for a fertility 
clinic, i.e. all attributes were important to them. Almost all coefficients had a 
positive sign, indicating that participants prefer a clinic with higher level on these 
attributes (e.g. higher pregnancy rates, or more continuity of care). The negative 
signs on the cost attribute indicate that both patients and health insurers were 
less likely to choose a clinic, when costs were higher. Our final model included five 
interaction terms that were significantly related to patients’ or health insurers’ 
choices for a fertility clinic (Table 3, last rows). The costs attribute turned out to 
be less important for couples with a female age >36 years, patients with a Dutch 
ethnicity, a high family income and patients receiving ART treatments. For health 
insurers, costs were less important for those who were older. 
The coefficients of the attributes and interaction terms were used to determine 
what patients and health insurers were willing to pay for higher pregnancy rates 
and more patient-centred care, with a special focus on the second improvement 
step. These results are presented in table 4, showing that patients were willing to 
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pay a median amount of €107 (range €36 - €187) for 1% higher pregnancy rates 
and €463 (range €157-€810) for the second improvement step of patient-centred 
care. Table 4 also shows that patients’ willingness-to-pay highly depended on 
their background characteristics. For example, patients with a low income were 
willing to pay €59 (€36-€77) for a one percent higher pregnancy rates, while 
the willingness-to-pay for patients with a high income was €107 (€47-€187). 
To provide an even more realistic picture of patients’ relative valuations of care 
aspects, we calculated the willingness-to-pay for two specific patients profiles, 
including all four relevant background characteristics. For instance, a patient older 
than 36 years with a Dutch ethnicity, a high income, receiving ART treatments 
was willing to pay €187 for one percent higher pregnancy rates and €810 for the 
second patient-centredness improvement step.
For health insurers, the median willingness-to-pay for a one percent higher 
pregnancy rate was €60 (range €27 to €150). For more patient-centred care, 
health insurers were willing to pay a median expense of €191 (€87-€477) for 
the second improvement step. The cost attribute appeared to be more important 
for health insurers who were younger. For example, health insurers being 30 
years old were willing to pay a median expense of €101 for more patient-centred 
care, while health insurers being 50 years old were willing-to-pay €274 for the 
corresponding improvement step of patient-centred fertility care.
Discussion
Our study showed that the level of patient-centred care significantly influenced 
patients’ choice for a fertility clinic. This is an important finding as it illustrates 
that consumers in healthcare place a high value on patient-centredness, also in 
relation to the effectiveness of care. Our results should therefore be stimulating 
for healthcare providers and policy makers to focus even more on the integration 
and improvement of patient-centredness in daily clinical care. Moreover, we 
showed that patient-centredness of care is important to health insurers as well, 
although to a lesser extent. It is of importance to take their views towards effective 
and patient-centred care into account, as health insurers can be considered the 
patients’ representatives in the Dutch healthcare system. The results of this 
study are therefore of interest for many different stakeholders, e.g. patients, 
health insurers, healthcare professionals, and policy makers and the practical 
implications should be discussed.
A key strength of our study is the methodologically strong DCE design in which 
the attributes and levels were optimally balanced. Moreover, we included 
rationality tests and corrected for several background characteristics to account 
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Table 2
Baseline characteristics of patients and health insurers
Characteristics
Patients Health insurers
(n = 540) (n = 45)
Age
Years (range)
35 (21-53) 41 (25-59)
Gender
Male / Female (%)
52.9 / 47.1 61.6 / 38.4
Ethnic background
Dutch / non-Dutch (%)
86.3 / 13.7 73.4 / 26.6
Level of educationa
Low – Middle / High (%)
51.2 / 48.8 n.a.
Net monthly family incomeb
At or below modal income  / ≥1.5x modal income
21.5 / 78.5 n.a.
Median duration of infertility
Months (range)
28 (2 -169) n.a.
Treatment type
ARTc / non-ARTd (%)
67.7 / 32.3 n.a.
Being childless
Yes / No (%)
67.6 / 33.4 n.a.
Current status
Pregnant / non-Pregnant (%)
22.7 / 77.3 n.a.
Experience as health-care purchaser 
Years (range)
n.a. 5 (1-37)
Considering infertility as an illness
Yes / No (%)
n.a. 62.9 / 37.1
Patients’ experiences in their own clinic with:
- Information provision
     Contradictory / General / Clear (%)
5.2 / 28.0 / 66.7 n.a.
- Patient involvement
     Never / Sometimes / Always (%)
9.1 / 51.9 / 39.0 n.a.
- Continuity of physicians
     Always different / One lead physician /  
     Always the same physician (%)
20.3 / 59.0 / 20.7 n.a.
a Low = Primary or lower vocational education; Middle = secondary or intermediate vocational education; 
   high = higher professional education or university.
b Net monthly family income of the couples was categorized according to the level of the Dutch modal income    
   in Euros: <2500, at or below Dutch modal income; ≥2500, ≥1.5 times Dutch modal income.
c Assisted reproductive technology (ART), encompassed IVF, IVM, ICSI, cryopreservation and testicular sperm 
   extraction.
d Non-ART included ovulation induction and intrauterine inseminations with or without controlled ovarian 
   stimulation.
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for heterogeneity of our study population. Therefore, we were able to quantify the 
preferences of our study participants most optimally. Furthermore, although we 
performed our study nationally and within one healthcare area, our results might 
be stimulating for others as well. Within an international fertility care setting, 
comparable results could even be expected as research has shown that patients 
across Europe have similar views regarding patient-centred care.24 
A number of limitations should also be taken into account when interpreting 
our results. The first limitation considers the DCE design in itself, because we 
cannot guarantee that other attributes, which we did not include in our study, are 
irrelevant. For example the travel time to a clinic or safety of treatments might 
be important for patients or health insurers as well when choosing a clinic. We 
did not include these attributes, because we wanted to compose clear and easy 
to follow scenarios. A maximum number of five attributes is suggested22,25 and we 
therefore selected the most important attributes from the literature.12,13 Second, 
the DCE scenarios will always be hypothetical for our study participants and it is 
unclear whether they would make other choices in real life. We tried to prevent 
this potential bias by grounding the definition of our attributes and levels on 
both the literature and the opinion of an expert panel. Moreover, we performed 
a pilot study among patients and a health insurer to test the validity of our 
questionnaire. Finally, we added a clear addendum to the questionnaire to instruct 
the study participants most optimally. A third limitation concerns the levels of the 
cost attribute, which were based on the Dutch fertility care setting and would 
obviously differ within other countries or different healthcare areas. Therefore, 
we suggest to interpret the willingness-to-pay for more patient-centred fertility 
care as a relative amount and consider it in relation to the willingness-to-pay of 
higher pregnancy rates, reflecting the effectiveness of fertility care.
Although this is the first study determining the monetary value of patient-centred 
care, it touches on the results of some other studies about the relevance of patient-
centredness. In the area of fertility care, Ryan showed that infertile patients were 
willing to pay for a good staff attitude, continuity of physicians, shorter waiting 
times and follow-up support.15 Moreover, Van Empel and colleagues found that 
patients were willing to trade off up to a third of their pregnancy rate for the 
improvement of different elements of patient-centred care (e.g. more information 
provision).17 This corresponds to our findings where patients were willing to 
trade of more than four percent of their chance to get pregnant for the second 
improvement step of patient-centred care (i.e. €463 / €107 = 4.3). Comparable 
results were also found within other healthcare areas. In a systematic review on 
patients’ choices in healthcare, several patient-centred aspects such as better 
staff’s competence, higher accessibility of the clinic, optimal communicating skills 
of the physician, and being able to see the same doctor were brought forward as 
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elements influencing patients’ choice for a provider or clinic.26 However, as the 
relative importance of these factors was not studied, translating these findings 
into implications for daily clinical practice is difficult. 
The results of our study ask for some recommendations for different stakeholders 
in healthcare. First, our study results should be an absolute motivator for 
professionals to monitor and improve their clinic’s level of patient-centred care, 
because patients appear to choose for a clinic with a more patient-centred approach. 
Although measuring patient-centredness might seem complicated, initiatives 
in different healthcare areas have shown that objectively measuring patients’ 
experiences with care is possible.12,27,28 Subsequently, publically publicizing 
clinics’ results on their level of patient-centredness could initiate competition 
among clinics, stimulating the improvement of patient-centred care even more.29 
Second, our results suggest that health insurers should take clinics’ levels of 
patient-centred care more into account when purchasing care as they placed 
less importance on patient-centred care than their customers did. This might 
be due to the different focuses of patients and health insurers. Where patients 
take into account their own perspective, health insurers have to cover the wishes 
and preferences of the entire population. Our results might therefore be helpful 
for health insurers, as we provided them with a clear picture of the preferences 
and needs of the infertile patient. Our final recommendation touches on the 
actual payment for more patient-centred care. Our results suggests that patients 
are willing to pay an additional fee for a clinic providing more patient-centred 
care. Although different studies have shown that ‘fee for performance’ does not 
enhance the improvement of quality of care30,31, the effect of introducing additional 
copayments for more patient-centred care has never been debated. It might, for 
instance, increase patients’ autonomy. Currently, patients are restricted to use 
care that is already purchased by their health insurer. When introducing additional 
copayments, patients would be able to use their own financial resources and 
directly choose a clinic matching their preferences and wishes regarding patient-
centred care. Moreover, it appears to be in line with a recent recommendation of 
the World Health Organization to increase patients’ copayments in case more than 
six percent of the gross national product (GNP) is spend on healthcare.32 In the 
Netherlands, 11.9 percent of the GNP is spend on healthcare, indicating the need 
for a debate on the reimbursement of care expenses. Of course, our suggestions 
considering copayments for more patient-centred care are very premature. For 
example, ethical, social and practical issues should be considered first and more 
research is needed to study the feasibility of introducing these payments. With 
this study, we have made a first initiative to actually determine the importance 
of patient-centredness by calculating its monetary value and relating it to the 
monetary value of another important outcome measure, i.e. the effectiveness of 
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care. Hopefully, our results will increase the motivation of professionals, health 
insurers and policy makers to aim at the improvement of patient-centred care, as 
it corresponds to the preferences and wishes of the most important stakeholder 
in healthcare, the patient.
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Abstract
Objectives
To determine the effect of audits and feedback on the level of patient-centredness 
in fertility care, and getting more in-depth understanding of professionals’ view 
on patient-centred care and achieving improvements.
Methods
In the quantitative part of this mixed method study, patient questionnaires 
were used in 15 Dutch fertility clinics among women who were under treatment 
for infertility. After auditing the level of patient-centredness of care in 2009, 
using the PCQ-Infertility questionnaire, feedback was provided to the clinics by 
a personalized paper-based feedback report. We measured patients’ reported 
differences in the level of patient-centred fertility care between 2009 and 2011. 
In the qualitative part, we performed semi-structured in depth interviews among 
fertility care professionals. Professionals’ view on improving patient-centred 
fertility care was arranged into Hibbard’s framework for behavior change.
Results
Multilevel regression analysis showed no significant differences between the 
overall levels of patient-centredness in 2009 and 2011. Qualitative research 
showed that professionals’ urge to change and their ability to translate feedback 
were suboptimal to achieve professionals’ behavior change. 
Conclusions
Audits and feedback alone are not enough to improve the level of patient-
centredness in fertility care. Increasing professionals’ desire to change and their 
ability to translate feedback about their performance into an optimal quality 
improvement strategy appear to be the key issues.
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Background
Patient-centredness has gained attention as an important dimension of quality 
of care.1,2 Health-care organizations increasingly focus on integrating patients’ 
preferences and needs into the delivery of health care, and they guide delivery by 
their patients’ values; this can be considered a definition of patient-centred care.2,3 
Providing patient-centred care has several presumed benefits, such as increasing 
both the patients’ quality of life4 and the professionals’ job satisfaction.5-7 Areas 
of health-care such as fertility care, which are associated with a high emotional 
impact and intensive treatment periods, especially could benefit from patient-
centred care.8,9 The stigmatizing character of infertility10,11 and the high dropout 
rates from treatment12 are valid reasons for fertility professionals to consider the 
importance of patient-centred. Moreover, a lack of patient-centred care has been 
one of patients’ main non-medical reasons for changing fertility clinics.13,14
In that market forces and competition between clinics are everyday aspects of 
modern health care, fertility clinics should be motivated to optimize their care 
toward a more patient-centred approach.14 Yet improvement is clearly needed in 
patient-centred care.15,16 Because professionals in fertility care underestimate the 
importance of patient-centredness13,17 and have difficulty adequately estimating 
their own performance17, they must be motivated to address these aspects. 
Tailored improvement strategies are thus needed for fertility clinics to adopt a 
more patient-centred approach.
A plethora of strategies exist for improving patient-centredness of care, but these 
strategies have rarely been evaluated in the fertility-care setting yet. In general, 
audits and feedback are key components of most quality-improvement projects.1 
However, when there is no appropriate measurement tool (i.e., an audit), no 
accurate baseline level of patient-centredness can be established. Without any 
feedback about the audit’s results, professionals may have difficulty understanding 
their patients’ preferences, wishes, and needs.1,17 Also, it is unknown whether 
professionals have the knowledge, skill, time, and ability to translate feedback to 
optimal quality improvement strategies. Moreover, for feedback to be effective, 
some studies have underlined that it must be part of an intervention, consisting 
of multiple components such as educational outreach visits and patient-mediated 
interventions.18-20 Others have doubted the effectiveness of such interventions in 
ensuring the implementation of patient-centredness throughout a clinic.1,21
Our study measured the effect of auditing and feedback on the patient-centredness 
of fertility care by use of a quantitative approach. Then, in a qualitative study, 
we gained insight into the professionals’ views of patient-centred fertility care 
and which aspects were seen as important for its improvement. The findings of 
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both the quantitative and qualitative studies can be applied to design a targeted 
strategy for the quality improvement of patient-centredness in Dutch fertility 
care.
Materials and methods
Study design
A mixed-method study design combining both qualitative and quantitative data 
not only provides a more comprehensive, in-depth understanding of the research 
objectives but also has a complementary function.22-24 The quantitative part of 
our study included patients, and the qualitative part focused on the fertility care 
professionals. The institutional ethics committee of Radboud University Nijmegen 
Medical Centre provided ethical approval for this research to proceed.
Quantitative part
In the quantitative part of this study, the effect of an audit and feedback on the 
level of patient-centred fertility care was determined in 2011, two years after 
clinics had been audited and received the feedback.
Setting
Baseline measurement (T0) of this study was nested within a study to validate 
a questionnaire measuring the level of patient-centredness of fertility care.15 A 
total of 29 Dutch fertility clinics participated in the validation study in 2009, 
which showed that there is room for improvement regarding patient-centred 
fertility care in the Netherlands.15 Data from 15 large and medium-sized clinics 
were selected for this study. In the Netherlands, a total of 13 large clinics are 
licensed to perform all kinds of fertility treatments; the medium-sized “transport” 
clinics must refer their patients to these larger clinic for the laboratory phase and 
embryo transfers of the in vitro fertilization (IVF) and intra-cytoplasmic sperm 
injection (ICSI) treatments.
Study population
The study population consisted of women undergoing infertility treatment in 
one of the 15 participating Dutch fertility clinics. All women who participated 
underwent at least one cycle of medically assisted reproduction (MAR) (e.g., 
ovulation induction, intrauterine insemination, IVF, or ICSI). Previous studies had 
shown that patients with positive treatment results are more likely to maintain 
a positive perspective on their care than patients who have had a negative 
treatment result.15,17 As this strong association between the treatment outcome 
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and the patient’ experiences would bias our results, we excluded all patients who 
had achieved pregnancy during the study period from our analyses.
Primary outcome measure: patient-centredness
We used the Patient-Centredness Questionnaire–Infertility (PCQ-Infertility), 
which is an instrument to assess a clinic’s level of patient-centredness by 
measuring patients’ experiences with fertility care. The questionnaire consists of 
46 items, covering seven subscales: Accessibility, Information, Communication, 
Respect for Patients’ Values, Continuity and Transition, Patient Involvement, 
and Competence.15 The higher the score on the total PCQ scale or one of the 
subscales (range: 0–3), the higher the level of patient-centredness. A baseline 
measurement of this study was part of the validation study of the PCQ-Infertility; 
some changes were made afterward to improve the reliability and validity of 
the questionnaire, but these differences were small (i.e., rephrased words and 
sentences).
Intervention: audit and feedback
To audit the level of patient-centredness of Dutch fertility care, infertile women 
were asked to share their experiences with fertility care by filling out the PCQ-
Infertility. After this audit, all hospitals received a personalized paper-based 
feedback report that consisted of clinic’s mean results on the level of patient-
centredness (i.e., total score and subscale scores). The results were presented 
in relation to all participating clinics (anonymously)—that is, benchmarking. 
To identify the aspects of care with the highest priority for improvement (e.g., 
information provision or communication), quality improvement (QI) scores for all 
questionnaire items (care aspects) were calculated per clinic and presented in the 
feedback report. The higher a QI score, the more need there is for improvement. 
For more information on PCQ and QI scores, the reader is referred to Van Empel 
et al.15 After receiving the report, clinics had the liberty to change or adjust the 
aspects of care that needed improvement according to their patients.
Data collection
T0-measurement
The clinics extracted from their diagnosis treatment combination (DBC) coding 
system the addresses of patients who underwent MAR in their clinic between 
April and June 2009. With we had the information from the clinics, we randomly 
selected 25 to 75 patients (depending on clinic’s size) to invite to participate. 
Participation was voluntary and anonymous. Patients were sent a reminder card 
3 weeks after the initial mailing. Another two weeks later, the non-responders 
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received a reminder with a copy of the questionnaire. In January 2010, all 
hospitals received the personalized feedback report.
T1-measurement
Two years later, selection of a new cohort of patients was performed in the same 
way as in T0. The questionnaire distribution was executed using a multiple mode 
method, as it has been shown that combining an Internet-based questionnaire 
with a papers-based follow-up improves the quality of data and is less expensive 
than a postal survey alone.25 Included patients received a letter and were invited 
to complete the PCQ-Infertility questionnaire online, which was accessible through 
a personal code. A reminder card was sent after three weeks. Non-responders 
received a paper-based version of the PCQ-Infertility another two weeks later. 
In the meanwhile, a small process evaluation was executed to determine what 
organizational changes could be associated with a possible change in patient-
centredness. To this end, the representative gynaecologists of all 15 clinics 
received a questionnaire with questions about the major changes they had made 
within their clinic between T0 and T1, both based on the feedback report and 
apart from the feedback report (e.g., clinic’s rebuilding).
Data analysis
First, differences in patient characteristics between T0 and T1 were determined 
to explore whether case-mix adjustment was necessary. Subsequently, patient-
centredness scores at T0 and T1 were compared with adjustment for clusters 
of patients within the same clinic. For this purpose, a multilevel multivariate 
regression analysis was performed in which the PCQ-Infertility’s total and subscale 
scores were considered as the dependent variables. Additionally, we focused on 
the clinics that reported major changes based on the feedback report. As we 
had expected an improvement in PCQ-Infertility scores to be found within these 
clinics, we explored the results of these clinics separately.
Significance for all analyses was set at P<0.05. However, as we are reporting 
about differences between patient-centredness scores, it is important to define a 
change that can be considered clinically important, that is, a minimally important 
difference (MID).26-28 Therefore, we considered differences of 0.3 or more (i.e., 
10% of the maximum difference) as clinically relevant for the present study’s 
purpose.26-28 Quantitative analyses were performed using SPSS (version 18.0 for 
Windows, SPSS Inc.).
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Qualitative part
The aim of the qualitative part of this study was to understand the effect of audit 
and feedback on the level of patient-centredness. Therefore, this part focused on 
professionals’ views on patient-centred fertility care as well as on barriers and 
facilitators for its improvement.
Study population
A total of ten gynaecologists, two fertility nurses, and three quality officers from 
ten different Dutch clinics participated. We performed semi-structured interviews 
with these professionals in 2010 and 2011.
Data collection
We performed semi-structured interviews and used Hibbard’s theoretical 
consumer choice model.29 According to this model, a series of events should take 
place before someone changes his or her behavior. Translating this toward the 
current study setting (i.e., changing behavior to achieve a more patient-centred 
approach in fertility care), [1] professionals must be aware of what patient-
centred care is and that there is room for improvement; [2] they should have 
knowledge about the way they (i.e., their clinic) provide patient-centred care and 
how to translate this into an action plan; and [3] they should feel that improving 
patient-centred fertility care is important and want to change. Only after these 
steps in awareness, knowledge and attitude have been achieved [4] professionals 
can really change their behavior toward improving patient-centred care.29
We performed the interviews in two phases. First, one author (J.A.) performed 
interviews a few months after feedback from the T0 measurement (spring 2010). 
During these interviews, we focused mainly on the first two steps of Hibbard’s 
choice model. Two years later, after the professionals had had the opportunity 
to change their clinic, another author (A.H.) performed the interviews for the 
T1 measurement (summer 2011). These interviews were mainly focused on the 
third and fourth step of Hibbard’s choice model. New interviews were performed 
until saturation was achieved and no new themes came up. A flowchart of both 
the quantitative and qualitative part of the study is presented in Figure 1. All 
interviews were tape recorded with the participants’ consent and were transcribed 
verbatim.
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Figure 1
Schematically flowchart of the study
Data analyses
We performed a thematic content analysis with constant comparison.30 One 
researcher (A.H.) performed open coding on selected transcripts to derive a 
list of themes emerging from the analysis. Subsequently, a second researcher 
(J.A.) used this list of themes to perform selected coding on all interviews. 
Differences in interpretation were small, and consensus was achieved 
promptly. Then the two researchers (A.H. and J.A.) categorically merged 
these codes and fitted them into the four steps of Hibbard’s theoretical 
consumer choice model—awareness, knowledge, attitude, and behavior—to 
understand what aspects are important to achieve behavior change among 
these professional. These aspects would be considered crucial in designing 
projects to improve patient-centredness.
Results
Quantitative: Effect of audit and feedback on patient-centredness
At T0, 759 patients received the PCQ-Infertility, of whom 575 filled out the 
questionnaire (response rate: 76%). A total of 462 questionnaires were eligible 
for analysis, as 112 patients were pregnant (19%) and thus excluded. At T1, 
Quantitative part Qualitative part
T0
(n=463)
Feedback
T1
(n=339)
Interviews T0
(n=6)
Interviews T1
(n=9)
2009
2010
2011
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448 out of 780 patients completed the PCQ-Infertility (response rate: 57%), of 
whom 109 patients (24%) were pregnant. Therefore, 339 questionnaires were 
eligible for analyses. Table 1 presents all patient characteristics and shows that 
the participating patients at T0 and T1 were statistically significantly differed in 
the following three characteristics: childlessness (P=.02), diagnosis (P=.01), and 
type of treatment (P≤.01). These characteristics were considered as case-mix 
adjusters for further analyses.
Table 1 
Patient characteristics stratified by 2009 and 2011
Table 2 presents the results of the multilevel multivariate regression analysis. 
When adjusted for the aforementioned case-mix adjusters, no statistically 
significant differences in PCQ-Infertility total scores were found between T0 and 
T1 (P=.13; 95% confidence interval [CI], −0.01–0.10). In three of the seven 
subscales, statistically significant differences between T0 and T1 were found. 
The PCQ-Infertility subscale Accessibility showed a statistically significant 
improvement in time (P≤.01; 95% CI, −0.37 to −0.13), whereas the scores 
on the subscales Continuity and Transition (P≤0.01; 95% CI, 0.07–0.23) and 
Competence (P=.03; 95% CI, 0.01–0.12) were statistically significantly lower at 
T1 than at T0. Nevertheless, none of these differences were considered clinically 
relevant (beta <0.3).
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Results
Quantitative: Effect of audit and feedback on patient-centredness
At T0, 759 patients received the PCQ-Infertility, of whom 575 filled out the questionnaire 
(response rate: 76%). A total of 462 questionnaires were eligible for analysis, as 112 patients 
were pregnant (19%) and thus excluded. At T1, 448 out of 780 patients completed the PCQ-
Infertility (response rate: 57%), of whom 109 patients (24%) were pregnant. Therefore, 339 
questionnaires were eligible for analyses. Table 1 presents all patient characteristics and 
shows that the participating patients at T0 and T1 were statistically significantly differed in the 
following three characteristics: childlessness (P=.02), diagnosis (P=.01), and type of 
treatment (P≤.01). These characteristics were considered as case-mix adjusters for further 
analyses.
Table 1 
Pati t characteristic  stratified by 2009 and 2 11
Characteristic 2009
n=463
2011
n=339
p-value
Median age (years, range) 33 (20-45) 33 (23-44) 0.27
Ethnic background
     Dutch / non-Dutch (%) 84.8 / 15.2 86.8 / 13.4 0.54
Level of education
     Low-medium / higha (%) 56.0 / 44.0 53.3 / 46.7 0.46
Median duration of infertility (months, range) 36 (2-174) 34 (3-133) 0.34
Childless couples (%) 70.2 77.8 0.02*
Diagnosis
     Female factor / male factor / other (%) 25.4 / 29.6 / 45.0 30.3 / 20.1 / 49.7 0.01*
Treatment type
     ARTb / non-ARTc (%) 63.1 / 36.9 52.6 / 47.4 <0.01*
a Low = primary or lower vocational education; middle = secondary or intermediate vocational education; 
  high = higher professional education or university.
b Assisted reproductive technology (ART), encompassed IVF, ICSI, cryopreservation and testicular sperm    
  extraction.
c Non-ART included ovulation induction and intrauterine insemination with or without controlled ovarian  
  stimulation.
* Significant difference (p<0.05) between 2009 and 2011 using t-tests for continuous variables and chi-square 
tests for dichotomous variables.
Table 2 presents the results of the multilevel multivariate regression analysis. When adjusted 
for the aforementioned case-mix adjusters, no statistically significant differences in PCQ-
Infertility total scores were found between T0 and T1 (P=.13; 95% confidence interval [CI], 
−0.01–0.10). In three of the seven subscales, statistically significant differences between T0 
and T1 were found. The PCQ-Infertility subscale Accessibility showed a statistically significant 
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Table 2
Differences in patient-centredness, adjusted for childlessness, 
diagnosis and treatment type 
Process evaluation
The questionnaire sent to the participating gynaecologists demonstrated that all 
gynaecologists studied the feedback report in detail and all but one discussed 
it within the clinic’s fertility team. Based on the results of the feedback report, 
five gynaecologists made major changes in their clinic between T0 and T1. 
Most changes were seen on the domains Information Provision (e.g., rewriting 
brochures) and Continuity and Transition (e.g., assigning one gynaecologist to 
be mainly responsible for an infertile couple). Of the five clinics who initiated an 
improvement project based on the feedback report, only one clinic improved over 
time on their mean total PCQ-Infertility score (1.72 to 1.89), two clinics had PCQ-
Infertility scores that were comparable at T1 and T0, and the other two clinics 
had scores that declined over time (i.e., 2.17 to 2.08, and 2.42 to 2.22).
To provide a complete picture of all clinic changes, we also asked which major 
parts of the clinics had been changed in the past 2 years apart from the results of 
the feedback report. Seven gynaecologists reported one or more such changes, 
of which most changes (n = 5) concerned the rebuilding of the clinic or a move 
to a new location.
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improvement in time (P≤.01; 95% CI, −0.37 to −0.13), whereas the scores on the subscales 
Continuity and Transition (P≤0.01; 95% CI, 0.07–0.23) and Competence (P=.03; 95% CI, 
0.01–0.12) were statistically significantly lower at T1 than at T0. Nevertheless, none of these 
differences were considered clinically relevant (beta <0.3).
Table 2
Differences in patient-centredness, adjusted for childlessness, diagnosis and 
treatment type 
2009
n=463
2011
n=339
Beta (95% CI)
Mean PCQ-Infertility total score 2.23 2.19 0.05 (-0.01 – 0.10
Mean PCQ-Infertility subscale scores  
     Accessibility 2.11 2.37 -0.25 (-0.37 – -0.13)*
     Information 2.15 2.13 <0.01 (-0.08 – 0.08)
     Communication 2.54 2.52 0.04 (-0.04 – 0.11)
     Respect for patients’ values 2.05 1.94 0.09 (-0.01 – 0.20)
     Continuity and transition 1.97 1.85 0.15 ( 0.07 – 0.23)*
     Patient involvement 2.39 2.30 0.08 (-0.01 – 0.18)
     Competence 2.48 2.42 0.06 (0.01 – 0.12)*
* Significant difference (P<0.05) between 2009 and 2010 using multilevel multivariate regression analysis.
Process evaluation
The questionnaire sent to the participating gynaecologists demonstrated that all 
gynaecologists studied the feedback report in detail and all but one discussed it within the 
clinic’s fertility team. Based on the results of the feedback report, five gynaecologists made 
major changes in their clinic between T0 and T1. Most changes were seen on the domains 
Information Provision (e.g., rewriting brochures) and Continuity and Transition (e.g., 
assigning one gynaecologist to be mainly responsible for an infertile couple). Of the five clinics 
who initiated an improvement project based on the feedback report, only one clinic improved 
over time on their mean total PCQ-Infertility score (1.72 to 1.89), two clinics had PCQ-
Infertility scores that were comparable at T1 and T0, and the other two clinics had scores that 
declined over time (i.e., 2.17 to 2.08, and 2.42 to 2.22).
To provide a complete picture of all clinic changes, we also asked which major parts of the 
clinics had been changed in the past 2 years apart from the results of the feedback report. 
Seven gynaecologists reported one or more such changes, of which most changes (n = 5) 
concerned the rebuilding of the clinic or a move to a new location.
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Qualitative: how to achieve behavioral change in professionals?
The interviews identified a range of opinions related to patient-centred fertility 
care and how improvement projects should be designed. We selected a total of 
975 statements from the interviews and divided them into 152 different codes. 
These codes were subdivided into 17 categories fitting the four steps of Hibbard’s 
theoretical consumer choice model. Table 3 provides an overview of all codes 
that emerged more than five times from the interview analyses. This table also 
presents the classification of these codes into the different steps of Hibbard’s 
choice model. Most important findings are presented per step of Hibbard’s choice 
model.
1. Awareness
According to the first step of Hibbard’s choice model, the professionals formulated 
definitions about patient-centred fertility care. First, patient-centred fertility care 
was stated to be about and performed around the patient as an individual, just 
as it is defined by the Institute of Medicine.3 For example: 
“Patient-centredness is particularly care in the way that the 
patient sees it. So, through the patients’ eyes. She can rate 
it with a report mark, or just tell us in words what she thinks. 
It is important to get that information in a direct conversation 
with the patient.” (interview no. 7)
Others gave more concrete answers, summarizing items that comprised patient-
centredness according to them. For example: 
“What is patient-centredness? Well, I can think about a lot of 
things… You can think about accessibility by phone or enough 
parking places or the attitude of the nurses and doctors.”   
(interview no. 10)
2. Knowledge 
Relatively few statements were made about this topic, in which we explored 
professionals’ knowledge about their actual provision of patient-centred care and 
difficulties they faced in daily practice. First, a number of respondents reported 
that it is difficult to estimate their own performance accurately. For example,
“The results about the waiting times were disappointing to us. 
Obviously, at some points we are totally beside the mark: we 
think that we provide really good care, but through the eyes 
of the patients, we don’t.” (Interview no. 1)
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Second, respondents noted that differences between clinics and between 
professionals within the same clinic complicated the continuous provision of 
patient-centred fertility care. For example, “I also realize that not every clinic is 
comparable with our clinic. For example: 
“I also realize that not every clinic is comparable with our 
clinic. For example, if you compare a university hospital to us 
[general hospital], things will be organized totally differently.” 
(Interview no. 3)
3. Attitude
Most professionals realized that it is important to improve patient-centred fertility 
care. Several reasons were put forward:
 “I don’t have any experiences with this kind of improvement 
projects, but I am open to new ideas, as will all of my 
colleagues be. So, you are more than welcome!” (Interview 
no. 8)
“I think that when you take a look at our clinic’s business 
plan, it says something like: ‘We want to be the best hospital 
of the whole country!’” (Interview no. 12)
 “Transparency about clinics’ performance is important…..
How is a clinic certificated? What are their results? We have 
to develop a quality label and put that on a clinic when it 
meets the criteria. (Interview no. 6)
To summarize, first, most professionals’ attitude toward patient-centredness could 
be defined as “open”: they believed in improving the level of patient-centredness 
and wanted to think about and discuss potential changes. Second, professionals 
mentioned that they wanted to improve their performance to become the best 
clinic in the region or the country. They suggested that publically publishing the 
study results would increase their desire to change, as no clinic wants to be the 
worst performing clinic.
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4. Behavior
Professionals provided many suggestions on strategies for the improvement 
of patient-centred fertility care. In general, professionals preferred to receive 
feedback on their performance. Subsequently, they felt this feedback needed to 
be discussed with the complete professional team. The format of feedback had to 
consist of several specific aspects, as these interviews showed:
 “I prefer visual feedback, because than you can really see it. 
You can see immediately how you perform and that is really 
clear.” (Interview no. 11)
 “I would prefer to receive real and concrete examples. For 
instance, patients state that they want to have an overview 
of all their treatments... ... then you [researcher] can provide 
us with a good overview that we can use immediately.” 
(Interview no. 10)
“If you really want to expand this research, you have to engage 
some kind of national consultancy team that can help Dutch 
fertility care centres. They should visit the clinics after they 
received the feedback report and provide them with the most 
efficient ways of improving the level of patient-centredness. I 
would even pay for that service.” (Interview no. 1)
In short, first, the professionals preferred visual feedback (i.e., tables, graphics, 
pictures). Second, they wanted the feedback to be as specific as possible and to 
represent their own clinic. Third, the professionals needed support with practical 
translation to an improvement plan and its execution. This support appeared to 
be particularly needed: lack of time was quoted as the most important barrier 
to improving the patient-centredness of care. Also, having a committed medical 
team was found to facilitate the process of improving patient-centred fertility 
care.
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Discussion
Our study showed that merely providing auditing and feedback to professionals 
in fertility care about their performance on patient-centredness may not be 
sufficient to increase the level of this important dimension of quality of care. 
Even those clinics who initiated improvement plans based on the feedback report 
did not show statistically significant differences on their PCQ-Infertility scores. 
This might imply that auditing and feedback alone are not enough and that clinics 
need a more advanced improvement strategy.
From the qualitative part of this study, we were able to collect information to 
assist in the design of such a strategy. Interviews with different professionals 
identified that they are aware of what patient-centred care is, and they provided 
many suggestions on how to improve it. However, two steps of Hibbard’s model 
were not met by the professionals and can therefore be considered as key factors 
toward optimizing the design of improving patient-centred fertility care.31 First, 
the professionals’ knowledge about their actual provision of patient-centred care 
seems suboptimal. Second, progress can be made with professionals’ desire to 
change toward more patient-centred fertility care.
To gain more insight into how to improve these two steps or key factors, we should 
explore the items that the professionals cited within the qualitative research. 
Professionals declared that they evaluated their performance regarding patient-
centredness inadequately. This finding is in line with the study of Aarts et al.17 that 
found that health-care professionals’ perceptions of their patients’ experiences 
with fertility care were not in line with the patients’ actual experiences. Also, 
studies in other health-care areas have reported similar results.32,33 To account for 
this inadequacy in professionals’ perceptions, feedback must be more detailed, 
concrete, and clear to lead to increased knowledge about how care delivery is 
actually organized and performed.
Another item mentioned by the professionals concerned interclinic differences. All 
professionals underlined the necessity of a high standard of patient-centredness 
throughout the country, but this standard appeared to be different among the 
clinics. For example, large university clinics devoted a lot of attention to the 
dimension Continuity of Care. By contrast, smaller clinics that have only a few 
gynaecologists wished to focus on aspects such as Information Provision or 
Emotional Support. To account for these interclinic differences, feedback should 
be tailored to each clinic individually and be provided to all professionals involved 
in the fertility patients’ care network. This is especially important when improving 
patient-centredness of care, which requires a more holistic, personalized approach 
that involves more than one physician.17,34-36
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The second factor that should be met to achieve improvement of patient-
centred care is the motivation to change. Professionals mentioned they want 
to become the best clinic of the country, but when we opened the “black box” 
between T0 and T137 it became clear that only five clinics had undertaken any 
action toward improvement. We found this remarkable, as there is a growing 
recognition of patient-centredness as one of the core dimensions of quality of 
care.1-3 Apparently, recognition does not result in a sufficient desire to improve 
the clinic’s level of patient-centredness. The professionals in our study mentioned 
that publically publishing the study’s results would help them in this process. 
This can be underlined by an example from Dutch fertility care: variation 
between clinics declined obviously after Dutch pregnancy rates per clinic were 
publically published.38 Thus, publishing the clinics’ levels of patient-centredness 
could be a next step toward realizing competition between clinics, increasing the 
professionals’ urge to change and improve.
After exploring two of the key factors toward achieving care improvement (i.e., 
knowledge and motivation), some other statements from the qualitative research 
deserve additional attention. First, professionals stated they need help in 
formulating a concrete action and improvement plan. Subsequently, they prefer 
one person to be responsible for the execution and prolongation of the plan to 
achieve care improvement. Professionals also mentioned the importance of being 
audited more frequently (e.g., every year) as this re-stimulates the professional 
team to evaluate what has been improved and to redefine the improvement plan if 
necessary.39 This notion on how to improve care corresponds with the complexity 
of implementing new procedures, which requires a substantial commitment of 
the professional team and sustained focus.39-40 Being part of a dedicated team41,42 
and having a strong, allied health-care network of professionals can facilitate 
improvement projects being implemented as customary care.43
A key strength of this study is the mixed-method design, which enabled us to 
both measure and understand the effect of auditing and feedback in one study. 
This provided us a more comprehensive picture of the difficulties and possibilities 
in light of improvements to patient-centred fertility care.22,23,44,45 Furthermore, the 
main outcome measure of the quantitative part was determined by a validated 
questionnaire, asking about patients’ experiences with care instead of the more 
subjective outcome measure of “patient satisfaction”.15,46,47 By involving different 
professions in the qualitative part of the present study, the recommendations are 
based on more than the gynaecologists’ opinions. The opinions of fertility care 
nurses, who are important members of the patients’ care network17, and the 
quality officers, who have more (factual) knowledge about quality improvement 
processes in general, were included in this study.
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Some limitations about this study need to be addressed. First, because the 
effect of auditing and feedback was determined after a period of two years, it 
was difficult to distinguish between the possible effect of our intervention (i.e., 
auditing and feedback) and the possible effect of time. By asking the clinics 
what changes they made based on the feedback report specifically, we tried to 
approach the effect of the intervention alone. Second, response rates differed 
between T0 and T1 (76% and 57%, respectively). Nevertheless, we considered 
both response rates as sufficient to ensure the representativeness of the Dutch 
population experiencing infertility.48 Third, we cannot exclude the possibility 
that only the professionals who are more motivated to improve patient-centred 
care agreed to take part in this study; our results may be partly influenced by 
selection bias. Fourth, we excluded all pregnant couples from our study; because 
they were a large proportion of our study population, this might have biased our 
results. However, we expected a confounding issue of strong association between 
patients’ experiences with care and treatment outcome 15,16, so we decided that it 
would be most optimal for our purposes to exclude those patients.
The results of this mixed-method study can contribute to the improvement of 
patient-centred fertility care, as it has been shown that auditing and feedback 
alone are not sufficient. Of the four steps necessary to achieve improvement, 
awareness, the first step, seems to be adequately met within the fertility care 
community. The second step, increasing professionals’ knowledge about the way 
they provide patient-centred care and translating that feedback into an actual 
improvement plan, is a challenging goal. Based on our study, we recommend 
providing fertility care professionals with detailed, concrete, individualized 
feedback on their performance. The third step, attitude, can be improved by 
increasing the professionals’ motivation to change—for example, by publically 
publishing study results about patient-centred fertility care. Subsequently, to 
take the final step for care improvement, changing behaviour, the results must 
be discussed within the professional team to define the improvement goals and 
develop a clear action plan. To achieve sustainability with improvement goals, 
the execution of the action plan must receive follow up, and the possible effects 
should be re-measured. By implementing these aspects, the improvement of 
patient-centred fertility care is just one step ahead of us.
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Abstract
Background
Beside traditional outcomes of safety and (cost-)effectiveness, the Institute of 
Medicine states patient-centredness as an independent outcome indicator to 
evaluate the quality of healthcare. Providing patient-centred care is important 
because patients want to be heard for their ideas and concerns. Healthcare areas 
associated with high emotions and intensive treatment periods could especially 
benefit from patient-centred care. How care can become optimally improved 
in patient-centredness is unknown. Therefore, we will conduct a study in the 
context of Dutch fertility care to determine the effects of a multifaceted approach 
on patient-centredness, patients’ quality of life (QoL) and levels of distress. 
Our aims are to investigate the effectiveness of a multifaceted approach and to 
identify determinants of a change in the level of patient-centredness, patients’ 
QoL and distress levels. This paper presents the study protocol.
Methods/Design
In a cluster-randomized trial in 32 Dutch fertility clinics the effects of a 
multifaceted approach will be determined on the level of patient-centredness 
(Patient-centredness Questionnaire - Infertility), patients’ QoL (FertiQoL) and 
levels of distress (SCREENIVF). The multifaceted approach includes audit and 
feedback, educational outreach visits and patient-mediated interventions. 
Potential determinants of a change in patient-centredness, patients’ QoL and 
levels of distress will be collected by an addendum to the patients’ questionnaire 
and a professionals’ questionnaire. The latter includes the Organizational Culture 
Assessment Instrument about the clinic’s culture as a possible determinant of an 
increase in patient-centred care.
Discussion
The study is expected to yield important new evidence about the effects of a 
multifaceted approach on levels of patient-centredness, patients’ QoL and distress 
in fertility care. Furthermore, determinants associated with a change in these 
outcome measures will be studied. With knowledge of these results, patient-
centred care and thus the quality of healthcare can be improved. Moreover, the 
results of this study could be useful for similar initiatives to improve the quality of 
care delivery. The results of this project are expected at the end of 2013.
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Introduction
Would it not be great if every hospital worldwide provides consistent, high-quality 
medical care to all patients? Unfortunately, this is still not daily reality, which 
underlines the importance of research projects on the improvement of quality of 
care.1 The Institute of Medicine structured the concept of ‘quality of care’ in 2001 
by defining six aims around the core need for high-quality healthcare; ‘safety’, 
‘effectiveness’, ‘timeliness’, ‘efficiency’, ‘equity’, and ‘patient-centredness’.1 
Subsequently, quality measures were developed mainly focusing on safety 
and effectiveness, while patient-centredness was often neglected.1-3 Patient-
centredness is defined as ‘care that is respectful of and responsive to individual 
patient preferences and needs and that is guided by patient values’.1 Providing 
patient-centred care is important, because it can build caring relationships 
between patients and healthcare providers4-5, improve health outcomes4,6,7, 
reduce costs4,6,8 and increase levels of patients’ quality of life (QoL).9 
Healthcare areas associated with high emotions and intensive treatment periods 
(for example, oncology or rheumatic care) could especially benefit from more 
patient-centred care. Fertility care is also one of these areas. In developed 
countries, infertility affects one in six couples who have tried to achieve 
pregnancy.10,11 About 55% of them seek medical help for their problem and start 
with a long lasting period of fertility workup and/or treatment12. This period is 
a physical and psychological burden for the couples13. For example, a woman 
undergoing in vitro fertilization (IVF) treatment has to inject herself for several 
weeks to stimulate the production of oocytes, visit the clinic multiple times for 
ultrasound check-up and has to undergo transvaginal retrieval of oocytes. After 
fertilization of the oocytes in the laboratory with sperm, the resulting embryo is 
transferred to the uterus. Subsequently, the couple has to wait two weeks to find 
out whether pregnancy has occurred. If not, the couple can start a new IVF cycle. 
Eventually, this treatment period can take several months to even years, which 
underlines the impact of infertility and its treatment on patient’s QoL. This may be 
seen in terms of impairments in psychosocial well-being, sexual satisfaction and 
marital relationship.13-16 Moreover, because of the high physical and emotional 
burden, about 23% of couples end treatment prematurely.17 Given these high 
percentage of patients deciding to terminate treatment early, frequently as a 
result of high psychological and psychical impact, every clinic should optimize its 
care towards more patient-centred care.13,14 
In Dutch fertility care, van Empel and colleagues showed that several parts of 
patient-centredness could be improved.18 How such improvement initiatives can 
be undertaken most successfully is still unknown. Moreover, there are potential 
barriers impeding improvement initiatives. For instance, professionals in fertility 
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care underestimate the importance of patient-centredness and have difficulties in 
estimating their performance correctly.19 Another barrier may be the organizational 
culture of a hospital. For instance, patients visiting hospitals that support 
teamwork are more satisfied with their care than patients visiting hospitals with 
other culture types (for example, hierarchical culture).20-23 Moreover, providing 
patient-centred care is often thought to be expensive and time consuming.24,25 
Obviously, steps need to be taken to achieve a behavioral change in professionals 
towards providing more patient-centred care. Because no magic bullets exist for 
changing healthcare providers’ behavior26, multiple interventions based on known 
barriers could accomplish this behavioral change and improve patient-centred 
care. 
We designed a study to evaluate the effects of a quality improvement strategy 
consisting of three different elements; that is, a multifaceted approach. We 
hypothesize that providing clinicians with this multifaceted approach will improve 
the level of patient-centredness and thus healthcare quality. If so, this is essential 
in improving patients’ QoL, reducing levels of distress and percentages of patients 
discontinuing treatment, and eventually reducing healthcare costs. 
The main aim of this study is therefore to determine the effects of a multifaceted 
approach on patient-centredness, patients’ QoL and levels of distress by: 
investigating the effectiveness of a multifaceted approach for care improvement on 
patient-centredness, patients’ QoL and levels of distress; identifying determinants, 
at both patient and clinic levels, of an increase in the level of patient-centredness, 
an increase in patients’ QoL and a decrease in distress levels; and performing a 
process evaluation to study the feasibility of the multifaceted approach and gain 
insight into factors that affected the impact of the intervention.
Methods / Design
Setting
In the Netherlands, secondary and tertiary fertility care is provided by three 
different types of clinics based on the kind of treatment they offer. Initial fertility 
assessment, ovulation induction and intra-uterine insemination are carried out 
in all Dutch clinics. The intermediate Dutch clinics can also start up and monitor 
the IVF and intra-cytoplasmic sperm injection treatments. However, oocytes 
retrieval and embryo transfer has to occur in one of the 13 licensed clinics (eight 
university hospitals, four general hospitals, and one private clinic). Almost all 
Dutch fertility clinics are national health service funded. Every Dutch citizen has 
a basic insurance coverage, which covers treatment and medication costs for 
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ovulation induction, intra-uterine insemination, and three cycles of IVF/intra-
cytoplasmic sperm injection.
Study population
The study will be performed in a representative Dutch infertile patient group, 
under treatment in one of 32 Dutch clinics. All couples that participate in this study 
underwent at least one cycle of medically assisted reproduction (for example, 
ovulation induction, intra-uterine insemination, IVF, and intra-cytoplasmic sperm 
injection). Both women and their partners will be invited to participate in this 
study individually. However, because it is still unknown whether women and 
partner experiences with patient-centred fertility care are associated, only the 
women’s data will be used to answer our main research questions. Partners’ 
data will be used to analyze whether gender is a determinant of patient-centred 
fertility care. Those couples who are pregnant while completing the questionnaire 
set will be excluded from all analyses, because most questions about patient-
centredness, patients’ QoL and levels of distress are confounded in this patient 
group.18,27,28
Ethical approval
The Regional Review Board for Research on Human Subjects (CMO) has received 
full ethical approval for this project (CMO No. 2011–034). The study is registered 
at clinicaltrials.gov NCT01481064.
Study design
In a cluster-randomized trial, the effects of a multifaceted approach on the level 
of patient-centred fertility care, patients’ QoL and the level of distress will be 
identified. To include a representative patient group for baseline measurement, 
clinics will be asked to extract the address files of all patients who underwent 
medically assisted reproduction in their clinics during the past three months 
(2011) from their diagnosis treatment combination coding system. Per clinic, 25 to 
75 patients will be randomly selected depending on the clinic’s size. Participation 
is voluntary and anonymous. The couples will receive a letter with an invitation 
to participate. If they are willing, they complete an online questionnaire set, 
accessible by a personal code. Two weeks after the initial mailing, all patients 
will receive a reminder. Another three weeks later, non responders will receive a 
reminder with their personal codes and the additional option to complete a paper 
version of the questionnaire.29 
Following baseline measurement, all 32 participating clinics will be randomly 
assigned to usual care (16 clinics) or to the multifaceted approach (16 clinics) with 
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stratification for clinic size (large/medium/small) and IVF facilities (full licensed 
/ intermediate / no IVF facilities). After one year of intervention exposure, all 
clinics again extract the address files of all patients who underwent medically 
assisted reproduction in the last three months for the after measurement. The 
same questionnaire set will be used, which again have to be completed by both 
the women and the partners separately. Figure 1 illustrates the study design 
schematically.
Questionnaires
The questionnaire set consists of three different questionnaires and some 
additional background questions for case-mix adjustment and to identify possible 
determinants of a change in the levels of patient-centredness, patients’ QoL and 
distress levels.
Patient-centredness Questionnaire – Infertility
The Patient-centredness Questionnaire – Infertility, a validated instrument 
measuring patient-centredness of fertility care by asking about patients’ 
experiences with care, is composed of 46 questions. This questionnaire contains 
seven subscales, namely: Accessibility, Information, Communication, Respect for 
patients’ values, Continuity and transition, Patient involvement, and Competence.18 
A higher score on the total Patient-centredness Questionnaire scale or one of the 
subscales represents a higher level of patient-centredness.
FertiQoL questionnaire
The internationally developed and validated FertiQoL questionnaire consists of 
two general items and two modules measuring QoL (the FertiQoL Core and the 
optional FertiQoL Treatment module). The Core module involves 22 fertility-specific 
items covering four subscales; Mind–Body, Emotional, Relational and Social. The 
optional treatment module assesses QoL related to the fertility treatment itself. 
In this study the Dutch version of the two general items and the FertiQoL Core 
module will be used. A higher score on the total FertiQoL scale or one of the 
subscales means better QoL.27
SCREENIVF questionnaire
The recently developed SCREENIVF questionnaire consists of 31 questions 
covering five emotional maladjustment scales (that is, five risk factors for 
increased emotional problems during fertility treatment); anxiety, depression, 
helplessness, acceptance regarding fertility problems, and perceived social 
support.30 The assessments of anxiety, depression and perceived social support 
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are based on generic instruments (that is, Spielberger State and Trait Anxiety 
Inventory31,32, Beck Depression Inventory33, and Inventory of Social Involvement34, 
respectively), and the assessments of helplessness and acceptance are based 
on a fertility specific instrument (that is, Illness Cognition Questionnaire35,36). 
Subscale scores will be calculated according to the cutoff values described by 
Verhaak and colleagues.30 Based on these five subscales, total SCREENIVF scores 
range from 0 to 5, indicating how many risk factors for increased emotional 
problems during fertility treatment are present.30
Figure 1 
Design of the study
Baseline measurement
(n=1600 couples, 32 clinics)
Randomization
Control group
(16 clinics)
Multifaceted approach
(16 clinics)
Usual care
After measurement
Feedback report
Educational 
Outreach Visit
Patient-mediated 
intervention(s)
Arter measurement
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The intervention
Clinics randomized for the multifaceted approach will be exposed to this intervention 
for one year. The content of the multifaceted approach is based on previous 
interviews with Dutch gynaecologists, fertility nurses and hospitals’ quality 
officers about their potential barriers and facilitators for quality improvement, 
and on previous studies on patient-centred fertility care.19,37,38 These studies 
reported a large variation between clinics and the need for feedback about 
current performance for the clinicians involved.18,19 However, it is shown that 
audit and feedback alone is not enough; the effectiveness increases if feedback is 
detailed, offered in high intensity, with professionals’ involvement and as part of 
a multifaceted intervention.39-42 We therefore designed a multifaceted approach 
consisting of three elements: audit and feedback, educational outreach visits 
(EOVs), and patient-mediated interventions. 
The feedback consists of a personalized paper report with the clinic’s own results, 
benchmarked and presented in relation to all 32 participating clinics. To identify 
aspects of care with priority for improvement, quality improvement scores will be 
calculated per clinic and presented in the feedback report. The higher a quality 
improvement score (3 – perceived experience score × importance score from 
the patients’ perspective), the more need there is for improvement.18 The clinics 
receive this report shortly after baseline measurement and one month before 
the EOV will take place. Prior to this visit, the researcher and representative 
gynaecologist will discuss the results from the baseline measurement and define 
the most important items for EOV. 
During EOV, the feedback reports will be discussed with the team of each clinic 
exclusively paying special attention to their high quality improvement scores. The 
EOVs are led by a researcher involved in baseline measurement and drafting the 
feedback reports. For the EOV, all members of the fertility team (gynaecologists, 
residents, nurses, secretaries, embryologists, analysts) will be invited. Each 
EOV results in the definition of improvement goals and a clear action plan 
with allocation of tasks defined by the professional team. The EOVs will also 
be attended by a quality officer of the hospital involved, who will manage the 
execution of the formulated action plan. Additionally, a representative of the 
Dutch Patients’ Association of Infertility ‘Freya’ who is a former patient of that 
clinic will be present. These representatives can present the needs and wishes 
of infertile patients during the EOV. All patients’ representatives will receive a 
manual about EOVs and undergo a short training program for fulfilling their role 
in the EOV. 
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Finally, to enable clinics to translate items mentioned in the feedback report to the 
clinic’s daily reality they are offered several patient-mediated interventions. For 
example, clinics can decide to organize focus groups or create online communities 
to gain more specific and detailed information from their patients about the care 
aspects with the highest quality improvement scores. 
Following the EOV, the hospital’s professional team and quality officer will be 
mainly responsible for the execution of the action plan. However, the researchers 
will monitor this process carefully by contacting the team every two months. 
Additionally, all professionals and representatives of Freya are invited to 
participate in an online study community. This community will be a platform 
for professionals to exchange their ideas about quality improvement programs. 
Besides, the researcher will write a blog at least every two months in which the 
quality improvement progress of all participating clinics will be described. The 
ideas and progress of one clinic can stimulate another clinic to improve even 
more.
Determinants of change in patient-centredness, patients’ QoL and 
distress levels
Patient characteristics
The following patient characteristics will be collected, based on general and 
fertility literature as possibly being associated with patient-centred care, QoL 
and/or levels of distress: gender, age, ethnicity, level of education, duration of 
relationship, economic status, duration and cause of infertility, fertility treatments 
so far received, consumption of professional emotional support during fertility 
treatment, medical history, and recently experienced lifetime events (for example, 
death of a relative, being fired from work).18,43-46
Clinic characteristics
Potential determinants at the clinic level will be collected by a professionals’ 
questionnaire during patients’ baseline measurement and by separate data 
collection during the EOV. The questionnaire will be spread electronically 
among all healthcare professionals (for example, gynaecologists, residents, 
nurses, laboratory employees, secretaries, and so forth) working at the fertility 
departments of the 32 participating hospitals. The questionnaire consists of two 
parts: twelve general questions about clinic characteristics (for example, number 
of fertility consultations per year, composition of the fertility team, mean age and 
sex ratio of the fertility team); and six questions from the Organizational Culture 
Assessment Instrument, a validated questionnaire to examine organizational 
culture based on the Competing Values Framework.47-49 The Competing Values 
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Framework recognizes that no hospital exhibits only one culture, but that 
multiple cultures and values coexist simultaneously50 (that is, clan/family culture, 
adhocracy culture, market culture, and hierarchy culture). The four culture types 
relate to each other on a two-by-two matrix with two axes denoting both the 
flexibility and the orientation of the hospital to the outside world.47-49,51-53 In this 
study the validated Dutch version of the Organizational Culture Assessment 
Instrument will be used.54 
Additional possible determinants at the clinic level of a change in patient-
centredness, patients’ QoL and distress levels will be collected during the EOV. 
According to the literature, these characteristics may influence successful 
implementation of the action plan – such as, for example, the level of preparation 
before and the enthusiasm and agreement of the professional team during the 
EOV.55 The researcher will record these team characteristics on a five-point Likert 
scale.
Sample size calculation
To account for a representative number of patients per clinic (that is, 25 to 
75 patients per clinic) at least 1,600 couples will be included. The sample size 
calculation, which was based on the results of the previous Patient-centredness 
Questionnaire validation study18, confirmed that this number of patients is sufficient 
for a proper analysis. To detect a mean difference score of 0.25 between usual 
care and the multifaceted approach on patient centredness ( = 0.05, two-sided 
testing, β = 0.8) at least 93 couples are required. Taking into account clustering 
of couples (30 couples/clinic) and a mean intracluster correlation coefficient 
of 0.1318, 1,023 couples have to be involved. With an expected response rate 
of 70%18, at least 1,462 couples have to be invited at both baseline and after 
measurement.
Data analysis
All data will be entered into a SPSS database (version 16.0 for Windows®; SPSS 
Inc., Chicago, IL, USA). Data analysis will be described following our two study 
aims.
Effectiveness of the multifaceted approach
To analyze the effectiveness of the multifaceted approach on patient-centredness, 
patients’ QoL and levels of distress, the difference in baseline and after-
measurement scores will be analyzed with adjustment for clustering of patients 
within clinics. Multilevel linear regression analyses will therefore be performed 
in which the intervention (multifaceted approach vs. usual care) will act as the 
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independent variable. The Patient-centredness Questionnaire – Infertility total 
and subscale scores, the FertiQoL total scores and the SCREENIVF scores will 
be used as dependent variables. Differences at baseline will be corrected for by 
taking baseline scores as a covariate in the final multilevel models.
Determinants of change in patient-centredness, patients’ QoL and distress levels
First, all independent variables concerning baseline patient and clinic 
characteristics will be checked for colinearity. These variables include all patient 
and clinic background characteristics, as well as the four variables concerning 
hospital culture, and the team characteristics collected during EOV. 
If a correlation coefficient >0.6 is found between two variables, preference will 
be given to the variable theoretically closest to actual outpatient performance. 
Subsequently, all independent variables will be tested in a univariate analysis with 
the dependent variables concerning the differences between patient-centredness, 
patients’ QoL and levels of distress in baseline and after measurement. The 
variables tend to be associated and show enough interclinic variation will be 
included in three multilevel linear regression models to explain differences in 
an increase in patient-centredness, an increase in patients’ QoL and a decrease 
in levels of distress, respectively. To assess which part of the variation can be 
explained by the determinants, the explained variance (R2) per model will be 
calculated. Significance for all analyses will be set at P <0.05.
Process evaluation
A process evaluation, according to Hulscher and colleagues56, will be performed 
during and after the intervention to investigate the feasibility of the action plan 
formulated during the EOV. This evaluation will also make clear whether and to 
what extent professionals and patients used and appreciated the elements of 
the multifaceted approach. Especially, process evaluation is essential to find out 
how and to what extent clinics accomplished the third part of the multifaceted 
approach; that is, patient-mediated interventions. 
During the intervention, telephonic interviews with the representative 
gynaecologists every two months will provide us with this information. Process 
evaluations at the end of the study will be based on a professional questionnaire, a 
questionnaire for the patients’ representatives, and an addendum to the patients’ 
questionnaire in the after measurement.
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Discussion
The study is expected to yield important new evidence about the effects of a 
multifaceted
approach on the improvement of patient-centredness, patients’ QoL and levels 
of distress in fertility care. Determinants at patient and clinic levels of a change 
in these variables will also be assessed. By having knowledge of these results, 
patient-centred care and thus quality of healthcare can be improved. This may 
lead to a higher patients’ QoL, lower levels of distress in infertile couples, a 
reduction in patient discontinuing treatment prematurely and a reduction in 
healthcare costs. 
To the best of our knowledge, this is the first study examining the effects of a 
multifaceted approach on patient-centred fertility care. In Dutch intensive care, a 
randomized trial is ongoing to determine the effect of a multifaceted approach on 
patient outcome and organizational process measures of care.57 Completed studies 
examining the effects of a multifaceted approach on guideline implementation 
showed incompatible results.26,42,58 In a systematic review on this subject the 
effects of different elements of a multifaceted approach were described, showing 
that the EOV is one of the most common evaluated interventions, resulting in 
modest improvements (6%, range -4 to 17.4%) in process of care.40 Audit and 
feedback and patient-directed interventions appeared to result in modest (7.0%, 
range 1.3 to 16.0%) and moderate (20.8%, range 10.0 to 25.4%) effects, 
respectively.40 Lewin and colleagues evaluated the effects of different interventions 
to promote patient-centred care.9 Significant effects on patient satisfaction were 
demonstrated when using multifaceted approaches instead of usual care [59,60]. 
The majority of these studies were undertaken in the area of primary care. In 
fertility care, no overall sustainable effect of a multifaceted approach was found 
over audit and feedback on the level of guideline implementation.37 This is in line 
with other studies on audit and feedback.39 
In sum, studies examining the effects of a multifaceted approach generally show 
slight improvements on patients’ well-being and patient-centred care. However, 
no clear evidence is available regarding how many and what combination of 
interventions provides the highest improvement in quality of care. One of the 
strengths of our study is that we will use a multifaceted approach consisting of three 
different interventions, which has been shown to be effective in different studies39 
and is based on known professional barriers.19,37,38 Further, our outcome measures 
will be determined by validated and internationally developed questionnaires 
enhancing our study results. Finally, because one-third of all Dutch hospitals from 
all regions in our country will be approached for participation, representativeness 
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of Dutch infertile couples can be ensured. Owing to these strong elements of our 
study, our results provide more evidence about the effectiveness of a multifaceted 
approach on patient-centredness, patients’ QoL and levels of distress in fertility 
care.
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Abstract 
Background
In recent years, it has become clear that healthcare should become more patient-
centred. However, an effective improvement strategy for patient-centred care, 
including the wishes and preferences of patients and tackling the barriers that 
professionals experience in daily clinical care, has not been found yet. Our main 
aim was to examine the effect of a multifaceted intervention on the improvement 
of patient-centredness in fertility care. 
Methods
We performed a cluster randomized controlled trial within 32 Dutch fertility clinics. 
A total of 1620 infertile women, under fertility treatment in one of the participating 
clinics, were randomly selected for participation during baseline measurement. 
They received the validated Patient-Centredness Questionnaire-Infertility (PCQ-
Infertility) to measure their clinics’ levels of patient-centredness. A multifaceted 
intervention strategy, consisting of audit and feedback, educational outreach 
visits, and patient-mediated interventions, was executed for one year in the 
intervention group, consisting of 16 clinics. The remaining 16 clinics performed 
care as usual. For the after measurement, we used the same PCQ-Infertility 
questionnaire among 1565 infertile women to measure clinics’ levels of patient-
centredness again.
Results 
A total of 696 patients (response 58.4%) were eligible for analysis at baseline 
measurement. At the after measurement, we analysed the data of 730 patients 
(response 60.4%). No significant differences in case-mix adjusted PCQ-Infertility 
total scores were found between the intervention and control group at after 
measurement. However, scores on the continuity of care subscale were significantly 
higher in the intervention group compared to the control group (B=0.20; 95% 
CI=0.00-0.40; p-value=0.047). Moreover, patients in the intervention group had 
significantly better experiences with fertility care than patients in the control 
group when they were younger than 36 years, when they began their fertility 
treatment after our study had started, and when they also used complementary 
and alternative medicine (B=0.31; 95% CI=0.14-0.48; p-value= <0.001).
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Conclusions
A multifaceted intervention including feedback and education was not sufficient 
to improve patient-centredness. An increase in the level of patient-centred 
care could however been achieved in specific patient groups. These results are 
stimulating and can guide future research in which we should focus even more on 
individualized strategies and outcome measures.
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Introduction
“Patient-centredness is not the route to a point, it is the point”. With this statement, 
Don Berwick emphasizes the importance of providing care that is adjusted to 
patients’ preferences, needs and values.1,2 Patient-centredness is a contemporary 
theme given the rising number of publications on this subject.3-7 There are several 
reasons why healthcare should become more patient-centred. First, because it 
is ‘just the right thing to do’, reflecting the ethical norms inherent in medicine.8 
Also the demonstrated associations between patient-centred care and improved 
clinical outcomes9,10, decreased healthcare costs11,12, and more satisfaction among 
patients and healthcare workers13-15 are motivators for professionals to improve 
their clinics’ levels of patient-centred care.
Previous studies have shown that the level of patient-centredness in current 
healthcare is not optimal yet.7,16,17 Apparently improvement needs more than 
professionals’ good intentions and could benefit from consistent and well-
performed improvement projects.18 An effective improvement strategy for patient-
centred care should include the wishes and preferences of patients and tackle the 
barriers that professionals experience in providing patient-centred care.3,4,7 Known 
barriers from the literature are, for example, a lack of professional urge to change 
their performance or difficulty to translate feedback into a concrete improvement 
design.3,19-23 Also a lack of time and monetary resources are brought forward by 
professionals as important reasons hampering the improvement of their clinics’ 
levels of patient-centredness.19,20 So far, the most optimal improvement strategy 
to overcome these barriers and really improve patients’ experiences with patient-
centred care has not been found yet. Moreover, patient-centredness has shown to 
be associated with several patient characteristics, such as age and education.24-26 
However, the effect of these characteristics on an improvement strategy for 
patient-centred care has not been studied yet.
Therefore, the main aim of our study was to determine the effect of a multifaceted 
approach, consisting of three elements, on the improvement of patient-centred 
care. Next, we identified determinants at the patient level of the effect of our 
intervention. Finally, we calculated the costs of the multifaceted approach from a 
societal perspective. We performed our study in the area of fertility care, as it is 
known that infertile patients suffer from a high physical and physiological burden 
during treatment and could especially benefit from patient-centred care.27
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Methods
Study design
We performed a cluster randomized controlled trial in 32 Dutch fertility clinics to 
determine the effect of a multifaceted approach on the level of patient-centred 
fertility care. After randomisation, 16 clinics were exposed to the intervention 
for one year and the other 16 clinics performed care as usual. The institutional 
ethics committee of Radboud University Medical Centre, Nijmegen provided 
ethical approval for this research to proceed (CMO nr 2011/034). Our trial was 
registered with ClinicalTrials.gov (NCT01481064) and we reported our results 
according to the CONSORT statement for cluster randomized trials. An extensive 
description of the design of our study is published elsewhere.28
Randomization
We used fertility clinics instead of patients as the unit of randomization to avoid 
contamination of the intervention. For randomization, clinics were stratified 
according to the clinic size (large, medium and small) and subsequently assigned 
to either the control group or multifaceted strategy. Three research associates 
performed the blinded randomization procedure by drawing randomly numbered 
and sealed envelopes.
Setting and study population
In the Netherlands, fertility care is provided through three different types of fertility 
clinics. A total of 13 large clinics are licensed to perform all kinds of Medically 
Assisted Reproduction (MAR). The intermediate clinics have to refer their patients 
to these larger clinics for the laboratory phase and embryo transfers of the in 
vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatments. 
The small fertility clinics only perform fertility assessment, ovulation induction 
(OI) and intra-uterine inseminations (IUI). In addition, a few very specialized 
fertility treatments are centralised within only one or two Dutch fertility clinics 
(e.g. Testicular Sperm Extraction (TESE) and Preimplantation Genetic Diagnosis 
(PGD)). For our study, we included patients who underwent at least one cycle of 
MAR in a small, intermediate or large Dutch fertility clinic. To do so, we asked 
clinics to extract the names and addresses of all patients who underwent MAR 
in their clinic in the past three months (i.e. summer 2011 and winter 2012) 
from their Dutch coding system for diagnosis and treatment. Subsequently, we 
randomly selected 25 to 75 patients per clinic, depending on the clinic size. We 
invited only the women of the infertile couples to participate as previous research 
has shown that women and their partners have comparable results on the 
primary outcome measure, i.e. patient-centredness of care.29 Because a strong 
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association between fertility treatment outcome (i.e. pregnancy) and our main 
outcome measure (i.e. patient-centredness of care) was previously shown30, we 
excluded all patients who had achieved pregnancy during the study period to 
avoid bias of our study results.
Sample size
Our sample size calculation was based on a previous Dutch study using the same 
patient questionnaire to determine the level of patient-centred fertility care as 
we did.30 The mean overall patient-centredness score in this study was 2.19 
(SD 0.43), and ranged from 1.72 (SD 0.62) to 2.47 (SD 0.28) on a scale from 
0 to 3. We considered an improvement of 0.25 points in our study as relevant. 
To detect this difference between usual care and the multifaceted approach 
(alpha=0.05, two-sided testing, beta=0.8) at least 93 couples were required. 
Taking into account clustering of couples (30 couples per clinic) and a mean 
intracluster-correlation coefficient of 0.1330, 1023 couples had to be involved. 
With an expected response rate of 70%30, at least 1462 couples had to be invited 
at both baseline and after measurement. 
Intervention
The content of the intervention was based on the existing literature about 
effective improvement strategies in healthcare4,22,31-33 and on previous interviews 
with Dutch fertility care professionals about their vision on patient-centred 
fertility care and its improvement.23 During one year, all 16 intervention clinics 
were exposed to the multifaceted approach, which consisted of three elements: 
1) Audit and feedback, 2) Educational Outreach Visits, and 3) Patient-mediated 
interventions. The audit was performed by means of a patients’ questionnaires, 
measuring clinics’ levels of patient-centred care. The feedback consisted of a 
paper report with the clinic’s own results regarding their level of patient-centred 
care. These results were benchmarked and presented in relation to all 32 
participating clinics. To identify aspects of care with priority for improvement, 
quality improvement scores (QI score) were calculated per clinic, which were 
based on both the patients’ importance of and experiences with different elements 
of patient-centred care, according to van Empel et al.30 The higher a QI score the 
more need there was for improvement. Two weeks after the clinics received the 
feedback report, we performed an Educational Outreach Visit (EOV) in each of 
the 16 clinics. We discussed the content of the feedback report with the entire 
fertility care team, paying special attention to their highest QI scores. Per clinic, 
a former patient and a quality officer were invited to participate in these EOVs 
as well. Former patients were invited for their personal experiences regarding 
fertility care in this particular hospital and were recruited by the Dutch Patients’ 
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Association of Infertility ‘Freya’. Prior to the EOV, these patients received a manual 
and underwent a short training to prepare their role in the EOV most optimally. 
Quality officers were invited for their experiences with performing improvement 
strategies in general. The main goal of each EOV was to define improvement 
goals and a clear action plan with allocation of tasks. We aimed for the definition 
of really concrete action points, such as ‘Provide all patients with a small card 
including the name of their main doctor and important phone numbers of the 
clinic’, or ‘At the end of each treatment phase, mention the possibility to visit 
a medical psychologist during consultation’. Furthermore, clinics were informed 
about different patient-mediated interventions to enhance the communication 
with their patients (e.g. organizing focus groups). Following the EOV, the fertility 
teams were mainly responsible for the execution of the action plans. However, 
the researcher monitored this process carefully and contacted the team every two 
months by phone to discuss the progress on the execution of their action plan. 
Moreover, we started an online community for the participating professionals and 
former patients to interchange their ideas and actions regarding the improvement 
of their care anonymously. Finally, clinics received an updated on the progress 
of the study every two months by means of a newsletter, intended to stimulate 
clinics’ willingness to improve.
Outcome measures
Patient-centredness of fertility care
To measure the level of patient-centredness in fertility care (i.e. our first study 
aim), we used the Patient-Centredness Questionnaire-Infertility (PCQ-Infertility). 
This is a validated instrument asking patients about their experiences with fertility 
care.30 The PCQ-Infertility is composed of 46 questions and contains seven 
subscales, namely: Accessibility (2 items, e.g. ‘Was it a problem for you to contact 
staff if you had any questions?’); Information (11 items, e.g. ‘Did you receive an 
overview of your treatment plan with a time schedule?’); Communication (7 items, 
e.g. ‘How often did your physician take you seriously?’); Respect for patients’ 
values (7 items, e.g. ‘How often did your physician show an interest in your 
personal situation?’); Continuity and transition (7 items, e.g. ‘How often did you 
have an appointment with the same physician?’); Patient involvement (3 items, 
e.g. ‘Was decision-making shared with you, if preferred?’); and Competence (6 
items, e.g. ‘How often was your physician well-prepared for an appointment?’). 
A higher score on the total PCQ scale or on one of the subscales (range 0-3) 
indicates a higher level of experienced patient-centredness.30 
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Determinants of the effect of the multifaceted intervention
In an addendum to the PCQ-Infertility, we asked for patients’ background 
characteristics to study their effect on the multifaceted approach. The selection of 
these characteristics was based on both general and fertility literature as possibly 
being related to patient-centred care, such as: age, ethnicity, level of education, 
duration and cause of infertility, consumption of professional emotional support 
during fertility treatment, and recently experienced life-time events (e.g. death 
of a relative, being fired from work).24,26,30,34,35 As a previous study showed a 
significant association between patient-centredness of fertility care and patients’ 
psychosocial status36, we also measured patients’ levels of QoL and risk factors 
for emotional maladjustment using the FertiQoL and SCREENIVF questionnaires, 
respectively. We used the Dutch version of the FertiQoL Core module, existing 
of 24 fertility-specific items covering four subscales, i.e. Mind-Body, Emotional, 
Relational and Social. A higher score on the FertiQoL questionnaire (range 0-100) 
means better QoL.37 The SCREENIVF questionnaire consisted of 31 questions 
covering five emotional maladjustment scales, namely: anxiety, depression, 
helplessness, acceptance regarding fertility problems, and perceived social 
support.38 All five scales had individual cut-off values to determine whether a 
patient was at risk at this specific domain.38 With a result above the cut-off value 
of at least one of these scales, a patient is considered at risk.38
Costs
We evaluated the costs associated with the implementation and execution of the 
multifaceted approach from a societal perspective, including the intervention costs, 
costs for additional healthcare consumption and productivity losses. All costs were 
calculated within a time frame of one year, as we expected no additional effects of 
our intervention after one year. For the intervention costs, we included costs on 
the basis of actual exposure with the audit and feedback, EOVs and execution of 
the action plans. We calculated the total intervention costs, the intervention costs 
per clinic and the costs per patient per clinic by dividing the clinic costs by the 
total number of patients that were under treatment in 2011 in that specific clinic. 
Costs for audit and feedback included the costs for the development, printing and 
shipping of the questionnaires and feedback reports. EOV costs included the time 
of the researcher and fertility team members and a treat for the EOV participants. 
We determined the costs of the execution of the action plan and patient-mediated 
interventions by means of a personalized questionnaire to the 16 representative 
gynaecologists of the intervention clinics. Clinic changes having no clear costs 
or costs that were not accurately measurable were not taken into account (e.g. 
gynaecologists paying more attention to patients’ emotions). Finally, researcher’s 
time expenses for coordinating the clinics were included.
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The costs for additional healthcare consumption included the medical costs for 
visiting other healthcare providers than gynaecologists, i.e. medical specialists, 
general doctors, physiotherapists, psychologists, dieticians, and physicians 
providing complementary and alternative medicine. For productivity losses, we 
measured the losses associated with patients’ visits to the fertility clinics (i.e. 
travelling time, waiting time and time for the actual appointment). Also productivity 
losses due to sickness absence were taken into account. Data concerning the 
additional healthcare consumption and productivity losses were collected through 
an addendum to the patients’ questionnaire. Subsequently, all prices were 
calculated from guidelines for cost related research in the Netherlands.39
Data collection
For data collection, we composed an online patient questionnaire consisting 
of the PCQ-Infertility, the FertiQoL and SCREENIVF questionnaires and several 
background questions. During baseline and after measurement, all selected 
patients received an invitation by mail in which they were asked to complete the 
online questionnaire set. Two weeks later, a reminder was sent by mail. The non-
responders received a paper version of the questionnaire three weeks later. At 
the after measurement, one gynaecologist per clinic (i.e. our contact) received a 
questionnaire per mail about the costs associated with the execution of the action 
plan and patient-mediated interventions. A reminder was sent after two weeks. 
Non-responders were contacted by phone as a final reminder. 
Statistical analysis
We compared all patient characteristics between the control and intervention 
groups at both baseline and after measurement using t-tests for independent 
samples and chi-quadrate tests when appropriate. We determined the effect 
of the multifaceted approach on the level of patient-centredness by comparing 
PCQ-Infertility total and subscale scores at the after measurement between the 
intervention and control group. Differences at baseline were corrected for by 
taking median baseline scores at the clinic level up as a covariate. Our analyses 
were performed with adjustment for clustering of patients within clinics and 
by taking into account relevant case-mix adjusters. Therefore, we performed 
multilevel multivariate regression analysis in which the PCQ-Infertility total 
and subscale scores acted as the dependent variables. The group variable 
(intervention vs. control), baseline scores and case-mix adjusters acted as the 
independent variables. To select relevant case-mix adjusters, we performed a 
series of univariate analyses with all background characteristics, including the 
results of the FertiQoL and SCREENIVF scores. Those associated with the PCQ-
Infertility total score (p<0.20) were selected as case-mix adjusters. In case of 
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collinearity (correlation analyses; Spearman’s ρ>0.6), we selected the clinically 
and theoretically most relevant characteristic. Finally, we excluded the statistically 
insignificant variables via manual backward elimination to come to our final model. 
Subsequently, we included interaction terms to our previous model concerning 
the PCQ-Infertility total scores to come to determinants of the effect of the 
intervention. We first dichotomized all continuous background characteristics into 
clinically relevant categories for a clearer interpretation of the interaction terms. 
For example, we dichotomized the characteristic: ‘Fertility care experience in 
months’ into ‘Already under treatment before the intervention started’ (i.e. more 
than 12 months experience) and ’Under treatment after the intervention started’ 
(i.e. 12 months experience or less). Then we created interaction terms for all 
background characteristics and the study group (intervention vs. control) and 
deleted the insignificant interaction terms through manual backward elimination. 
Finally, to study a potential difference in costs for additional healthcare 
consumption and productivity losses between the control and intervention groups, 
we performed multilevel linear regression analyses after we had log-transformed 
the data because of a skewed distribution of the costs. Significance for the 
analyses was set at P<0.05. Analyses were performed using SPSS (version 20.0 
for Windows®, SPSS Inc., Chicago, IL, USA). 
Results
At baseline measurement, a total of 1620 patients were invited to participate and 
946 patients (response 58.4%) completed the questionnaire set. After excluding 
250 pregnant patients, the results of 696 patients were taken up in the analysis. 
Shortly after baseline measurement, two intermediate fertility clinics merged to 
one new clinic. As it concerned one control clinic and one intervention clinic, we 
decided to exclude these clinics from our study to avoid extensive contamination 
of our intervention. After measurement was thus performed among 30 clinics 
and we invited a total of 1565 patients. The questionnaire set was completed by 
946 patients (response rate 60.4%). After excluding 216 pregnant patients, 730 
patients were eligible for our main analysis. Figure 1 shows the flowchart of this 
study.
Patients’ background characteristics at baseline measurement were comparable 
between the control and intervention group (p>0.05). Table 1 presents the patient 
characteristics at after measurement. Except for the scores on the FertiQoL and 
SCREENIVF questionnaires, no differences existed between the control and 
intervention group. Table 1 also shows which 14 background characteristics were 
selected as case-mix adjusters for our main analysis. 
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32 clinics 
Stratification
Randomisation with strata
Large clinics
(n=8)
Intermediate clinics
(n=16)
Small clinics
(n=8)
CONTROL
       
16 clinics: 4 large,
8 intermediate, 4 small
INTERVENTION
       
16 clinics: 4 large,
8 intermediate, 4 small
Baseline measurement
n=842
Respons
n=491 (58.3%)
Pregnant
n=124 (25.3%)
Eligible for analysis
n=367
Baseline measurement
n=778
Respons
n=455 (58.4%)
Pregnant
n=126 (27.7%)
Eligible for analysis
n=329
1. Feedback report
2. Eductional Outreach Visit
3. Patient-mediated 
interventions
Care as usual
After measurement
n=755
Respons
n=459 (60.8%)
Pregnant
n=106 (23.1%)
Eligible for analysis
n=353
After measurement
n=810
Respons
n=487 (60.1%)
Pregnant
n=110 (22.6%)
Eligible for analysis
n=377
O
ne
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ea
r
N
ov
 2
01
1 
– 
O
ct
 2
01
21 clinic excluded 1 clinic excluded
Figure 1. 
Flowchart of the study
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The mean PCQ-Infertility total and subscale scores from baseline and after 
measurement are presented in table 2. This table also shows the results of the 
multilevel multivariate regression analysis (i.e. case-mix adjusted differences). 
At the after measurement, case-mix adjusted PCQ-Infertility total scores did 
not significantly differ between the intervention and control group (B=0.06; 
95% CI= -0.04-0.15; p-value=0.246). However, on the PCQ-Infertility subscale 
‘Continuity of care’, the case-mix adjusted scores were significantly higher in the 
intervention group compared to the control group (B=0.20; 95% CI=0.00-0.40; 
p-value=0.047). No significant differences were found on the remaining PCQ-
Infertility subscales.
Table 3 shows the effect of the intervention on the PCQ-Infertility total scale 
after adding three significant interaction terms to the model. The effect of the 
intervention turned out to be significantly better when patients were younger 
than 36 years, when patients started their fertility treatment after the start of 
the intervention (i.e. fertility care experiences was 12 months or less) and when 
patients used complementary and alternative medicine (CAM). In cases patients 
met all three conditions, the scores in the intervention group were on average 
0.31 points higher compared to the control group (95% CI=0.14-0.48; p-value= 
<0.001). 
Figure 2 provides an overview of the effect of the intervention for all different 
combinations of the three relevant background characteristics. In four of the 
eight possible scenarios (i.e. 35% of our entire patient group), the intervention 
group scored significantly better than the control group.
An overview of all costs is presented in table 4. Total intervention costs of the 
multifaceted approach were €64.628. Of these costs, €4.110 was due to the 
audit and feedback, €14.327 was spend on the educational outreach visits. The 
costs for the patient-mediated interventions and execution of the action points 
was €46.191. Median intervention costs per clinic per year were €3324 (range: 
€959 – €11.550). The median yearly costs per patient per clinic were €13, 
ranging from €2 to €28 an in general, these costs were lower for the larger IVF 
clinics and higher for the smaller clinics. Also the costs for additional healthcare 
consumption and productivity losses are presented in table 4. Multilevel linear 
regression analyses on log-transformed data showed no significant differences 
between the productivity losses in the intervention and the control group during 
after measurement.
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Discussion 
A multifaceted approach, consisting of audit and feedback, educational outreach 
visits and patient-mediated interventions, did not improve the entire level of 
patient-centred fertility care. However, we can still consider our results as an 
important step towards the improvement of patient-centred care, because patients’ 
experiences did improve among three important patient sub groups. These results 
suggest that patient-centredness improvement initiatives should also concentrate 
on (sub groups of) patients that could especially benefit from a personalized and 
patient-centred approach, as this might not be the same for every patient. We 
will continue on this statement more in depth. However, we should consider some 
interesting results for our entire patient group first, as we did find a significant 
improvement on the patient-centredness subscale ‘Continuity of care’. This 
subscale received the lowest scores at baseline measurement and could therefore 
be considered as the subscale with the highest priority for improvement. Worse 
scores at baseline measurement might have motivated professionals just a bit more 
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The mean PCQ-Infertility total and subscale scores from baseline and after measurement are 
presented in table 2. This table also shows the results of the multilevel multivariate regression 
analysis (i.e. case-mix adjusted differences). At the after measurement, case-mix adjusted 
PCQ-Infertility total scores did not significantly differ between the intervention and control 
group (B=0.06; 95% CI= -0.04-0.15; p-value=0.246). However, on the PCQ-Infertility 
subscale ‘Continuity of care’, the case-mix adjusted scores were significantly higher in the 
intervention group compared to the control group (B=0.20; 95% CI=0.00-0.40; p-
value=0.047). No significant differences were found on the remaining PCQ-Infertility subscales.
Table 3 shows the effect of the intervention on the PCQ-Infertility total scale after adding three 
significant interaction terms to the model. The effect of the intervention turned out to be 
significantly better when patients were younger than 36 years, when patients started their 
fertility treatment after the start of the intervention (i.e. fertility care experiences was 12 
months or less) and when patients used complementary and alternative medicine (CAM). In 
cases patients met all three conditions, the scores in the intervention group were on average 
0.31 points higher compared to the control group (95% CI=0.14-0.48; p-value= <0.001). 
Table 3
Case-mix adjusted difference between intervention and control group on the PCQ-
Infertility total score when taking into account relevant interaction terms.
a When adjusted for the nine presented patient characteristics, the intervention group had a 0.31 points (95% 
CI=0.14-0.48) higher score on the PCQ-Infertility total scale compared to the control group in case patients 
started treatment after the intervention had started, were younger than 36 years and used CAM.
 
Characteristics
Differences in PCQ-Infertility total scores
              B (95% CI)
Intercept                            0.18 (-0.41-0.76)
Intervention vs. Control 0.31 (0.14-0.48)a
Lower level of education 0.06 (0.00-0.12)
Male vs. unknown diagnosis 0.11 (0.03-0.19)
ART treatment 0.14 (0.07-0.20)
Visits as a couple 0.09 (0.03-0.15)
Quality of life 0.01 (0.01-0.01)
Baseline measurement 0.62 (0.36-0.87)
CAM use -0.18 (-0.28- -0.07)
Under treatment after intervention started 0.01 (-0.08-0.09)
Age < 36 years -0.11 (-0.20- -0.03)
INTERACTION TERMS: Characteristic * Study group
Under treatment after intervention started -0.11 (-0.23-0.00)
Age < 36 years -0.11 (-0.23-0.00)
CAM use -0.17 (-0.31- -0.03)
Table 3
Case-mix adjusted difference between intervention and control 
group on the PCQ-Infertility total score when taking into account 
relevant interaction terms.
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to improve especially this patient-centredness domain. In addition, the continuity 
of care had the highest potential for improvement as well, which corresponds to 
the findings within other healthcare areas, showing that lower baseline scores 
are associated with the highest improvements.32 It should however be noted that 
the results on this subscale are on the margin of being statistically significant. 
Concerning the intervention costs, it is stimulating that the costs per patient per 
year were relatively low, especially for some of the clinics (median: €13, range 
€2 - €28). In general, costs per patient were lower for the larger clinics as the 
majority of their action points were executed by secretaries and nurses instead of 
gynaecologists, who are obviously much more expensive per hour. Clinics should 
therefore learn from each other to discover how similar improvement projects 
could be executed for relatively lower amounts of money. Also the most optimal 
balance between the effects and costs of a multifaceted improvement strategy 
for patient-centred care should be debated. In addition, the costs for additional 
healthcare consumption and productivity losses did not differ between the control 
and intervention groups, suggesting that the provision of patient-centred care is 
not associated with increased indirect medical and societal costs. 
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Figure 2 pr vides an overview of the effect of the intervent on f r all different combi a ions of 
the th ee relevant background charac eristics. In four of the eight p ssible scenarios (i. . 35% 
of our entire patient group), the intervention group scored significantly better than the control 
group.
Figure 2
The case-mix adjusted effect of the intervention on the PCQ-Infertility total score for 
eight different patient profiles
 
Case-mix adjusted coefficients (B) with 95% confidence intervals and corresponding p-values are demonstrated 
here. In four out of eight possible scenarios (bold outlines), the intervention group had significantly higher scores 
on the PCQ-Infertility subscale total scale compared to the control group. For example, when patients had less 
than one year fertility care experience, were younger than 36 years and did not use CAM, the intervention group 
had a 0.14 points (95% CI=0.01-0.26) higher score on the PCQ-Infertility total scale than the control group. 
An overview of all costs is presented in table 4. Total intervention costs of the multifaceted 
approach were €64.628. Of these costs, €4.110 was due to the audit and feedback, €14.327 
was spend on the educational outreach visits. The costs for the patient-mediated interventions 
and execution of the action points was €46.191. Median intervention costs per clinic per year 
were €3324 (range: €959 – €11.550). The median yearly costs per patient per clinic were €13, 
ranging from €2 to €28 an in general, these costs were lower for the larger IVF clinics and 
higher for the smaller clinics. Also the costs for additional healthcare consumption and 
productivity losses are presented in table 4. Multilevel linear regression analyses on log-
transformed data showed no significant differences between the productivity losses in the 
intervention and the control group during after measurement.
Patient
...after studie 
started
...before study 
started
<36 years
=36 years
<36 years
=36 years
B=0.20 (0.04-0.36), p=0.012
B=0.03 (-0.08-0.14), p=0.639
B=0.09 (-0.08-0.26), p=0.295
B=-0.08 (-0.21-0.05), p=0.217
Yes
No
Age CAM useUnder treatment...
Yes
No
Yes
No
Yes
No
B=0.03 (-0.12-0.18), p=0.710
B=0.20 (0.01-0.39), p=0.035
B=0.14 (0.01-0.26), p=0.037
B=0.31 (0.14-0.48), p=<0.001n=29
n=133
n=15
n=54
n=66
n=249
n=26
n=122
Differences in PCQ-Infertility 
total score between intervention 
and control group
Figure 2
The case-mix adjusted effect of the intervention on the PCQ-Infertility 
total score for eight different patient profiles
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Table 4
Overview of all costs from a societal perspective
a Clinical data refers to empirical data collected in this study.
b PostNL is the national mail delivery company taking care of the shipping of all questionnaires, feedback reports
  and newsletters: http://www.postnl.nl/tarieven/partijenpost/binnenland
c Recommended prices according to national guidelines for cost calculations in health care by Hakkaart-van 
  Roijen et al.39
d Bakery
e Additional healthcare consumption included the frequency of visiting six different healthcare providers per 
  year (i.e. general practitioners, dieticians, physiotherapists, psychologists, alternative doctors and other 
  medical specialists) multiplied by the Dutch medical costs per consultation, according to Hakkaart-van Roijen   
  et al.39
Unit / Unit price (€) Intervention Control
Intervention costs
costs per year
(€) (€)
Audit and feedback
Development of online questionnaire Fixed / 845,00a 845 -
Printing and shipping questionnaires Questionnaire / 6,88a,b 2408 -
Developing feedback reports Hour / 32,58a 489 -
Printing and shipping feedback reports Report / 13,57a,b 368 -
Total 4.110 -
Educational Outreach Visits
Time expenses researcher Hour / 32,58a,c 671 -
Time expenses fertility team Hour / 20,61 – 135,50a,c 13.303 -
Treats EOV’s Treat / 2,35d 353 -
Total 14.327 -
Patient-mediated interventions and action points
Coordinating time researcher Hour / 32,58a,c 2.111 -
Developing newsletters Hour / 32,58a 201 -
Execution action points Clinic / 0 – 9.294a 43.879 -
Total 46.191 -
Total intervention costs 64.628 -
Median costs per clinic (range) 3.324 (959-11.550) -
Median costs per patient per clinic (range) 13 (2-28) -
Additional healthcare consumptione
costs per patient per year, median (range)
112 (0-8000) 112 (0-7056)
Productivity losses 
costs per patient per year, median (range)
Fertility clinic visits 
Travel time 376 (0-6.467) 343 (0-4.720)
Waiting time 120 (0-2.451) 127 (0-1.470)
Appointment 148 (0-1.612) 159 (0-932)
Sickness absence 944 (0-31.468) 892 (0-47.203)
Table 4
Overview of all costs from a societal perspective
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The most important strength of our study is the involvement of patients in the 
design, intervention and measurement of the study. We included more than 
1500 infertile patients at both baseline and after measurement who received 
different treatments in all different phases ensuring representativeness of the 
Dutch infertile population. We measured the level of patient-centred care with 
a validated questionnaire asking for objective patients’ experiences with care. 
Moreover, patients played an important role in the execution of the intervention, 
as former patients of the participating clinics took part in the EOVs. Finally, 
we corrected for clustering of patients within one clinic and adjusted for many 
background characteristics related to patient-centred care.
Some limitations of our study should also be taken into account. First, although 
our response rates seem sufficient (i.e. about 60%), the responses of many 
patients are still lacking which could have biased our results. For example, 
patients who were not satisfied with their care could not have completed the 
questionnaire. As we expect this to be true for patients in both the control and 
the intervention group, we consider the potential bias to be limited. Second, we 
performed our study within the area of Dutch fertility care. The results of our 
study might therefore be less representative for other healthcare areas or other 
countries. More research is needed to study the effect of such an intervention in 
a more broader and international setting. Within Europe however, comparable 
results could be expected as Dancet et al. showed that patients’ preferences and 
needs in fertility care are similar throughout Europe.40 Also the need for more 
patient-centred care has been describes in other healthcare areas.41-43 Third, 
patient-centredness scores at baseline measurement were already reasonably 
high, which might have limited the effect of our intervention. This is supported 
by our results showing that only the ‘continuity of care’ subscale, receiving the 
lowest scores at baseline measurement, improved significantly. Possibly, the level 
of patient-centredness of Dutch fertility care was already rather good at the start 
of our study and a higher impact of the multifaceted approach could not have 
been expected.
The results of our study are of interest, as the evidence on how to improve 
patient-centredness in current healthcare is scarce. A review of Dwamena et al. 
showed that many interventions that promote patient-centred approaches were 
largely successful in teaching professionals new skills (e.g. clarifying patients’ 
concerns and communicating about treatment options).4 However, when providers 
practiced these skills, it was not clear whether patients were more satisfied with 
their care.4 These conflicting results might be due to poor methodological quality 
or the use of less relevant strategies for care improvement.4,44 It might also be 
explained by the use of satisfaction surveys, which lack discriminative power as 
they often provide an overly optimistic picture of patients’ perception of health 
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care.45 We therefore asked for patients’ more objective experiences with care 
instead of measuring patient satisfaction.
Despite this, our multifaceted approach did not reach a significant effect in our 
entire patient group. This could be due to an incomplete execution of the action 
points or to contamination because of major clinic changes that were executed by 
both the intervention and control clinics apart from the intervention (e.g. rebuilding 
of a clinic or change in the composition of the fertility team). An extensive and 
systematic process evaluation could be helpful to evaluate the actual exposure to 
the several elements of the multifaceted approach and to study whether a clinic’s 
higher performance rate on the action plan relates to a higher increase in patient-
centredness scores46. Also reduced sensitivity of the PCQ-Infertility questionnaire 
could have contributed to a lack of effect. However, since the questionnaire 
had good psychometric properties and was able to discriminate between clinics 
in a previous study30, other explanations may seem more obvious. We should 
therefore consider the significant interactions in our study in more detail, as they 
showed that we were able to increase patients’ experiences with fertility care 
within specific patient groups. 
First, patient-centredness of care significantly improved due to the multifaceted 
approach when patients started treatment during the intervention period (i.e. 
less than 12 months ago). In other words, our intervention seemed to be less 
effective for patients who were already under treatment before this study 
started. This suggests that patients are biased by their expectations and previous 
experiences with care, reducing the effect of the intervention, which is supported 
by the literature.47,48 Based on these results, we might state that improving 
patients’ experiences should probably include the management of patients’ 
expectations as a first step. The second characteristic influencing the effect of 
our intervention was women’s age. Previous studies about the relation between 
patients’ perspectives on fertility care and age did not always find significant 
associations.49-51 An explanation for our study results might however be found 
in women’s infertility problem itself. Because older women have decreasing per-
cycle pregnancy rates, they might care less about their clinic’s level of patient-
centred care as getting pregnant is the only thing that is on their mind. This 
corresponds to the results of van Empel et al. showing that, compared to the level 
of patient-centred care, pregnancy rates were relatively more important to older 
patients than to younger patients.52 Third, the multifaceted approach appeared 
to be more effective when patients received some kind of CAM, such as hypnosis, 
homeopathy or acupuncture. About 20% of our patients used CAM, which is quite 
comparable with CAM use by infertile patients in other western countries.53-55 The 
relation between CAM and patient-centred care or its improvement has never 
been studied, but Nachtigall et al. suggest that cultural factors affect patients’ 
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decision to choose for CAM.56 Also in other healthcare areas, racial and ethnic 
differences in CAM use have been described.57,58 Presumably, CAM users are a 
unique patient group being more sensitive to the improvement of patient-centred 
care, as suggested by our study results. This is in concordance with the results of 
Vincent et al., showing that CAM users belief in the value of treating the person 
as a whole and strive for more patient participation in one’s care.59
Due to the success of our intervention in specific patient groups, we might suggest 
focusing more on strategies and outcome measures at the sub group level or 
even at the individual level to improve the experiences of all our patients. In the 
last decades, physician-defined outcomes were mainly evaluated in research to 
determine the success of new therapies or medication.60 Recently, important steps 
have been made towards the use of more patient-reported outcome measures as 
we also did in our study through the PCQ-Infertility questionnaire. The introduction 
of more individual reported outcome measures has now been suggested in the 
literature as a new and innovating step.60-62 By putting the patient in the centre 
of outcome assessment, we could increase the interaction between patients and 
professionals and probably improve patients’ experiences with care.60 This is 
especially true in cases of a wide inter-individual variation in patients’ needs and 
expectations, causing a limited responsiveness of a fixed-item instrument, such 
as the PCQ-Infertility.61 Future research should concentrate on the value of these 
individual outcome measures and its integration in usual care.
In conclusion, a multifaceted intervention including patient guided feedback and 
education does not improve care experiences of all patients in fertility care. An 
increase in the level of patient-centred care could however been achieved in patients 
who were under treatment after the intervention had started, were younger than 
36 years and also used CAM. To increase the effect of our intervention in the 
future, we might have to focus on more individualized strategies and outcome 
measures by organizing our care around the patient.
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Abstract
Background
Process evaluations are of high importance when studying the effects of 
complex, multifaceted interventions. Results could namely be useful for adjusting 
improvement strategies to potentially more effective ones and for applying 
interventions to a larger scale. Therefore, we complement the findings of our 
randomized controlled trial (RCT) on the improvement of patient-centredness in 
Dutch fertility care by giving a detailed evaluation of our multifaceted intervention 
strategy. 
Methods
We performed an observational study within 32 Dutch fertility clinics that were 
included in a RCT, studying the effects of a multifaceted strategy, including audit 
and feedback, educational outreach visits and patient-mediated interventions, on 
the level of patient-centred care. Questionnaires were used to study professionals’ 
and patients’ experiences with the intervention and clinics’ exposure to the 
improvement strategy. We used multilevel linear regression analyses to study 
the relation between clinics’ intensity rate on the intervention and the increase 
in patient-centredness and to identify determinants at the clinic level of an 
improvement in patient-centred care.
Results 
In general, patients’ and professionals’ experiences with the intervention were 
mainly positive. Clinics came up with a median number of five action points 
(range: 3-7) for improving their patient-centredness levels and after one year, 
they finished 75% of their improvement plan (range: 20-100%). The numbers of 
clinics’ executed improvement projects were not related to patient-centredness 
improvement. However, improvement in patient-centredness scores was 
significantly associated with higher levels of patient participation during the EOV, 
higher organizational group culture scores, and the absence of structured, weekly 
meetings to discuss all patients within the fertility team.
Conclusions
A multifaceted improvement strategy for patient-centred fertility care was 
positively evaluated. The resulting determinants of an improvement in patient-
centredness showed that, in future projects, patients need to have a more 
important voice in the intervention and clinics should not only focus on their 
guidelines and protocols but listen to their individual patients’ preferences 
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and needs as well. Finally, managers have to work on their teams to improve 
teamwork, especially to act as a group to reach their common goal of optimal 
patients’ experiences with care. 
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Introduction
In previous decades, researchers mainly studied the effect of ‘simple’ interventions 
on predefined health outcomes, such as the effect of a new drug on survival or 
quality of life.1,2 However, due to the growing complexity of interventions and 
outcome measures over the last years, studies need to focus on more than their 
outcome alone.3 Studies investigating complex interventions, e.g. existing of 
different elements or executed at multiple levels, should at least be guided by an 
in-depth process evaluation2,3, as the ‘same’ intervention could be implemented 
in different ways.3,4 Process evaluations are not interested in a study’s success or 
lack of success, but take a look into the ‘black box’ of the intervention to see what 
actually happened.1,5 Therefore, they can be helpful in the interpretation of study 
results. For instance, by understanding the relationship between specific study 
elements and study outcomes.1,3 Moreover, having knowledge of the processes 
is important for the replication of interventions, for modifying an intervention to 
a potentially more effective one, and for applying interventions to a larger scale. 
Process evaluations might also aid the improvement of implementation science 
in general.2 However, few complex interventions have included the evaluation of 
both the outcomes as well as the processes.2
We recently performed a randomized controlled trial in the area of fertility care 
that could benefit from a systematic process evaluation. In this study, we aimed 
for the improvement of patient-centred care, one of the six dimensions of quality 
of care, that takes into account individual patients’ preferences and needs in 
healthcare.6 Because improvement potential for Dutch patient-centred fertility 
care had been shown in previous studies7-9, we designed a multifaceted strategy 
that existed of three elements (i.e. feedback reports, educational outreach visits 
and patient-mediated interventions) and was executed within 32 Dutch hospitals. 
Our results showed no significant improvement in the total level of patient-
centred care one year after clinics were exposed to the multifaceted strategy. We 
did however show a significant improvement among specific domains of patient-
centredness and in specific patient groups, indicating the need for a more in-
depth understanding and evaluation of the multifaceted intervention. 
Therefore, our main aim was to complement the findings of our RCT by giving 
a detailed account of the multifaceted intervention strategy for patient-centred 
fertility care. The process evaluation was based on three research questions: 
(i) How did both professionals and patients evaluate the importance, their 
expectations and experiences with the different components of the 
intervention? 
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(ii) What was the relation between the improvement of patient-centred care 
and clinics’ intensity on the multifaceted strategy? 
(iii) Which characteristics at the clinic level could be identified as determinants 
of an increase in the level of patient-centredness?
Methods
Design 
We performed an extensive process evaluation study which belonged to a 
previously performed RCT about the improvement of patient-centred fertility 
care.10 Based on the framework of Hulscher et al., we described the multifaceted 
intervention and we evaluated the intervention through the eyes of the study 
participants by asking them about the importance, expectations and experiences 
with the multifaceted strategy.5 Furthermore, we determined clinics’ intensity on 
the intervention, as measured by the number of executed improvement projects 
on patient-centred care, in relation to clinic’s levels of patient-centredness. Finally, 
we studied the relation between the improvement of patient-centred care in our 
intervention group and several characteristics at the clinic level, i.e. standard 
characteristics, clinics’ culture types, and study related characteristics.
Setting
Clinical setting
Our study was performed in the area of fertility care. In the western world, one in 
six couples suffer from involuntary childlessness as they were not able to achieve 
pregnancy after twelve months of regular, unprotected sexual intercourse.11-13 
About 50% of these couples seek help for their fertility problem and start with an 
often lengthy period of fertility work up and treatment.14,15 In the Netherlands, 
fertility care is provided by three different types of clinics. Large IVF clinics perform 
all kinds of fertility treatments, while intermediate clinics refer their patients 
to an IVF clinic for the laboratory phase and embryo transfers of the In Vitro 
Fertilization (IVF) and Intra-cytoplasmic Sperm Injection (ICSI) treatments. The 
smaller Dutch clinics carry out only initial fertility assessment, ovulation induction 
(OI), and intra-uterine inseminations (IUI). Almost all Dutch fertility clinics are 
national health service funded and every Dutch citizen has a basic insurance 
coverage, covering treatment and medication costs for OI and IUI and three 
cycles of IVF / ICSI.
CHAPTER 10204
The randomized controlled trial
Our RCT was performed from June 2011 until April 2013 within 32 Dutch fertility 
clinics; eight IVF clinics, 16 intermediate clinics and eight smaller clinics. During 
baseline measurement, we measured clinics’ levels of patient-centredness 
using the Patient-Centredness Questionnaire-Infertility (PCQ-Infertility) among 
696 women who had undergone at least one cycle of fertility treatment in the 
previous three months. The validated questionnaire asked for objective patients’ 
experiences with fertility care within 46 questions, divided into seven subscales; 
‘Accessibility’, ‘Information provision’, ‘Communication’, ‘Respect for patients’ 
values’, ‘Continuity and transition’, ‘Patient involvement’, and ‘Staff’s competence’.8 
Subsequently, 16 clinics were randomized to the multifaceted improvement 
strategy and the remaining 16 clinics performed care as usual. After one year, 
we used the same PCQ-Infertility questionnaire to measure patient-centredness 
levels in a comparable group of 730 infertile women.
The intervention
In general, our intervention consisted of audit and feedback, educational outreach 
visits, and patient-mediated interventions. Furthermore, we used three tools (i.e. 
contacts by phone, newsletters, and an online study community) to monitor and 
stimulate the execution of the intervention during the entire study period. The 
first element of the multifaceted intervention, the feedback report, consisted of a 
personalized paper report with clinics’ own results, benchmarked and presented 
in relation to all 32 participating clinics. The 16 intervention clinics were pointed 
at care aspects with priority for improvement by providing them with quality 
improvement scores (QI scores). These scores combined both patients’ actual 
experiences with the different care aspects and their corresponding importance 
scores as collected in a previous study.8 One month after a clinic received the 
feedback report, its content was discussed with all members of the fertility team 
during an EOV. The EOVs were also attended by a quality officer of the hospital 
involved and a representative of the Dutch Patients’ Association of Infertility 
‘Freya’ who was a former patient of that clinic. Each EOV resulted in the definition 
of improvement goals and a clear action plan with allocation of tasks. Furthermore, 
clinics were offered several patient-mediated interventions. For example, they 
could decide to organize focus groups, or create online communities to gain more 
specific and detailed information from their patients’ wishes and preferences with 
fertility care. These interventions were also taken up in the clinic’s action plan. 
For monitoring and stimulating the execution of the action plan, the researchers 
contacted the team every two months and send them newsletters. Additionally, 
all professionals and former patients were invited to participate in an online study 
community to exchange their ideas and actions regarding the improvement of 
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patient-centred fertility care.
Process evaluation measures
Importance, expectations and experiences
We first evaluated the quality of the feedback reports and EOVs through a 
questionnaire for all EOV participants (i.e. professionals, quality officers and 
former patients) and gathered their experiences on a 5-points Likert scale (e.g. 
1=the feedback report was not meaningful at all to 5=the feedback report was 
very meaningful). Furthermore, we asked the representatives of both the control 
and intervention clinics about the importance of the study, expectations regarding 
their clinic’s results and their general experiences with the different study 
elements. To evaluate the study importance, gynaecologists had to distribute 
a hypothetical research subsidy of €1000 between three research subjects, i.e. 
effectiveness, safety and patient-centredness of fertility care. Subsequently, they 
provided their expected scores at after measurement (i.e. worse, comparable 
or better than baseline measurement) on the PCQ-Infertility total and subscale 
scores. Next, we evaluated professionals’ general experiences with the study. For 
this part, the gynaecologists rated the quality of the research team and scored 
the meaningfulness of the different study elements on a scale from 0 to 10.
Clinics’ intensity on the intervention
We evaluated clinics’ intensity on the multifaceted intervention by collecting data 
regarding clinics’ actual execution of the action plans at two moments; six months 
after the EOV and during after measurement. At six months, we contacted the 
representative gynaecologists by phone and asked for the number and kind of 
action points that were already executed. Then, during the after measurement, 
gynaecologists received a personalized questionnaire per mail in which they 
could indicate the number and kind of action points they had actually performed 
after one year. In addition, we were interested in clinic changes of both the 
intervention and control clinics that were executed apart from the RCT and that 
could have influenced the main outcome measure of our RCT, the level of patient-
centredness. Therefore, we provided all gynaecologists with a list consisting of all 
action points of the 16 intervention clinics and asked them which of these care 
elements had been improved in the past year as well. We also left some room for 
other, spontaneous improvement projects that were not mentioned in the list, but 
could be considered as ‘noise’ in our study (e.g. a clinic’s rebuilding or change in 
composition of the fertility team).
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Determinants of improvement
We collected relevant potential determinants of an improvement of patient-
centred care at the clinic level, based on the literature as possibly being related 
to patient-centredness or quality improvement in healthcare.16-22 The different 
clinic characteristics could be divided into three levels. 
First, we gathered eight standard clinic characteristics, i.e. the clinic type, 
the number of gynaecologists, whether clinics had specialized fertility nurses 
and / or clinic psychologists, the presence of a separate waiting room and / 
or semen production room, and whether clinics had structured meetings to 
discuss all patients and / or regularly measured clinic’s quality levels. Second, 
we identified the organizational culture of all clinics as a potential determinant 
of an improvement of patient-centred care using the Organizational Culture 
Assessment Instrument (OCAI). This validated questionnaire is based on the 
Competing Values Framework (CVF)23-25, which recognizes that a combination 
of four cultures coexist simultaneously within one hospital (i.e. group, rational, 
developmental, and hierarchical culture).26 These four culture types relate to 
each other on a two-by-two matrix with two axis denoting both the flexibility (i.e. 
stabile vs. change) and orientation (i.e. internal vs. external) of the hospital to the 
outside world.23-25,27-29 To determine a clinic’s organizational culture, we used the 
online version of the validated Dutch OCAI questionnaire at the start of the RCT.30 
For each of the six questions, members of the 32 fertility teams were asked to 
distribute 100 points across four statements representing the four culture types 
that best fitted their own clinic’s organization. For each clinic, we determined the 
mean scores on the four culture types. In addition, we calculated the balance 
of the scores for the different culture types, using the Blau index as described 
in previous studies.26,27,31 A higher score on this index (scale 0-1) indicates a 
more even distribution of points among the four culture types.26 The third group 
of potential determinants of patient-centredness improvement existed of eleven 
study related characteristics, e.g. a clinic’s willingness to participate, the number 
of participants during the EOV, and consensus of the professional team regarding 
their action plan. Items reflecting an opinion on or attitude towards the fertility 
team (e.g. willingness to participate) were measured on a 5-points Likert scale by 
the main researcher who also led the EOVs (e.g. 1=no willingness to participate 
to 5= very high willingness to participate).
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Data collection
We used four different questionnaires in this study to collect our data. First, 
at baseline measurement, we collected eight standard clinic characteristics as 
a potential determinant of patient-centredness improvement through an online 
questionnaire for the 32 representative gynaecologists. The non-responders were 
contacted by phone to guarantee a complete response. Meanwhile, the online OCAI 
questionnaire was send to all 476 members of the 32 fertility teams to evaluate 
clinics’ organizational culture types. We send a reminder to the non-responders 
after two and after five weeks. A third questionnaire was used to evaluate the 
quality of the feedback reports and EOVs among all EOV participants. The online 
questionnaire was send shortly after the EOVs and non-responders received a 
reminder after two and after five weeks. The fourth and last questionnaire was 
used during after measurement. We composed a paper questionnaire for all 
32 representative gynaecologists to evaluate the actual exposure to the study 
and their importance scores, expectations and experiences with the study. The 
questionnaires were personalized as every intervention clinic worked on their 
own, unique action plan and some of the questions were not applicable to the 
control clinics.
Statistical analysis
We first expressed all EOV participants’ evaluations of the feedback reports 
and EOVS and professionals’ importance of the study, their expectations and 
experiences by their median values or numbers and corresponding percentages. 
When appropriate, differences between intervention and control clinics were 
calculated using chi-quadrate tests or Mann-Whitney U tests. 
For further analyses, we excluded the data of pregnant patients as it has been 
shown that the results of the PCQ-Infertility are confounded in this group.8 We 
described the number of action points that were defined by the intervention 
clinics during the EOVs and calculated the percentage of actual performed action 
points per patient-centredness dimension. Also the number of additional clinic 
improvements was described and compared to the number of spontaneous clinic 
improvements by the control clinics, using Mann-Whitney U tests. To analyse 
the relationship between patient-centredness improvement and the number 
of executed improvement projects (i.e. clinics’ intensity on the intervention), 
we performed multilevel linear regression analyses to account for clustering of 
patients within clinics. The delta PCQ-Infertility total or subscales scores acted 
as the dependent variables. The number of improvement projects per patient-
centredness dimension represented the independent variables. To come to these 
variables, we added the number of executed action points to the number of 
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additional clinic improvements for the intervention clinics. For the control clinics, 
we used the number of executed spontaneous clinic improvements.
To analyse determinants at the clinic level of the effect of the multifaceted 
intervention, we first performed a series of univariate linear regression analyses 
with the delta PCQ-Infertility total score as the dependent variable. Data of the 
control group were excluded as the multifaceted improvement strategy did not 
aim at these clinics and especially the study related clinic characteristics could 
not be gathered in this group. In the univariate analyses, all clinic characteristics 
(i.e. standard, culture and study related characteristics) acted as the independent 
variables and only characteristics with p<0.15 were selected for multivariate 
analysis. Next, we tested for significant correlations between the selected 
variables using correlation analyses with Spearman’s ρ. In case of two strongly 
correlated variables (ρ>0.60), we gave preference to the characteristic that was clinically and 
theoretically most relevant. Then we included these characteristics in a multilevel 
multivariate linear regression model and excluded the statistically insignificant 
variables to come to our final model. Finally, we calculated the explained variance 
(R2), indicating what percentage of variance in patient-centredness improvement 
is attributable to the characteristics that were part of our final model.
Statistically significance was set at P<0.05 and our analyses were performed 
using SPSS (version 20.0 for Windows®, SPSS Inc., Chicago, IL, USA). 
Results
At baseline measurement, 1620 patients were invited to participate and 946 
patients (response 58.4%) completed the PCQ-Infertility questionnaire. A total of 
250 pregnant patients were excluded and data of 696 patients were consequently 
left for analysis. Shortly after baseline measurement, two intermediate fertility 
clinics merged to one new clinic. As it concerned one control clinic and one 
intervention clinic, we decided to exclude these clinics from our study to avoid 
extensive contamination of our intervention. After measurement was thus 
performed among 30 clinics, 15 intervention and 15 control clinics, and we invited 
a total of 1565 patients. The PCQ-Infertility was completed by 946 patients 
(response rate 60.4%). After excluding 216 pregnant patients, 730 patients were 
eligible for analysis.
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Importance, expectations and experiences
The EOVs were attended by 133 members of the fertility teams, 10 quality 
officers and 12 former patients. A total of 58 fertility team members (43.6%), 
five quality officers (50%), and ten former patients (83.3%) completed the online 
questionnaire about the quality of the feedback reports and EOVs. These results 
are presented in table 1, showing that only 50% of the fertility team members 
had read the feedback report on forehand. However, the majority of respondents 
(80-100%) rated the general quality and meaningfulness of the reports as good 
to very good. Participants’ personal input during the EOVs was considered low 
with the lowest input for quality officers (none of the quality officers rated their 
input as high or very high). Almost all fertility team members and quality officers 
believed that the action plan would be executed and that their clinics’ level of 
patient-centredness would improve. However, only 50% and 70% of the former 
patients believed in the execution of the action points and improvement in patient-
centredness, respectively.
Table 1
Baseline characteristics of EOV participants and their evaluation of the 
feedback reports and EOVs
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a Percentage of people who rated the statements on the feedback report and the EOV with no. 4 (e.g. ‘good’ or 
‘high’) or no. 5 (e.g. ‘very good’ or ‘very high’) on a five-points Likert scale.
The evaluations provided by the representative gynaecologists are presented in table 2.
Considering the study’s importance, gynaecologists seemed to spend the highest amount of 
research money on patient-centred fertility care and the lowest amount on safety. No 
significant differences could be detected between the intervention and control group, although 
the intervention group tended to place more money on effective fertility care than the control 
group (p=0.06). Next, 71.4% of the gynaecologists from the intervention group expected to 
have better results at the after measurement compared to baseline measurement. The 
highest improvement was expected on the patient-centredness domains ‘Information 
provision’ and ‘Continuity of care’ and no one expected lower scores compared to baseline. 
The gynaecologists from the control group had significantly different expectations as only 
Members of 
fertility team
Quality 
officers
Former 
patients
Baseline characteristics
Present on EOV, number 133 10 12
Completed questionnaire, number (%) 58 (43.6) 5 (50.0) 10 (83.3)
Feedback report (%)a
Read the report on forehand 50 60 100
General quality 100 80 90
Meaningfulness 92 100 100
EOV (%) a
Personal input in EOV 21 0 10
The atmosphere 98 100 90
Listening to each other 95 100 100
Willingness to change 96 100 90
Supporting the action points 98 100 80
Believing in execution of action points 89 100 50
Improving level of patient-centredness 93 100 70
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The evaluations provided by the representative gynaecologists are presented 
in table 2. Considering the study’s importance, gynaecologists seemed to 
spend the highest amount of research money on patient-centred fertility care 
and the lowest amount on safety. No significant differences could be detected 
between the intervention and control group, although the intervention group 
tended to place more money on effective fertility care than the control group 
(p=0.06). Next, 71.4% of the gynaecologists from the intervention group 
expected to have better results at the after measurement compared to 
baseline measurement. The highest improvement was expected on the patient-
centredness domains ‘Information provision’ and ‘Continuity of care’ and no 
one expected lower scores compared to baseline. The gynaecologists from the 
control group had significantly different expectations as only 33.3% expected 
higher scores compared to baseline measurement and 66.7% was expecting 
comparable scores (p=0.04). Also in this group, no lower scores were presumed 
at the after measurement compared to baseline. Further, gynaecologists were 
rather positive about their experiences with the study. High ratings were 
provided on the majority of study elements, with the highest scores on the 
feedback reports, educational outreach visits, participation of former patients 
and contacts with the researcher. The online community, which was only seldom 
used by the study participants, received the lowest median rating of 5 (range 
1-9).
Clinics’ intensity on the intervention
During the EOVs, the fertility teams, quality officers and former patients came up 
with a total of 76 action points, which was a median number of five action points 
per clinic (range: 3-7). The majority of action points considered the improvement 
of information provision (n=29), respect for patients’ values (n=15) and continuity 
of care (n=11). No clinics focused on the improvement of staff’s competence. Ten 
action points could not been divided into one of the seven patient-centredness 
dimensions (e.g. ‘improving waiting times for a new appointment’ and ‘improving 
the delivery procedure of semen in the laboratory for men’). These action points 
were therefore summarized within an additional dimension, i.e. ‘Organisation 
of care’. Table 3 shows both the total and median number of action points per 
clinic, the percentages of action points that were actually performed and the 
executed additional and spontaneous clinic improvements. At six months, clinics 
had finished 29 action points (i.e. 33%); one clinic already performed the entire 
action plan while four clinics did not start working on their action plan yet. After 
one year, the median percentage of executed action points was 75%, ranging 
from 20 to 100%. Four of the fifteen intervention clinics were able to perform 
their entire action plan within the study period. Furthermore, the intervention 
clinics focused on the improvement of 88 additional care aspects apart from the 
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action plan, which was a median number of six additional improvement per clinic. 
The control clinics performed 75 spontaneous self-reported care improvements 
(median = 3, range 0-14). No significant differences in the executed additional 
and spontaneous clinic improvements existed between the intervention and 
control group (p=0.217). Furthermore, results from the regression analyses 
showed no significant association between the number of improvement projects 
and the improvement in patient-centred care. 
Table 2
Study evaluation on three levels: the importance, professionals’ 
expectations and experiences with the study
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33.3% expected higher scores compared to baseline measurement and 66.7% was expecting 
comparable scores (p=0.04). Also in this group, no lower scores were presumed at the after 
measurement compared to baseline. Further, gynaecologists were rather positive about their 
experiences with the study. High ratings were provided on the majority of study elements, 
with the highest scores on the feedback reports, educational outreach visits, participation of
former patients and co tacts with the researcher. T e online community, which was only 
sel om used by th  study participants, received the lowest median rating of 5 (range 1-9).
Table 2
Study evaluation on three levels: the importance, professionals’ expectations and 
experiences with the study
Intervention clinics Control clinics p-value
IMPORTANCE
Division of a research subsidy of €1000 
(median, range)
Effectiveness 400 (0-800) 300 (0-1000) 0.06
Safety 200 (0-300) 250 (0-300) 0.35
Patient-centredness 400 (100-900) 500 (0-1000) 0.22
EXPECTATIONS
Changes in patient-centredness scores 
(better / same / worse, %)
Total score 71.4 / 28.6 / 0.0 33.3 / 66.7 / 0.0 0.04*
% improvement (median, range) 25 (10-40) 10 (10-40) 0.37
Accessibility 50.0 / 50.0 / 0.0 33.3 / 66.7 / 0.0 0.36
Information provision 57.1 / 42.9 / 0.0 60.0 / 33.3 / 6.7 0.57
Communication 42.9 / 50.0 / 7.1 33.3 / 66.7 / 0.0 0.45
Respect of patients’ values 21.4 / 78.6 / 0.0 6.7 / 93.3 / 0.0 0.25
Continuity of care 57.1 / 28.6 / 14.3 13.3 / 73.3 / 13.3 0.03*
Patient involvement 14.3 / 71.4 / 14.3 20.0 / 73.3 / 6.7 0.76
Staff’s competence 21.4 / 78.6 / 0.0 13.3 / 86.7 / 0.0 0.56
EXPERIENCES
Quality of research team
(too little / good / overload, %)
Accessibility by phone or e-mail 0.0 / 100.0 / 0.0 -
Knowledge 0.0 / 100.0 / 0.0 -
Willingness to help 0.0 / 100.0 / 0.0
-
Meaningfulness of study elements
(0-10, median (range))
Feedback report 9 (7-10) -
Educational Outreach Visit 8 (6-10) -
Participation of former patients during EOV 8 (2-8) -
Participation of quality officer during EOV 7 (1-9) -
Online community 5 (1-9) -
News letters 7 (3-9) -
Contacts with researcher every two months 8 (7-9) -
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* Significant difference (p<0.05) between the intervention and the control group after using Chi-quadrate tests.
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Determinants of improvement
All clinic characteristics are presented in table 4 together with the results of the 
univariate regression analyses. A total of six clinic characteristics were associated 
with the delta PCQ-Infertility total scores (p<0.15) and therefore selected as 
potential determinants of an improvement of patient-centred care. Subsequently, 
two characteristics were excluded due to collinearity; ‘Structured meetings to 
discuss all patients’ was chosen in favour of ‘Number of gynaecologists’ (Spearman’s 
ρ =0.625) and ‘Clinic type’ was chosen in favour of ‘Number of functions present at 
EOVs’ (Spearman’s ρ = 0.807). After manual backward elimination, three characteristics were 
significantly related to an improvement in patient-centred care. First, when adjusted for the other 
clinic characteristics, a higher score on the organizational group culture was significantly 
related to a higher improvement score (B=0.014; 95% CI=0.006-0.021; 
p-value=<0.01). Second, a higher input of former patients during the EOVs was 
significantly associated with higher adjusted patient-centredness improvement 
scores (B=0.051; 95% CI=0.015-0.088; p-value=<0.01). Third, clinics having 
a structured meeting to discuss all patients had significantly lower delta PCQ-
Infertility total scores (B=-0.138; 95% CI=-0.256 - -0.020; p-value= 0.02). It 
turned out that 8.9% of the variance in delta PCQ-Infertility total scores (i.e. R2) 
was attributable to these three clinic characteristics. 
Table 3
Execution of action points and additional clinic improvements
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Table 3
Execution of action points and additional clinic improvements
Intervention clinics Control clinics
Defined action 
points EOV
Executed action 
points: 
6 months
Executed action 
points: 
one year
Executed 
additional 
improvements
Executed 
spontaneous 
improvements
n (%) n (%) n (%) n (%) n (%)
Total 76 (100) 29 (38.2) 55 (72.4) 88 (100) 75 (100)
Accessibility 7 (9.2) 6 (85.7) 7 (100.0) 6 (6.8) 4 (5.3)
Information provision 29 (38.2) 12 (41.4) 22 (75.9) 23 (26.1) 23 (30.7)
Communication 2 (2.6) 0 (0.0) 1 (50.0) 0 (0.0) 0 (0.0)
Respect of patients’ values 15 (19.7) 2 (13.3) 11 (73.3) 19 (21.6) 18 (24.0)
Patient involvement 2 (2.6) 0 (0.0) 2 (100.0) 0 (0.0) 0 (0.0)
Continuity of care 11 (14.5) 6 (54.5) 8 (72.7) 16 (18.2) 4 (5.3)
Staff’s competence 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Organisation of care 10 (13.2) 3 (30.0) 4 (40.0) 24 (27.3) 15 (20.0)
n (range) % (range) % (range) n (range) n (range)
Clinic levela 5 (3-7) 33 (0-100) 75 (20-100) 6 (2-11) 3 (0-14)
a Clinics’ median numbers (n) or median percentages (%) with corresponding ranges are presented here.
A Mann-Whitney U test showed no significant difference in the median number of additional clinic improvements 
(intervention clinics) and the median number of spontaneous clinic improvements (control clinics).
Multilevel linear regression analyses showed no significant association between the improvement of patient-
centred care (delta PCQ-Infertility total and subscale scores) and the number of improvement projects per clinic
(i.e. clinics’ intensity on the intervention).
Determinants of improvement
All clinic characteristics are presented in table 4 together with the results of the univariate 
regression analyses. A total of six clinic characteristics were associated with the delta PCQ-
Infertility total scores (p<0.15) and therefore selected as potential determinants of an 
improvement of patient-centred care. Subsequently, two characteristics were excluded due to 
collinearity; ‘Structured meetings to discuss all patients’ was chosen in favour of ‘Number of 
gynaecologists’ (Spearman’s ρ =0.625) and ‘Clinic type’ was chosen in favour of ‘Number of 
functions present at EOVs’ (Spearman’s ρ = 0.807). After manual backward elimination, three 
characteristics were significantly related to an improvement in patient-centred care. First, 
when adjusted for the other clinic characteristics, a higher score on the organizational group 
culture was significantly related to a higher improvement score (B=0.014; 95% CI=0.006-
0.021; p-value=<0.01). Second, a higher input of former patients during the EOVs was 
significantly associated with higher adjusted patient-centredness improvement scores 
(B=0.051; 95% CI=0.015-0.088; p-value=<0.01). Third, clinics having a structured meeting 
to discuss all patients had significantly lower delta PCQ-Infertility total scores (B=-0.138; 
95% CI=-0.256 - -0.020; p-value= 0.02). It turned out that 8.9% of the variance in delta 
PCQ-Infertility total scores (i.e. R2) was attributable to these three clinic characteristics. 
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Table 4
Clinic characteristics and results of univariate regression analyses with 
delta PCQ-Infertility total scores of 377 non-pregnant patients from 15 
intervention clinics 
IMPROVING PATIENT-CENTREDNESS OF FERTILITY CARE: A PROCESS EVALUATION STUDY | 137
 
 
 
Table 4
C inic characterist cs and results of univariate regression analyses with delta PCQ-
Infertility total scores of 377 non-pregnant patients from 15 intervention clinics 
Standard clinic characteristics
     Univariate analyses
B p-value
Clinic type         
     Large IVF clinic, n (%) 5 (33) Ref -
     Intermediate clinics, n (%) 5 (33) 0.08 0.13*
     Small clinics, n (%) 5 (33) 0.10 0.06*
Number of gynaecologists, median (range) 3 (1-7) 0.03 0.15**
Specialized fertility nurses, n (%) 10 (67) -0.05 0.46
Presence of clinic psychologist(s), n (%) 10 (67) 0.06 0.43
Separate waiting room, n (%) 4 (27) 0.05 0.58
Structured meetings to discuss all patients, n (%) 11 (73) -0.13 0.09*
Separate semen production room, n (%) 10 (67) -0.09 0.17
Regularly measuring clinic’s quality levels, n (%) 11 (73) -0.03 0.67
Organizational culture (0-100), median (range)
Group 39.4 (27.5-47.4) 0.01 0.13*
Rational 20.5 (16.1-24.5) -0.05 0.22
Developmental 13.6 (8.7-18.5) -0.01 0.29
Hierarchical 26.4 (18.5-34.6) <-0.01 0.70
Culture balance (0-1), median (range) 0.71 (0.68-0.74) -0.02 0.21
Study characteristics
Willingness to participate, n (%)a 9 (60) -0.03 0.46
Duration of EOV, min (range) 75 (50-120) <0.01 0.96
No. of EOV participants, median (range) 13 (4-16) <-0.01 0.42
No. of functions present at EOVs, median (range) 5 (1-9) -0.03 0.06**
Input quality officer during EOV, n (%)a 5 (33) 0.03 0.17
Input former patients during EOV, n (%)a 4 (27) 0.05 0.07*
Preparation team, n (%)a 4 (27) <0.01 0.94
Consensus action plan, n (%)a 9 (60) -0.04 0.24
Enthusiasm regarding action plan, n (%)a 8 (53) -0.02 0.55
No. of action points, median (range) 5 (3-7) 0.02 0.40
% of executed action points, median (range) 75 (20-100) <0.01 0.32
a Numbers and percentages of clinics scoring 4 (e.g. ‘good’) or 5 (e.g. ‘very good’) on a five-points Likert scale. 
Results based on the data collected by the main researcher.
* Characteristics associated with the delta PCQ-Infertility total score (p-value<0.15) and therefore allowed in 
multivariate analysis.
** The characteristics ‘Number of gynaecologists’ and ‘Functions during EOVs’ were also associated with the 
delta PCQ-Infertility scores, but due to collinearity with respectively the items ‘Structured meetings to discuss 
all patients’ (Spearman’s ρ=0.625) and ‘Clinic type’ (Spearman’s ρ=0.807) we excluded these variables from 
further analysis. 
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Discussion
This study gave us the possibility to take a look into the ‘black box’ of our RCT 
and enhance our understanding of professionals’ and patients’ experiences with 
the multifaceted improvement strategy, clinics’ intensity on the intervention and 
clinic characteristics being related to patient-centredness improvement. The 
study received high satisfaction ratings by both the patients and professionals 
and, in general, the intervention was carried out as planned. Unfortunately, the 
number of executed improvement projects by both the intervention and control 
clinics could not been related to the improvement of patient-centred care. We 
did however find some important clues on how to increase the effect of the 
multifaceted intervention in the future, as an increase in patient-centredness 
scores was related to higher levels of patient participation, higher organizational 
group culture scores, and the absence of structured, weekly meetings to discuss 
all patients within a fertility team. Our results are therefore highly relevant, as 
studies regarding the improvement of patient-centred care were already scarce, 
but no literature was available on the in-depth process evaluation of such a study. 
Our results could therefore be useful for adjusting the improvement strategy to 
a potentially more effective one, and for increasing our knowledge about more 
optimal implementation of complex interventions in general.
Because this study was performed within more than one third of all Dutch hospitals 
and among more than 3000 infertile patients, we can ensure representativeness 
of the Dutch infertile population. Another important strength of this study is 
the collection of many clinic characteristics that could have influenced the 
improvement of patient-centred care. We did not only consider standard clinic 
characteristics, such as the number of gynaecologists, but also included study 
related characteristics and clinics’ organizational culture types. So far, the 
organizational culture of a clinic has never been related to objective patients’ 
experiences with patient-centred care before.
When interpreting the results of our study, some limitations should be taken 
into account as well. First, we measured the actual exposure to the multifaceted 
intervention through a questionnaire for the representative gynaecologists. 
Therefore, the percentage of executed action points depended on the opinion of 
the gynaecologist, instead of on objective facts or measures. From the literature, 
it is known that professionals often overestimate their performance on patient-
centred aspects of their care.32-34 This corresponds to our own findings as many 
gynaecologists in the intervention group (i.e. 71.4%) expected an improvement 
in their clinics’ level of patient-centredness. We tried to prevent this potential bias 
by asking for more details regarding clinics’ performance on the action plan (e.g. 
who executed the action points, how many hours did this person spend on it, etc). 
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In case of ambiguity, we contacted the gynaecologists by phone to make clear 
whether an action point was really executed or not. Second, only a relative small 
proportion of fertility care members completed the questionnaire about the quality 
of the feedback reports and EOVs (i.e. response rate was 43.6%). It is possible 
that only professionals who were positive about the study responded, which might 
have biased our results. In addition, this response rate could tell us something 
about professionals’ motivation to participate in this patient-centredness study, 
especially when comparing it to the response rate of the former patients, which was 
almost twice as high (i.e. 83.3%). A comparable conclusion could be drawn from 
another part of the questionnaire, as only half of the fertility team members had 
read the feedback report on forehand compared to 100% of the former patients. 
Possibly, an improvement program for patient-centred care should focus more on 
professionals’ behaviour and motivation. This is also suggested by O’Donnell, who 
developed a framework for behaviour change among healthcare professionals in 
which the enhancement of professionals’ motivation has a prominent place.35 Also 
Rogers et al. showed that a high degree of professionals’ motivation is needed in 
interventions that ask for active participation of health professionals.36 Obviously, 
future studies should take this into account. 
This study is an example of an in-depth evaluation of a multifaceted improvement 
strategy for patient-centred care. Also previous research has already focused on 
the evaluation of multifaceted interventions. However, both in the area of fertility 
care as well as in other healthcare areas, the majority of studies concentrate 
on the implementation of guidelines instead of on patients’ care experiences in 
order to improve quality of care.2,4,37-39 These studies have mixed findings, as for 
example, Mourad et al. found no improvement in fertility guideline implementation 
after performing a multifaceted strategy that was both professional and patient 
orientated.38 Ouwens et al. however showed an improvement in several 
management aspects (e.g. support for stopping smoking and nutrition support) 
after implementing an integrated care program for patients with head and neck 
cancer.37 Because our research could hardly be compared to these studies, we 
should consider our study as an interesting addition to the existing process 
evaluation literature, by stressing out the importance of evaluating interventions 
that aim at patient-centredness of care as well. 
Some recommendations and lessons can obviously be learnt from this process 
evaluation, for example about the length of the improvement strategy. In the 
literature, it is recommended to repeat a cycle of audit and feedback with regular 
intervals, but the length of these intervals is not clear yet.40 In our study, only 
one-third of the action plans were performed after six months. After one year, 
already 75% of the action plans were executed, which might indicate that we 
did not reach the maximum improvement potential yet and higher percentages 
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could be reached after for example two years. This should be an interesting 
topic for future research. When focusing on the results we obtained after one 
year of intervention, we can state that still a high percentage of action points 
were executed by the clinics. However, clinics’ individual scores ranged from 20 
to 100%, indicating that some clinics only performed a very small part of their 
improvement plan. Some gynaecologists mentioned a lack of time or having 
different priorities as reasons for not performing one or more action points. 
Because we did not explicitly asked for these reasons in our questionnaire, we 
cannot draw conclusions on these statements. However, they seemed to be in 
line with the available literature41-43 and more attention should consequently be 
paid to these barriers when aiming at the improvement of patient-centred care 
in the future.
In this process evaluation study, we did not find a relation between the number of 
clinics’ improvement projects and the improvement in patient-centredness scores. 
This could mean that the content of the action plans was not optimal yet, or that 
the execution of the action plans could still be improved. A lack of association 
might also be due to the ‘noise’ of additional and spontaneous improvement 
projects by both the intervention and control clinics. The total number of executed 
additional improvement projects by the intervention clinics was even higher than 
their number of executed action points. Although we did take these additional 
action points into account in our analyses, it is seems natural that the additional 
improvements were less focused on what clinics actually needed regarding their 
level of patient-centredness. This could have biased our study results. For future 
studies, it would be very difficult to prevent this potential bias, but being more 
aware of this ‘normal improvement behaviour’ would already be an important 
step forwards.
Recommendations for daily clinical care and future research should also be 
based on the three clinic characteristics that were related to an increase in 
clinics’ patient-centredness levels. It should however be mentioned that only a 
small proportion of variance in patient-centredness scores (i.e. 8.9%) could be 
attributed to these characteristics and many other, still unknown factors will be 
of importance as well. Nevertheless, a significant association was found between 
patient-centredness improvement and the absence of structured, weekly meetings 
to discuss all patients within the fertility team. This is an interesting finding as 
it suggests that clinics with structured meetings have a more standardized and 
protocol-guided way of treating patients instead of aiming at patient-centred care 
by listening to their patients’ individual expectations, preferences and needs. 
This is in line with the debate of Jozien Bensing, who discussed already in 2000 
that both paradigms of evidence-based and patient-centred medicine belong to 
different worlds and are not integrated.44 Our results now suggest that if we really 
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want to improve patients’ experiences with healthcare, we have to focus more 
on patient-centred aspects of care by for example discussing patients’ individual 
expectations and preferences during treatment. Also a strong focus on patient 
participation in healthcare has been associated with patient-centred medicine44, 
which corresponds to our second determinant for improving patient-centredness, 
i.e. more intense patient participation during the EOV. Apparently, action plans 
of clinics with an intense patient participation during EOV were more optimally 
adjusted to patients’ wishes and needs than the action plans of clinics with less 
or even no patient participation. Patients should therefore not only be involved 
in the development of guidelines45-47 and in decision-making regarding their own 
treatment48-50, but in improvement projects about patient-centred care as well. 
The final determinant of an increase in patient-centred care was a higher group 
culture score, which seems to be in line with the literature showing that more 
teamwork relates to patients’ satisfaction with care.17,51-53 Meanwhile, Marshall et 
al. debated that, in case of group cultures, quality improvement is difficult due to 
clinics’ tendency to be ‘inward looking’ and inflexible.54 Our results indicate that 
‘inward looking’ can also be considered as a positive outcome, as these teams 
were able to work together and improve important patient-centred elements of 
their care. Therefore, striving for a more group-based organizational culture is 
an ambitious but important goal for the future. Especially managers and other 
professionals on executive positions should have a leading role in this process, 
for example by implementing existing frameworks or strategies for improving 
teamwork in healthcare.55-57 Because studies regarding organizational culture 
types are still limited in medical care, our results should be motivating for others 
to perform more research regarding this interesting subject.
In conclusion, evaluation of a multifaceted improvement strategy for patient-
centred fertility care revealed that both patients and professionals had both 
positive experiences with the intervention, although professionals’ motivation 
for participation could still be increased. Clinics performed their action plans for 
patient-centredness improvement largely as planned, but our study results were 
likely to be influenced by the noise of additional improvement projects of all 
participating clinics. A lesson learnt for future improvement studies on patient-
centredness is that patients should have an important voice in this research. 
Moreover, clinics should strive for a more optimal balance between evidence-
based and patient-centred medicine by not only focusing on their guidelines and 
protocols but by listening to their individual patients’ preferences and needs. 
Finally, managers should work on their teams to improve teamwork and work 
together as a group towards their common goal of optimal patients’ experiences 
with care.
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General Discussion
This thesis is about improving patient-centredness of Dutch fertility care. In the 
first part of this thesis, we explored the concept of patient-centred fertility care 
extensively, as relevant information regarding this subject was lacking. In the 
second part, we tried to come to an optimal improvement design for patient-
centred care and studied the effect in a large randomized trial. 
In this final chapter, we present answers to the eight research questions we stated 
in the general introduction. Subsequently, we will discuss our main findings in light 
of the available literature and point out some methodological considerations. This 
chapter concludes with our recommendations for patients, healthcare providers, 
policy makers and future research.
Answers to the research questions
Question 1 - How do patient-centred care, quality of life (QoL) and distress relate 
to each other in fertility care?
The results of chapter 2 show us that patient-centred fertility care and infertile 
patients’ QoL and levels of distress (i.e. anxiety and depression) are related 
in women. High psychosocial well-being could therefore lead to positive care 
experiences and improved patient-centredness of care. However, because of the 
cross-sectional design of our study, associations could also be presented the other 
way around, i.e. more patient-centred care leads to better QoL and lower levels of 
anxiety and depression. If this is true, our results should motivate professionals 
even more to provide patient-centred care as it would improve their patients’ 
psychosocial well-being. To find out the actual direction of the relationship 
between patient-centredness and psychosocial well-being, future research should 
focus on identifying causal relationships among these variables. For now, we can 
state that patient-centred fertility care, QoL and distress are related in a group of 
infertile women, stressing out the importance of a comprehensive approach when 
providing care to these women suffering from infertility. 
Question 2 - Do infertile women and their partners differ regarding their fertility 
care experiences, quality of life and risk factors for emotional problems?
We explored the possible differences between infertile women and their partners 
in two chapters. First, in chapter 3, we found that both members of the infertile 
couple evaluate their overall experiences with patient-centred fertility care 
comparable. Only small differences were detected on two of the seven domains of 
patient-centred care (i.e. ‘Respect for patients’ values’ and ‘Patient involvement’), 
but these results were considered as not being clinically relevant. When aiming 
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at the improvement of patient-centred care, it is important to be aware of the 
similar care experiences within the infertile couple. 
However, on patients’ level of QoL and risk factors for emotional problems, clear 
differences were found between infertile women and their partners, as described 
in chapter 4. Infertile women appeared to have lower levels of fertility-related QoL 
than their partners. Moreover, infertile women had more risk factors for emotional 
problems than their partners, and differed in the kind of risk factors. Therefore, 
both members of the infertile couple might be vulnerable to different sources of 
psychological stress. This stresses out the importance of identifying risk factors 
for emotional problems for both members of the infertile couple separately. Only 
then, infertile women and partners can receive the tailored psychosocial support 
they need.
Question 3 - Can we use the level of patient-centredness as a predictor for 
dropout in fertility care? 
We performed a prospective, longitudinal study on the association between 
clinic factors, including the level of patient-centred care, and premature dropout 
in fertility care. The results of this study, as described in chapter 5, showed 
no significant relation between patient-centred fertility care and dropout. This 
suggests that patient-centredness is no optimal predictor for dropout in fertility 
care. In our additional analysis however, we found significant associations 
between patient-centredness and dropout in specific patient groups. First, 
patients undergoing non-ART treatments (e.g. intra-uterine inseminations) had 
significantly lower scores on the PCQ-Infertility subscale ‘Respect for patients’ 
values’ when they dropped out. Moreover, patients who received ART treatments 
(e.g. in vitro fertilization) and, subsequently, dropped out had significantly 
higher scores on the PCQ-Infertility subscale ‘Patient involvement’ than those 
who continued treatment. Further research should indicate if and to what extent 
patient-centredness of care could be used as a predictor for other patient groups.
Question 4 - What is the monetary value of patient-centred fertility care?
Based on the results of a discrete choice experiment, we can state that infertile 
patients take the level of patient-centredness into account when choosing a 
fertility clinic. They even wanted to pay a considerable amount of money for more 
patient-centred fertility care. In chapter 6, we showed that patients were willing to 
pay a median amount of €463 for a relevant one-step increase in patient-centred 
care. We also putted this in perspective to the willingness-to-pay (WTP) for more 
effective fertility care: for a clinic offering one percent higher pregnancy rates, 
patients were willing to pay €107. Also health insurers, which can be considered as 
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the patients’ representatives in the Dutch healthcare setting, pay attention to the 
patient-centredness of care when purchasing care for their insurance company. 
Healthcare purchasers’ median WTP for more patient-centred care was €191. 
For one percent higher pregnancy rates, they were willing to pay €60. These 
results reflect the importance of patient-centredness in healthcare, as clinics’ 
levels of patient-centred care significantly influenced both patients’ and health 
insurers’ choices for a clinic. This should motivate both professionals and policy 
makers to aim at the improvement of patient-centredness in current healthcare. 
Our results might even suggest that the improvement of patient-centred care 
could be stimulated by introducing optional copayments for clinics offering more 
patient-centred care. Future research should focus on the feasibility of patients’ 
optional copayments for patient-centred care by studying for example practical, 
social and ethical issues.
Question 5 - What is the effect of audit and feedback on the improvement of 
patient-centred fertility care? 
In chapter 7, we described the effect of audit and feedback on the level of patient-
centred fertility care. A total of 15 clinics received a feedback report, showing their 
performance on patient-centred fertility care in relation to all participating clinics. 
Two years after the feedback was provided, we found no significant improvement 
on the level of patient-centred care, indicating that solely audit and feedback is 
not enough for improving patients’ experiences with patient-centred fertility care. 
Our results also showed that only five of the fifteen clinics had undertaken some 
kind of action towards improvement after they had received the feedback report. 
Possibly, providing professionals with feedback regarding their clinic’s level of 
patient-centred care does not result in sufficient motivation to actually come to 
improvement. Alternative strategies are therefore needed to further optimize the 
level of patient-centredness in fertility care. 
Question 6 - Which aspects should be included into an optimal improvement 
design for patient-centred fertility care according to professionals?
In a qualitative research, which was also described in chapter 7, we interviewed 
different fertility care professionals about their views on providing and improving 
patient-centred care. First, professionals appeared to be aware what patient-
centred care is and they provided many suggestions on how to improve it. 
However, professionals’ motivation to change and their ability to translate feedback 
about their own performance into an effective quality improvement strategy 
were suboptimal. We considered this as the key issues to come to improvement. 
Publically publishing clinics’ results on their level of patient-centred care might 
be a tool to actually increase professionals’ motivation for change. For increasing 
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professionals’ knowledge about the way they provide patient-centred care and 
translating this into an actual improvement plan, the use of detailed, concrete 
and individualized feedback to professionals was recommended. Subsequently, 
according to the professionals, the feedback must be discussed within the 
professional team to define improvement goals and develop a clear action plan. 
To achieve sustainability with improvement goals, the execution of the action 
plan should receive follow up, and the possible effects must be re-measured.
Based on the input of this qualitative study and additional literature concerning the 
improvement of patient-centred care, we designed a multifaceted improvement 
strategy for Dutch fertility care. The multifaceted approach consisted of audit and 
feedback, educational outreach visits and patient-mediated interventions.
Question 7 - What is the (cost-)effectiveness of a multifaceted approach on the 
improvement of patient-centred fertility care?
We performed a large cluster-randomized trial on the improvement of patient-
centred fertility care by means of a multifaceted approach. In chapter 9, both the 
effects and the costs from a societal perspective of this multifaceted improvement 
strategy are described, showing no significant improvement on the total level of 
patient-centred fertility care. Also when taking into account clinics’ intensity on 
the intervention (i.e. the number of executed improvement projects per clinic) no 
significant improvement in patient-centred scores could be found, as presented 
in chapter 10. Therefore, we can state that a multifaceted intervention, including 
patient-guided feedback and education, does not have the capacity to improve 
patients’ care experiences for all patients in fertility care. However, scores on the 
patient-centredness domain ‘Continuity of care’ were significantly higher (i.e. 
better) in the intervention group compared to the control group. Because this 
domain received the lowest scores during baseline measurement, our intervention 
seemed to be successful in improving care elements with the highest priority 
for improvement. The median total costs of the execution of the multifaceted 
approach per clinic were €3.324 per year (range €959-€11.550). The median 
costs per patient per clinic were €13 (range €2-€28). The additional health care 
consumption and productivity losses did not significantly differ between the 
intervention and the control group, which suggests that the provision of patient-
centred care is not associated with increased indirect medical and societal costs.
Question 8 - Which determinants at the patient and clinic level are associated 
with an increase in the level of patient-centredness?
Next to the effect and costs of the multifaceted approach, we also explored the 
influence of different determinants at the patient and clinic level on the effect of 
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the multifaceted intervention. In chapter 9, we found three patient characteristics 
being significantly associated with an increase in patient-centred fertility care. 
First, our multifaceted improvement strategy was successful when patients 
recently started treatment (i.e. less than 12 months ago). Second, patients who 
were younger than 36 years were more sensitive to the effect of the multifaceted 
approach, and third, patient-centredness levels significantly improved in the 
intervention group compared to the control group when patients received 
complementary and alternative medicine (CAM). This suggests that specific 
patient groups could benefit from a patient mediated improvement strategy 
for patient-centred care. Furthermore, chapter 10 provided us with three clinic 
characteristics that were significantly associated with a higher increase in patient-
centredness levels in the intervention group. This was true for clinics with a more 
intense patient participation during the study, clinics having higher group culture 
scores, and clinics that did not have structured, weekly meetings to discuss all 
patients, reflecting the level of ‘protocolized thinking’ within a clinic. These results 
are of high importance for professionals, managers, and researchers when taking 
a next step towards better patients’ experiences with patient-centred care. 
Interpretation and discussion of the main findings
“Improving patient-centredness of care!” In this thesis, we strived for this 
ambitious but important goal in current healthcare, reflecting the numerous 
studies that have explored the concept of ‘patient-centredness’ in recent years. In 
these studies, patient-centredness is recognized as a multidimensional concept1-3, 
including domains on the organizational level, such as information provision and 
continuity of care, but also domains on the human level, e.g. communication and 
respect for patients’ values.4 A complex concept thus, which might be difficult 
to measure, but maybe even more difficult to improve. We used a validated 
questionnaire, asking for objective patients’ experiences with care to measure 
clinics’ levels of patient-centred fertility care5 and used these results to offer 
feedback to the clinics. However, the use of solely audit and feedback turned 
out to be unsuccessful for a significant improvement in patient-centred care. We 
continued our research by studying the effect of a more extended intervention 
strategy within a large randomized controlled trial. Again, on the entire level 
of patient-centredness, our intervention was not successful in improving care 
experiences for all women. However, we did find some interesting results within 
subgroups of patients. 
What does these results mean? Did we fail in improving the patient-centredness 
of fertility care or did we just find some important clues on how patients’ 
experiences with care could be optimally improved in the future? A more in-depth 
discussion regarding patient-centred care and both the positive and negative 
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results of our studies is obviously needed to provide some recommendations 
on how to proceed, both in daily clinical care and in research. We will start with 
our ideas on the concept of patient-centredness in itself and how to put the 
‘science’ of studying patient-centred care in relation to other outcome measures 
in healthcare. 
Alpha and beta sciences
According to the Institute of Medicine, quality of healthcare should include 
effective, safe, efficient, timely, equal and patient-centred care.1 It is interesting 
to point out how patient-centredness differs on many aspects from the other 
dimensions of quality of care. For example, healthcare providers will agree on 
the importance of effective, safe and timely healthcare for their patients.6 This is 
however more complicated for patient-centredness, as most healthcare providers 
agree that patient-centredness is important, but disagree on why it is important. 
Duggan et al. pointed out that some professionals consider patient-centredness 
only as a good thing if it has good consequences, such as improved patient 
outcomes or decreased costs.7 However, others belief that providing patient-
centredness is important because it is morally good and possess some intrinsic 
property of ‘rightness’.7 Finally, a third group attaches importance on solely the 
development of patient-centred attitudes, which would eventually influence their 
behaviour toward their patients.7 Obviously, professionals’ visions and motives 
towards patient-centred care vary, distinguishing patient-centredness from other 
dimensions of quality of care.
This can also be illustrated when focusing on the measurement and improvement 
of different quality of care dimensions. For example, measuring the effectiveness 
and safety of fertility care might be relatively simple by calculating pregnancy 
rates per clinic and determining the number of complications during IVF treatment, 
respectively.8,9 Also the efficiency of an intervention to improve pregnancy rates 
in fertility care could easily be studied by means of a cost-effectiveness study 
in a large patient sample. Subsequently, professionals, managers and policy 
makers can use these evidence-based results to optimize treatments or develop 
guidelines. From this point of view, the science considering the majority of quality 
of care dimensions can be seen as ‘beta science’, since the outcome measures 
are merely independent of the context. This does clearly not count for patient-
centredness. Patient-centredness is defined by the Institute of Medicine as ‘care 
that is respectful of and responsive to individual patient preferences and needs 
and that is guided by patient values’.1 This definition already implies the need 
for another approach when measuring or improving this outcome measure as it 
should take the wishes, needs and preferences of patients into account, which 
obviously differs among them. Objectively measuring mean patient-centredness 
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scores of a clinic might therefore be considered a contradiction in terminis.10 
Accordingly, we can see the science of patient-centred healthcare as an ‘alpha 
science’, since the outcome measurements are highly dependent of the individual 
patient’s context. This can be underlined with findings from the general literature, 
showing relations between patient-centredness or positive care experiences 
and patient characteristics such as gender, age, race, and marital status.11-13 
Furthermore, we illustrated in the first chapters of this thesis that also in fertility 
care patient-centredness could be considered an alpha science as it was associated 
with different patient-related outcomes, such as patients’ psychosocial well-being 
and gender. To get a better understanding of the context of patient-centred care, 
we will take a closer look at these chapters and relate the results to the literature 
to put it in a broader perspective.
Patient-centred fertility care and its context
In chapter 2, we found significant associations between patient-centred fertility 
care and patients’ QoL and levels of distress. This touches on the results of studies 
within other healthcare areas, showing for example higher satisfaction rates 
when patients needed less psychosocial support.14,15 Also significant associations 
between more patient-centred care experiences, improved well-being and higher 
levels of QoL are described.16,17 This might imply that paying attention to patients’ 
psychosocial well-being could improve the level of patient-centred care. However, 
the cross-sectional study designs limit us to draw conclusions on the actual 
direction of this association. More research on this subject is needed, but that will 
not be enough. Within the setting of fertility care, where patients are represented 
by both the woman and her partner, information regarding both members of the 
infertile couple is needed. Results from this thesis showed that infertile women 
and their partners report comparable experiences with patient-centred care. This 
relates to the results of a Danish study, showing no differences between infertile 
women and partners on their evaluation of different patient-centred services (e.g. 
decision making, personal interest of the doctor).18 These similarities between 
both members of the infertile couple can be considered a positive finding as 
it has been shown that a couple’s agreement increases the ability to manage 
stressful events, such as the experience of being infertile.19 However, we detected 
some important differences between women and partners as well, as women had 
significantly lower levels of QoL and more risk factors for emotional problems 
during treatment than their partners. Different studies in fertility care confirm 
this20-23 and also within other healthcare areas (i.e. paediatric care and oncology), 
more stressors and higher levels of psychological distress were shown among 
female compared to male patients.24-26
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When aiming at the improvement of patient-centred care, both in fertility care 
and in other healthcare areas, we have to keep these study results in mind. 
We therefore composed a figure that integrates these results and consequently 
points out how healthcare professionals should take the relevant context of 
their patients into account. Moreover, it shows which information is still lacking, 
stressing out the focus for further research.
Figure 1. 
Interactions between patient-centred care and psychosocial well-being 
for women and partners 
The relation between patients’ experiences with patient-centred care and patients’ psychosocial 
well-being are pointed out for both women and partners here. The large arrows represent the 
improvement on the different outcome measures that could maximally been achieved. 
Considering the left side of the figure (i.e. the situation for women), the dotted 
double arrow between ‘level of patient-centred care’ and ‘psychosocial well-being’ 
illustrates our limited knowledge about the direction between these outcome 
measures. First, more patient-centred care could relate to more psychosocial well-
being for women. If this is true, it should strengthen professionals’ motivation to 
improve their clinic’s level of patient-centredness as it would, for example, reduce 
women’s effects of treatment on their mood or decrease feelings of isolation. 
However, the association could also be explained the other way around (i.e. 
better psychosocial well-being relates to more experienced patient-centredness). 
This stresses out the importance of integrating QoL aspects into care delivery 
and paying attention to anxiety and depression symptoms to improve patient-
centredness of care. Also a more complex situation among these outcome 
measures is possible in which both outcomes interact with each other or even 
with another, still unknown, outcome measure. For example, paying attention 
to anxiety and depression would improve patients’ experiences with patient-
centred care, which in turn improves other aspects of patients’ psychosocial 
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well-being, such as their relational or social status. Until more information is 
known regarding the actual direction of the association, we advice professionals 
to pay more attention to women’s psychosocial status in daily clinical care, as 
improvement regarding their psychosocial status is needed27 and it might help 
them in improving their clinic’s level of patient-centred care as well. Instruments 
like the FertiQoL, HADS and SCREENIVF questionnaires could be used to identify 
women at risk of emotional problems during or after treatment.28-31 Consultation 
of a psychologists or social worker could be helpful for these patients to cope 
with their psychologically difficult situation. However, paying attention to the 
psychosocial well-being of a patient could also be considered as a continuum 
process which is not only set aside for psychologists or social workers. Also 
physicians and nurses should provide emotional support to their patients in daily 
clinical practice by discussing for example patients’ relational or social situation 
or just by showing some personal interest in a patient’s situation.4,27,32 
According to the right side of figure 1, focusing on partners’ psychosocial well-
being in order to improve their experiences with patient-centred care might 
seem less beneficial. First, because an association between patient-centred 
care and psychosocial well-being was never studied or evaluated at all. Second, 
the psychosocial well-being of partners seems already rather good and the 
maximum improvement potential on this outcome measure might therefore 
be limited. Some criticism regarding this statement is however needed. Since 
we used questionnaires that were only validated in women28,29, we might have 
missed issues that are relevant to partners. For example, a questionnaire for men 
experiencing infertility due to a male factor consisted of many questions about 
‘sexual relationship’ and ‘gender identity’, while these items are only seldom part 
of a women’s questionnaire.33 Also in the area of urology, it was shown that 
a questionnaire for men suffering from erectile dysfunction consisted of many 
different items than the questionnaire for the female partners of these men.34 
These clear differences might be due to the use of different coping strategies of 
men and women.35,36 In fertility care, women appeared to use greater amounts of 
confrontative coping, accepting responsibility and avoidance coping. In contrast, 
partners tend to use coping techniques, such as distancing, self-controlling and 
planful problem-solving.35,36 Moreover, van Dongen et al. showed that partners 
that were indicated as at risk for emotional problems during treatment felt less 
need for professional psychosocial support than women37, possibly because they 
did not recognize themselves into the questionnaire items. This underlines the 
importance of studying topics that are relevant for partners in fertility care and 
incorporate them within a new questionnaire. A next step would be to explore the 
relationship between the results of this questionnaire and patient-centredness, 
illustrating the need to focus on partners’ psychosocial well-being as well in order 
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to improve their experiences with patient-centredness of care.
The mainstream patient vs. the individual patient
We already considered the study of patient-centredness as an alpha science as 
it very much depended on patients’ emotional and psychosocial context. In daily 
care and research however, it seems like we still consider patient-centredness 
as an independent beta science since we use fixed-item instruments to measure 
concepts such as patient satisfaction, patients’ experiences with care and / or 
patient-centredness.5,18,38,39 These fixed instruments reflect the importance of the 
mainstream patient while the experiences of the individual patient are neglected.10 
Consequently, fixed-item instruments have a reduced responsiveness when it is 
used in healthcare settings with a wide inter-individual variability in patients’ 
preferences and needs.40 Fertility care can be considered such a healthcare 
setting as the often lengthy diagnostic and treatment periods will alter the needs 
and wishes of the individual patient over time.27,41 For instance, when infertile 
patients visit the clinic for the first time, they want to fulfil their child wish, but 
also receive as much information as possible and have the same doctor every 
meeting. On the contrary, patients being under treatment for already one or two 
years, might want to receive more emotional or psychosocial support as well, 
as they feel socially isolated or have feelings of anxiety or depression due to 
the burden of infertility and its treatment. This stresses out the need for more 
focus on at least relevant subgroups of patients (e.g. patients who are in similar 
treatment phases, or have similar feeling of anxiety or depression) instead of 
concentrating on the entire infertile patient group. 
Within our study, we tried to take this into account by using the PCQ-Infertility 
questionnaire, which was based on the input of many patients from different 
focus groups across the Netherlands. Therefore, the PCQ-Infertility represents 
the most important wishes, preferences and needs of Dutch infertile patients 
throughout their entire treatment course.5 Moreover, this questionnaire was able 
to discriminate between clinics as has been shown in the validation study of the 
PCQ-Infertility.5 We can therefore state that individualization at the clinic level was 
reached in our study as patient-centredness levels were measured in 32 Dutch 
clinics and all intervention clinics worked on their own, ‘individual’ action points 
that needed improvement. However, as we stated before, patient-centredness 
is about the experiences and expectations of the individual patient instead of 
the individual clinic. Because the PCQ-Infertility is still a fixed-item instrument, 
it might lack the ability to take into account all wishes and preferences of the 
individual patient. This might be an important reason for why we did not find a 
significant effect in our entire study group. This is even strengthened by the fact 
that we did find significant improvements among specific patient groups, namely 
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younger, less experienced patients, and those who received complementary and 
alternative medicine. Possibly, our outcome measures and interventions were 
adjusted to the preferences and wishes of these subgroups. For the other patients 
however, none or only a few of the aspects that their clinics focused on were in 
line with their own preferences or expectations. Any improvement on these items 
could consequently be lost in the overall ‘noise’ of the other items.42 This is in line 
with the literature, showing that patients are biased by their expectations and 
previous experiences with care, reducing the effect of interventions aiming at 
care improvement.43,44 More individualized strategies might therefore be needed.
Improving patient-centred care, the next step!
The previous paragraph illustrated that we should move away from studying entire 
patient groups and aim at relevant subgroups of patients. But maybe we should 
go even one step further and focus on the most optimal subgroup of patients, 
i.e. the individual patient. For daily clinical care, this means that healthcare 
professionals have to concentrate on outcomes and goals that are important to 
one particular man or woman.40 In current healthcare, mainly standard or fixed 
outcomes are evaluated by professionals and patients’ individual expectations 
for treatment outcomes are largely ignored.45,46 Unmet expectations however, 
might result in treatment dissatisfaction and increase patients’ discontinuation of 
treatment.47,48 This partly joins the results of our prospective longitudinal study 
where more focus on specific domains of patient-centredness was related to 
treatment dropout. Again however, this only counted for specific patient groups, 
underlining the need for a more personalized approach in fertility care.
An instrument that can be used to measure personalized patient goals is Goal 
Attainment Scaling (GAS).40,42,45,49-51 GAS consists of a multistep approach that is 
centred on the communication and interaction between the patient and healthcare 
provider. GAS starts with the composition of a care and treatment plan that is 
jointly developed by the professional and the patient and includes goals that are 
relevant for this individual patient.49 For example, the possibility to combine the 
fertility treatments with a fulltime job, or involving both members of the couple 
most optimally in the decision making process. Subsequently, patients indicate 
the importance of the various goals and discuss the expected outcome levels with 
their healthcare provider. This opens a dialogue and provides an opportunity to 
eliminate unrealistic goals, address misinformation, and possibly reset patients’ 
expectations for treatment.49 Next, the joint care and treatment plan can be used 
to maintain and reinforce the partnership between patient and professional by 
evaluating the plan regularly and adjusting it if necessary.50 
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The use of GAS has never been studied in a fertility care setting, but stimulating 
results have been found within other healthcare areas, such as urology, cardiology 
and neurology.42,45,50 For example, the implementation of GAS was associated 
with reduced hospital stay, preserved ADL and improved communication among 
patients and professionals.50 Also Velikova et al. found that when physicians 
were provided with the individual wishes and preferences of their patients, the 
discussion between patient and physician was more in-depth and focused on 
items that were relevant for the patient, without increasing the overall amount of 
time.52 Moreover, patients reported better emotional functioning52 and last but not 
least, GAS measures were found to be more responsive to change than measures 
commonly used to evaluate the effectiveness of specialized interventions.51 This 
seems especially valuable when aiming at and estimating the improvement of 
patient-centred care. GAS could therefore be a suitable tool within the area of 
fertility care as well, and consequently improve infertile patients’ experiences 
with care, although this hypothesis should be studied first.
Now that we have mentioned GAS as a potential new tool in fertility care, it might 
seem like we focused on the wrong outcome measure or did not use the most 
optimal intervention to improve the patient-centredness of fertility care in this 
thesis, but that is not the case. We have to keep in mind that information regarding 
the improvement of patient-centredness was scarce at the start of our study53-56, 
especially in the area of fertility care.57,58 Because our intervention integrated the 
input of physicians, fertility nurses and quality officers and even included (former) 
infertile patients in different phases, we already strived for a rather individualized 
approach compared to previous studies. Given the stimulating results of our study 
on one domain of patient-centredness and on several subgroups of patients, both 
the multifaceted improvement strategy and the PCQ-Infertility questionnaire 
can still be of high value in daily practice. However, we should be aware that 
we might oversee important elements at the individual patient level. A unique 
combination of a patient-centred approach at both the clinic and the individual 
level is therefore needed. This was also suggested by Khullar et al. where GAS 
appeared to be more suited to complement rather than to replace established 
outcome measures, since both measures have their own, unique advantages and 
disadvantages.46 We therefore suggest clinics to measure their clinics’ levels of 
patient-centredness regularly by means of the PCQ-Infertility questionnaire. In 
the absence of a more individualized questionnaire, the PCQ-Infertility can be 
considered the most optimal tool to measure patients’ experiences with fertility 
care. Next, feedback can be provided through a report and an educational meeting, 
providing insight for professionals into the need for more general improvement 
projects in their clinics. For example, keeping their information provision up to 
date or improving the accessibility of their fertility care department by phone 
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or e-mail. This cycle needs to be repeated at regular intervals to keep clinics’ 
general status of patient-centredness up to date.59 Evidence regarding the most 
optimal length of these interval is scarce, but we suggests to repeat the cycle of 
auditing, feedback, and defining concrete action points for improvement every 
one or two years. As an additional step, GAS could be incorporated in daily care 
by listening to patients’ personal wishes and needs and come up with a shared 
treatment plan. In future research we should study the most optimal combination 
of improving patient-centredness at both the clinic and the individual level. 
Designing future research
One last question regarding the measurement and improvement of patient-
centred care is still unanswered. It was already mentioned that more research 
is needed regarding the improvement of patient-centred care, but how the most 
optimal design of such a study should look like should be discussed. In the 
second part of this thesis, we performed a mixed method study to determine the 
effect of audit and feedback on patient-centred fertility care and simultaneously 
explore professionals’ views regarding the improvement of patient-centred care. 
A comprehensive study design thus which can be considered as an optimal design 
for a complex outcome measure such as patient-centredness. When it turned 
out that solely audit and feedback was unsuccessful we tested the effect of the 
more extended, multifaceted improvement strategy within a cluster-randomized 
controlled trial (RCT). RCTs are widely viewed to provide the greatest value to 
assess the effects of interventions and are therefore hailed as the gold standard. 
Nevertheless, they may not always be feasible or adequate for evaluating the 
effectiveness of care interventions that include more complex outcome measures 
or interventions.60-62 It is therefore debatable whether a change in patients’ 
personal experiences with care can be captured within a randomized controlled 
trial. More experimental, qualitative or pragmatic study designs may for example 
be more suitable.63-65 For evaluating patient-centred care, ‘story telling’ could 
even be used as the most distinct form of qualitative research.66,67 Although 
these study designs are sometimes labelled as ‘weak’, we would recommend 
considering such a study design when studying complex outcome measures, such 
as patient-centredness. In the end, when applying it in a correct setting, the 
results of these studies may really show us how to improve patients’ experiences 
with patient-centred fertility care.
Implications for practice and further research 
In this chapter, we already mentioned several implications for daily practice 
and research while discussing the results of our studies. However, we feel that 
applying our study results is highly important and we therefore summarize the 
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most important implications for patients, healthcare providers, policy makers and 
future research here.
Patients
This thesis is not only about the patient, but also for the patient. Implications 
for infertile patients should therefore not be missing. Our thesis showed that 
patients have an important voice when it comes to their wishes and preferences 
in fertility care. Importantly, this should not only be applied within research 
settings, but especially in daily clinical practice. We therefore encourage patients 
to let professionals hear their voice and feel responsible about their own role in 
increasing the patient-centredness of care. This can be practiced at the secretary 
desk, in the doctor’s room, but also for example via patients’ organizations. 
Showing your own wishes and expectations of a particular treatment opens the 
discussion with the healthcare provider and will just improve the relation between 
patient and professional. Only by an optimal commitment of both the infertile 
patient and the healthcare provider, we can perfectly ‘work together’ to a patient-
centred approach in fertility care, just as mentioned by the patient in the prologue 
of this thesis.
Healthcare providers
The different chapters in this thesis underlined the importance of patient-
centredness in fertility care, which should be an eye-opener for healthcare 
providers in fertility care. More focus on patient-centred elements in daily 
clinical care is needed, but being aware of professionals’ own strengths and 
shortcomings is maybe even more important. Our mixed-method study showed 
that professionals are in general aware of the value of patient-centred care, 
but knowledge about their own performance and how to translate this into 
improvement projects is difficult. Professionals should therefore measure their 
clinic’s levels of patient-centredness regularly and discuss their results within the 
entire team, particularly with the help of a quality officer or another professional 
apart from the fertility team. These meetings will be motivating for the entire 
team to keep their focus on the patient and provide care that is most important 
to them. Moreover, healthcare providers should keep in mind the preferences and 
needs of the individual patient, by discussing patients’ expectations and wishes at 
the start of their treatment. The formulated treatment plan with individual patient 
goals can subsequently be used as an optimal guidance throughout the entire 
treatment process. Only when professionals are more open-minded towards this 
individualized approach in healthcare we can really provide patient-centred, and 
thus high quality healthcare.
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Policy makers 
Also for managers and other policy makers, the results of the studies in this 
thesis should stress out the importance of patient-centredness in fertility care. 
Especially the chapter about the monetary value of patient-centred care seems 
interesting for policy makers as the results of this study suggest the need for a 
debate about the payment for patient-centred care. Patients were willing to pay 
a considerable amount of money next to their insurance premium in order to 
be treated in a clinic providing more patient-centred care. Policy makers should 
therefore explore the introduction of additional copayments for patient-centred 
clinics. This would not only be in line with the preferences of infertile patients, 
according to our study, but could also enhance marked forces and competition 
among clinics. From the perspective of the policy maker, this could be a new, 
challenging policy for the future.
Future research
The results of the first part of this thesis have completed a few pieces of the 
large puzzle of patient-centredness and its context. However, more research on 
this subject is still needed. First, the actual direction of the association between 
patient-centredness and patients’ psycho-social well-being should be further 
studied to make clear how for example QoL, depression and anxiety should be 
taken into account when improving patient-centredness of fertility care. Second, 
we have given a voice to the partner of the infertile couple, but information 
regarding partners’ preferences and needs in fertility care is still limited. Therefore, 
more qualitative or mixed-method research is needed to study the preferences 
and needs of partners regarding patient-centred fertility care. Considering the 
improvement of patient-centred care, the use of an individualized approach such 
as GAS could complement a multifaceted improvement strategy aiming at clinics’ 
levels of patient-centredness. We should learn from other healthcare areas on 
how GAS could be optimally studied and implemented in daily care. Moreover, we 
should keep in mind that a randomized trial is not always the most optimal study 
design to study outcome measures at an individual patient level. For example, 
large cohort studies, qualitative, mixed method or experimental designs are 
recommended to use in the future. 
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Final conclusion
In this thesis, we have shown that healthcare needs to be more patient-centred 
and improvement strategies are within our reach. Because patient-centredness 
is a multidimensional and complex concept is must be ‘treated’ accordingly. We 
should therefore consider patients’ individual context when measuring the patient-
centredness of healthcare. Furthermore, strategies for improvement should not 
only aim at the clinic level, but incorporate patients’ personal views towards 
patient-centred care as well by listening to their individual expectations, wishes 
and needs throughout the entire treatment process. Obviously, an ambitious but 
important journey is ahead of us and staying on our route towards more patient-
centred healthcare could be the most challenging task for the future!
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Summary
Chapter 1
The rationale for this thesis is described in this first chapter, the General 
Introduction. Paying attention to patient-centredness of care is gaining more 
and more attention in daily practice nowadays. According to the Institute of 
Medicine, patient-centredness is defined as ‘care that takes into account patients’ 
preferences and needs and is guided by patients’ values’. Especially patients 
suffering from infertility could benefit from patient-centred care, as fertility 
treatments are a physical and psychological burden to them. Previous studies have 
shown that the level of patient-centred fertility care varies considerably among 
clinics and improvement is needed. However, no golden standard is available on 
how to promote and improve patient-centred fertility care. The different studies 
in this thesis will contribute to the development of such a standard
_______________________________________________________________
PART I
In the first part of this thesis, we put patient-centred fertility care in a broader 
perspective and created a proper basis to come to an optimal intervention for 
improving patient-centred fertility care. This part consists of five chapters.
_______________________________________________________________
Chapter 2
Providing patient-centred care by tailoring care to patients’ individual needs and 
preferences could remove some of the emotional burden of infertility (e.g. quality 
of life and distress). This might also be true the other way around: the patient’s well-
being could influence their experiences with care, because of the high emotional 
impact of being infertile. To gain more insight into these possible associations we 
performed a cross-sectional study in which we studied the relationship between 
the level of patient-centred care, measured by the PCQ-Infertility, and their 
well-being, measured by the FertiQoL and HADS questionnaires. From 29 Dutch 
fertility clinics, 427 non-pregnant patients filled out the Patient-Centredness 
Questionnaire-Infertility (PCQ-Infertility), FertiQoL and HADS (response rate 
74%). Multilevel linear regression analysis showed significant associations 
between the PCQ total scale, the FertiQoL total scale (B=0.250) and the HADS 
subscales (B=-0.215 for ‘Anxiety’; B=-0.180 for ‘Depression’). Thirteen percent 
of the variance in patient-centred care could be explained by their perceived 
quality of life, twelve percent by their level of anxiety and ten percent by their 
12
SUMMARY 249
level of depression. The inter-relationship between patient-centred fertility care 
and their well-being implies that paying attention to a patients’ well-being could 
lead to positive care experiences and improved patient-centredness of care. 
However, because of the cross-sectional study design, the results in this chapter 
could also mean that improved patients’ experiences could lead to better quality 
of life and less anxiety and depression among infertile patients. Future research 
should focus on identifying causal relationships among these variables. 
Chapter 3
Infertility seems to be the perfect example of a condition involving both a woman 
and her partner, both having their own wishes, needs and expectation regarding 
treatment. Therefore, it is remarkable that available fertility care research typically 
includes infertile couples as a whole or women alone, while partners seems to 
be a forgotten party. Especially if we aim at the improvement of patient-centred 
fertility care, we should focus on both members of the infertile couple. Therefore, 
we performed a cross-sectional study within 32 Dutch fertility clinics to assess 
possible differences in experiences with patient-centred care between women 
and their partners. We selected a total of 1620 infertile women and their partners 
and measured the level of patient-centred care with the PCQ-Infertility. We used 
multilevel multivariate linear regression analysis to investigate intra-couple 
experiences and to account for significantly related background characteristics 
(e.g. age and treatment type). After excluding pregnant couples, questionnaires 
from 696 women (response rate 58%) and 520 partners (response rate 41%) 
could be analyzed. No significant differences in PCQ-Infertility total scores were 
found between women and their partners. The partners scored significantly 
higher on the subscales ‘Respect for patients values’ and ‘Staff’s competence’ 
compared to their women. These results implicate that patient’ experiences with 
fertility care are only slightly different between women and their partners, which 
is valuable information in the process of improving patient-centred fertility care. 
Chapter 4
It is already known that the psychological impact of infertility negatively affects 
patients’ quality of life (QoL). However, it is unclear if differences in QoL and 
emotional status exist between infertile women and their partners. Moreover, 
research mainly focuses on generic instruments to measure infertile patients’ 
QoL, while these instruments do not represent all the unique problems of patients 
experiencing infertility. The main aim of this study was therefore to explore possible 
differences in QoL and well-being between women and their partners, using the 
disease-specific FertiQoL and SCREENIVF questionnaires. In this cross-sectional 
study, we included 1620 infertile women and their partners under treatment in 
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one of the 32 participating clinics. We used the FertiQoL questionnaire to measure 
patients’ QoL, and risk factors for emotional problems during and after treatment 
were measured with the SCREENIVF questionnaire. To determine possible intra-
couple differences in FertiQoL and SCREENIVF scores between women and their 
partners, we performed multilevel linear regression analyses in which we included 
twelve relevant patient characteristics. Questionnaires from 696 women (58%) 
and 520 partners (41%) could be analysed. Women scored significantly lower 
on the FertiQoL total scores and three of the FertiQoL subscales (‘Emotional’, 
‘Mind-Body’ and ‘Social’) than their partners, indicating lower QoL. Scores on the 
SCREENIVF questionnaire were significantly higher for women, indicating that 
women are more at risk for developing emotional problems during and after 
fertility treatment than their partners. Moreover, there were differences in the 
kind of risk factors. This indicates that both members of the infertile couple are 
vulnerable to different sources of psychological stress, which underlines the 
importance of identifying risk factors for emotional problems for both members 
of the couple separately. Only then, infertile women and partners can receive the 
tailored psychosocial support they need. 
Chapter 5
In fertility care, a significant proportion of patients does not achieve pregnancy 
because they discontinue treatment prematurely. This is often due to the physical 
or psychological burden they encounter. Identifying prognostic factors for 
dropping out treatment could be useful to develop interventions targeting exactly 
those burdensome aspects of treatment. Previous studies regarding this subject 
show inconsistent results, which could be explained by their poor methodological 
quality or their focus on factors at the treatment and patient level, while clinic 
factors have not been paid attention to. Clinic factors could include standard 
characteristics, such as the size of a clinic, but also patients’ experiences with 
patient-centred care can be considered a clinic factor. The aim of this study was to 
explore prospectively to what extend clinic factors, including the level of patient-
centred care, can be used as a predictor for dropout in fertility care. At T0, 693 
infertile women completed a questionnaire about their experiences with patient-
centred fertility care (PCQ-Infertility). Meanwhile, a professionals’ questionnaire 
was used to gather additional clinic characteristics. After one year (T1), 434 
patients (response 81.3%) completed a questionnaire about their current status 
in fertility care, including their main reason for discontinuation, if applicable. Of 
these women, 153 women (35.2%) continued treatment and 76 women (17.5%) 
dropped out. The remaining patients were excluded from analysis, for example 
because they achieved pregnancy. Binary logistic regression analyses showed 
that either levels of patient-centredness nor the additional clinic characteristics 
did significantly differ between dropouts and compliers. However, patients who 
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received non-ART treatments before they dropped out had significantly lower scores 
on the PCQ-Infertility subscale ‘Respect for patients’ values’ than patients who 
continued their treatment. Patients receiving ART treatments and subsequently 
dropped out treatment, had higher scores on the PCQ-Infertility subscale ‘Patient 
involvement’. These results suggest that most clinic factors are not related to 
dropout and seem therefore no optimal predictor for dropout. However, clinic 
factors might be of use when predicting dropout for specific patient groups. 
Chapter 6
In this chapter, we studied the importance of patient-centredness in current 
healthcare by determining its monetary value. Therefore, we performed a Discrete 
Choice Experiment (DCE) to assess what both patients and health insurers were 
willing to pay for more patient-centred fertility care. We included infertile patients 
from ten Dutch fertility clinics and healthcare purchasers from the five largest 
Dutch healthcare insurer companies. All participants received a DCE questionnaire, 
consisting of choice sets representing hypothetical but realistic fertility clinics 
that differed on the following attributes: pregnancy rate, patient-centredness 
(i.e. information provision, patient involvement, and continuity of care) and out-
of-pocket costs. All attributes were divided into three levels covering a realistic 
range. With logistic regression analysis, we determined the attributes’ relative 
importance and calculated a willingness-to-pay for more patient-centred care 
for both patients and health insurers and related this to the willingness-to-pay 
for higher pregnancy rates. In total, 521 patients (52.5%) and 45 healthcare 
purchasers (53.6%) completed the DCE questionnaire. All five attributes were 
significantly important to patients’ and healthcare insurers’ choice of a fertility 
clinic. However, patients and insurers differed in the value they placed on different 
attributes. In particular, patients were willing to pay a medium amount of €463 for 
a relevant one-step increase in patient-centred care and €107 for a one percent 
increase in pregnancy rates. Healthcare insurers’ valuations were lower: €191 
for more patient-centred care and €60 for one percent increase pregnancy rates. 
These results reflect the importance of patient-centredness for infertile patients 
and should increase professionals’ urge to improve their clinics’ levels of patient-
centred care. Moreover, as patients were willing-to-pay a considerable amount of 
money for a clinic offering more patient-centred care, there may be a willingness 
to allow for optional copayment for patient-centred aspects of care.
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_______________________________________________________________
PART II
The second part of this thesis contains three chapters about the improvement of 
patient-centred fertility care.
_______________________________________________________________
Chapter 7
Beside traditional outcomes as safety and (cost-)effectiveness the Institute 
of Medicine calls patient-centredness as an independent outcome indicator to 
evaluate quality of healthcare. Providing patient-centred care is important 
because patients feel to be heard in their ideas and concerns. This is also 
true in the area of fertility care where patients suffer from a high physical and 
physiological burden. How care can become optimally improved in patient-
centredness is unknown, but audit and feedback are often key components of 
quality improvement projects. Therefore, we performed a mixed methods study 
to determine the effect of audit and feedback on the level of patient-centredness 
in fertility care, and getting more in-depth understanding of professionals’ view 
on the improvement of patient-centred care. In the quantitative part, we first 
measured the level of patient-centred care in 15 Dutch fertility clinics using the 
PCQ-Infertility (T0). Then, feedback was provided to the clinics by means of a 
personalized feedback report. After two years, the level of patient-centred care 
was measured again (T1) and we used multilevel linear regression analysis to 
determine possible differences in the level of patient-centredness between T0 
and T1. In the meanwhile, we performed semi-structured in depth interviews 
with 15 fertility care professionals to explore their views on improving patient-
centred care. Our results showed that the overall levels of patient-centredness 
did not differ between T0 and T1, indicating that audit and feedback solely is 
not enough to improve the level of patient-centred fertility care. The results of 
our qualitative research indicated that professionals’ urge to change and their 
ability to translate feedback were suboptimal to achieve professionals’ behavior 
change. Consequently, this appeared to be the key issues when aiming at the 
improvement of patient-centred fertility care.
Chapter 8
The previous study has provided us with some important clues on how an optimal 
improvement strategy for patient-centred fertility care should look like. Based on 
these results and the corresponding literature, we designed a study to determine 
the effects of a multifaceted intervention strategy. In this chapter we presented 
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the study protocol. In a cluster-randomized trial in 32 Dutch fertility clinics, 
the effects of a multifaceted approach were determined on the level of patient-
centredness, as measured with the PCQ-Infertility. Also the effect on patients’ 
QoL (FertiQoL) and levels of distress (SCREENIVF) were studied. We collected 
potential determinants of a change in patient-centredness, patients’ QoL and levels 
of distress by an addendum to the patients’ questionnaire and a professionals’ 
questionnaire. Then, a total of 16 clinics were randomized to the multifaceted 
approach, consisting of three different elements. First, all clinics received a 
personalized feedback report with their own results on the questionnaires, 
presented in relation to all 32 participating clinics. Subsequently, the content of 
the feedback report was discussed per clinic in an Education Outreach Visit with 
the entire professional team. This resulted in an action plan on how to improve 
their level of patient-centred fertility care. Finally, patient-mediated interventions 
were offered to all clinics to enhance their patient-professional communication, 
such as organizing focus groups. The 16 clinics in the control group provided care 
as usual. After one year, we measured levels of patient-centred care, patients’ 
QoL and distress again. The study expected to yield important new evidence 
about the effects of a multifaceted approach on levels of patient-centredness, 
patients’ QoL and distress in fertility care. By having knowledge of these results, 
patient-centred care, and thus quality of healthcare, can be improved. Moreover, 
the results of this study could be useful for similar initiatives to improve the 
quality of care delivery. 
Chapter 9
In chapter 9, we studied the effect of the multifaceted approach on the total and 
subscale scores of the PCQ-Infertility using multilevel multivariate linear regression 
analysis. We also determined the influence of different patient characteristics 
on the effect of our intervention by adding significant interaction terms to our 
model concerning the PCQ-Infertility total score. Finally, we calculated the costs 
of the multifaceted approach from a societal perspective. A total of 696 patients 
(response 58.4%) from 32 Dutch fertility clinics were eligible for analysis at 
baseline measurement. One year later, at the after measurement, we analysed 
the data of 730 patients (response 60.4%). The total level of patient-centredness 
did not significantly differ between the intervention and the control group at 
after measurement, when adjusted for baseline scores and relevant case-mix 
adjusters (e.g. age and treatment type). On one of the seven PCQ-Infertility 
subscales (i.e. ‘Continuity of care’), scores were significantly higher in the 
intervention group compared to the control group (B=0.20). Moreover, patients 
in the intervention group had significantly better experiences with fertility care 
than patients in the control group when they were under treatment for less 
than one year, when patients were younger than 36 years and when they used 
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complementary and alternative medicine. Total yearly costs for the multifaceted 
approach were €64.628, which was €13 per patient per clinic (range €2-€28). 
Additional healthcare consumption and productivity losses did not significantly 
differ between the intervention and control group during after measurement. 
This study showed that an intervention including patient-mediated feedback 
and education is not sufficient to improve care experiences for all patients in 
fertility care. An increase in the level of patient-centred care could however been 
achieved in specific patient groups. Future research should therefore explore 
more individualized strategies and outcome measures to improve care for all 
patients.
Chapter 10
When studying the effect of complex, multifaceted interventions an extensive 
process evaluation is of high importance. Process evaluations are not interested 
in a study’s success or lack of success, but take a look into the ‘black box’ of 
the intervention to see what actually happened. Therefore, they can be helpful 
in the interpretation of study results. In chapter 10, we performed a process 
evaluation of our RCT to evaluate patients’ and professionals’ experiences 
with our study. Moreover, we studied the relation between the improvement 
of patient-centred care and clinics’ intensity on the multifaceted strategy and 
collected determinants at the clinic level of an improvement in patient-centred 
care. We used different questionnaires to collect our data, showing that both 
patients and professionals were mainly positive about the different elements of 
the multifaceted improvement strategy. During the EOVs, clinics came up with 
a median number of five action points (range: 3-7) to improve their level of 
patient-centredness. After one year, they had performed 75% of these action 
points (range: 20-100%), but both the intervention and control clinics did work 
on many different, additional improvement projects during the study as well. 
Linear regression analyses showed that the number of executed improvement 
projects on patient-centred care aspects was not significantly related to patient-
centredness improvement. Finally, multivariate regression analyses revealed 
that improvement in patient-centredness scores (scale: 0-3) was associated 
with higher levels of patient participation during the EOV (B=0.051), higher 
organizational group culture scores (B=0.014), and the absence of structured 
meetings to discuss all patients within the team (B=-0.138). Patient participation, 
improving teamwork and less fixation on protocols can therefore be considered 
as key elements to really improve patient-centredness in daily clinical practice.
_______________________________________________________________
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Chapter 11
This final chapter contains the General Discussion and concentrates on the main 
findings of this thesis. We presented answers to the eight research questions we 
stated in the General Introduction and discussed these findings by presenting our 
ideas on the concept of patient-centredness in itself. We debated how studying 
the patient-centredness of healthcare could be considered as ‘alpha science’, as it 
is highly dependent on the individual patient’s context. This contrasts with other 
studies, such as studies investigating efficiency or safety of care. Since these fixed 
outcome measures are merely independent of the patient’s context, we name this 
‘beta sciences’. As a result, measuring and improving patient-centredness should 
be approached differently from other quality of care dimensions. First, patients’ 
psychosocial well-being should be taken into account as it had significantly been 
associated to patient-centred care within many different healthcare areas. In 
fertility care however, the direction of this association is not clear yet and only 
studied for women while also the partner is an important member of the infertile 
couple. More research in this area is obviously needed. Second, levels of patient-
centredness are often measured with fixed-item instruments, focusing on the 
experiences of the mainstream patient, while preferences and expectations of 
the individual patient are neglected. Therefore, we advise professionals to aim 
at the improvement of patient-centred fertility care at both the clinic and the 
individual level. To do so, the PCQ-Infertility questionnaire should be used as 
a tool to regularly identify elements for improvement for specific clinics. The 
results of these audits should be discussed within the entire fertility team to 
come to a collaboratively created improvement plan. Furthermore, healthcare 
providers have to acknowledge the preferences and needs of the individual 
patient, by discussing patients’ expectations and wishes at the start of their 
treatment. This should result in a treatment plan that is tailored to the individual 
patient’s needs and goals and should guide the healthcare provider and patient 
throughout the entire treatment process. Finally, we point out that the use of 
randomized controlled trials, the gold standard for study designs, is most optimal 
when studying independent ‘beta sciences’. However, when focusing on more 
context-related ‘alpha sciences’, such as patient-centredness, mixed-method, 
qualitative or pragmatic study designs might for example be more suitable. 
We end the General Discussion with our most important recommendations for 
patients, healthcare providers, policy makers and future research, showing that 
an ambitious but important journey is still ahead of us!
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Hoofdstuk 1
In dit hoofdstuk, de Algemene Inleiding, beschrijven we de aanleiding voor 
dit proefschrift. Tegenwoordig wordt er meer en meer aandacht besteed aan 
het leveren van patiëntgerichte zorg. Ook patiënten die onder behandeling zijn 
vanwege een onvervulde kinderwens hebben baat bij patiëntgerichte zorg, omdat 
de fertiliteitsbehandelingen zowel lichamelijk als emotioneel erg belastend zijn. 
Eerdere studies hebben aangetoond dat de mate van patiëntgerichte fertiliteitszorg 
enorm varieert tussen ziekenhuizen en verbetering is dus meer dan nodig. Er 
bestaat echter geen gouden standaard hoe patiëntgerichte fertiliteitszorg geleverd 
en verbeterd moet worden. De studies in dit proefschrift hopen hier een bijdrage 
aan te kunnen leveren.
_______________________________________________________________
DEEL I
Het eerste deel van dit proefschrift beslaat vijf hoofdstukken waarin we de 
patiëntgerichtheid van de fertiliteitszorg van verschillende kanten bekijken. Dit 
vormt de basis voor een optimaal verbeterplan voor patiëntgerichte fertiliteitszorg.
_______________________________________________________________
Hoofdstuk 2
De emotionele impact van subfertiliteit kan verminderd worden door het 
afstemmen van de zorg op de behoeften van de individuele patiënt en verbeteren 
van patiëntervaringen met de zorg. Anders gezegd, de gemoedstoestand van 
de patiënt kan ook zijn of haar ervaringen met de zorg beïnvloeden, vanwege 
de grote emotionele impact (verminderde kwaliteit van leven en verhoogde 
stress) van fertiliteitsproblemen. Om meer inzicht te krijgen in deze mogelijke 
associaties, voerden we een dwarsdoorsnede onderzoek uit, waarin we de relatie 
bepalen tussen patiëntervaringen met de zorg, gemeten met de PCQ-Infertility, 
en hun gemoedstand, gemeten met de FertiQoL en SCREENIVF vragenlijsten. Uit 
29 Nederlandse fertiliteitsklinieken vulden 427 niet zwangere vrouwen de drie 
vragenlijsten in (respons 74%). We pasten multilevel lineaire regressie analyses 
toe op de data waarin de totale schaal van de PCQ de afhankelijke variabele 
was. Achtergrondkarakteristieken van de patiënten, de FertiQoL en HADS 
resultaten beschouwden we als onafhankelijke variabelen. De analyses lieten 
significante associaties zien tussen de PCQ totale schaal en de FertiQoL totale 
schaalt (B=0.250) en de HADS subschalen (B=-0.125 voor ‘Angst’; B=-0.180 
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voor ‘Depressie’). Dertien procent van de variantie in patiëntervaringen kond 
verklaard worden door hun kwaliteit van leven, twaalf procent door de mate van 
angst en tien procent door de mate van depressie. De onderlinge relatie tussen 
patiëntervaringen met de fertiliteitszorg en hun gemoedstoestand impliceert dat 
door aandacht te besteden aan deze variabelen de ervaringen met de zorg, en de 
patiëntgerichtheid, verbeterd kunnen worden. Echter, vanwege de opzet van de 
studie, kunnen de resultaten in dit hoofdstuk ook betekenen dat het verbeteren 
van de patiëntgerichtheid van de zorg kunnen leiden tot een betere kwaliteit 
van leven en minder angst en depressie. Toekomstig onderzoek zou zich moeten 
richten op het identificeren van het causale verband tussen deze variabelen.
Hoofdstuk 3
Subfertiliteit betreft een aandoening die zowel de vrouw als de partner in de 
relatie aangaat. Vanzelfsprekend zullen beide leden van het subfertiele paar hun 
eigen ideeën, voorkeuren en ervaringen met de fertiliteitszorg hebben. Het is 
daarom opvallend te noemen dat fertiliteitsonderzoek hoofdzakelijk het paar als 
geheel of de vrouw alleen bestudeerd en de partner dus vaak vergeten wordt. 
Vooral als we de patiëntgerichtheid van de fertiliteitszorg willen verbeteren, is 
het belangrijk om de voorkeuren van zowel de vrouw als de partner in beeld 
te hebben. Daarom hebben we een cross-sectionele studie verricht onder 32 
Nederlandse fertiliteitsklinieken om mogelijke verschillen in patiëntgerichte 
ervaringen tussen subfertiele vrouwen en hun partners te bepalen. We vroegen 
hiervoor aan 1620 vrouwen en hun partners om de PCQ-Infertility vragenlijst 
in te vullen. Met behulp van multilevel multivariate lineaire regressie analyse 
konden we vervolgens de verschillen binnen de koppels analyseren en corrigeren 
voor relevante patiëntkarakteristieken, zoals leeftijd en soort behandeling. Nadat 
we alle (partners van) zwangere vrouwen hadden geëxcludeerd, analyseerden 
we de vragenlijsten van 696 vrouwen (response 58%) en 520 partners (respons 
42%). We vonden geen verschillen in PCQ-Infertility totaalscores tussen vrouwen 
en hun partners. Partners scoorden wel significant hoger op de domeinen 
‘Respect voor patiëntwaarden’ en ‘Professionaliteit’. Deze resultaten laten zien 
dat de ervaringen van vrouwen en hun partners met patiëntgerichte zorg voor 
het overgrote deel met elkaar overeen komen. Dit is belangrijke informatie bij 
het ontwerpen van een strategie om de patiëntgerichtheid van de fertiliteitszorg 
te verbeteren.
Hoofdstuk 4
Eerdere studies hebben laten zien dat de psychologische impact van 
fertiliteitsproblemen een negatief effect hebben op de kwaliteit van leven van 
subfertiele patiënten. Er is echter geen duidelijkheid in welke mate de kwaliteit 
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van leven en emotionele status van subfertiele vrouwen en hun partners 
verschillen. Bovendien gebruiken de meeste studies generieke vragenlijsten om 
de kwaliteit van leven en emotionele status van patiënten te meten, terwijl deze 
vragenlijsten niet ingaan op de specifieke problemen waar fertiliteitspatiënten 
tegenaan lopen. Het doel van deze studie was dan ook om te achterhalen of 
er verschillen in kwaliteit van leven en welbevinden bestaat tussen subfertiele 
vrouwen en hun partners, gemeten met de ziektespecifieke FertiQoL en 
SCREENIVF vragenlijsten. In deze cross-sectionele studie werden 1620 vrouwen 
en hun partners geïncludeerd die bij één van de 32 deelnemende ziekenhuizen 
onder behandeling waren voor hun vruchtbaarheidsprobleem. We gebruikten 
de FertiQoL vragenlijst om kwaliteit van leven te meten. Met de SCREENIVF 
vragenlijst werden risicofactoren voor het ontwikkelen van emotionele problemen 
tijdens of na de behandeling achterhaald. We gebruikten multilevel multivariate 
lineaire regressie analyse om mogelijke verschillen binnen het subfertiele koppel 
te achterhalen en corrigeerden voor twaalf relevante patiëntkarakteristieken. In 
deze studie analyseerden we de vragenlijsten van 696 vrouwen (respons 58%) 
en 520 partners (respons 41%). Vrouwen hadden significant lagere scores op de 
FertiQoL totaal score en drie van de vier subschalen van de FertiQoL, wat duidt 
op een lagere kwaliteit van leven. De scores op de SCREENIVF vragenlijst waren 
significant hoger voor vrouwen, wat aangeeft dat zij meer risicofactoren hadden 
voor het ontwikkelen van emotionele problemen tijdens of na de behandelingen. 
Ook het soort risicofactoren verschilde tussen vrouwen en hun partners. Dit laat 
zien dat subfertiele vrouwen en hun partners gevoelig zijn voor andere soorten 
van psychische stress en onderstreept het belang om deze risicofactoren bij beide 
leden van het paar apart te identificeren. Alleen op deze manier kunnen zij beiden 
de psychosociale ondersteuning krijgen die ze nodig hebben.
Hoofdstuk 5
In de fertiliteitszorg lukt het veel paren niet om zwanger te worden, omdat 
zij al voortijdig stoppen met de behandelingen. Vaak is dat, omdat ze het 
fertiliteitstraject lichamelijk en psychisch te belastend vinden. Het zou daarom 
goed zijn om prognostische factoren voor deze voortijdige uitval te identificeren, 
zodat we interventies kunnen ontwikkelen die precies die problemen aanpakken 
waar paren tegenaan lopen. Eerdere studies die dit onderzochten lieten wisselende 
resultaten zien, mogelijk vanwege de matige methodologische kwaliteit van veel 
studies, maar ook omdat de focus vaak alleen op patiënt- of behandelfactoren 
lag, terwijl kliniekfactoren ook een rol kunnen spelen bij voortijdige uitval. Het 
doel van deze studie was om prospectief te bepalen in welke mate kliniekfactoren, 
waaronder de mate van patiëntgerichte zorg, als voorspeller voor voortijdige uitval 
in de fertiliteitszorg gebruikt kunnen worden. Aan het begin van deze studie (T0) 
vulden 693 subfertiele vrouwen, afkomstig uit 32 verschillende ziekenhuizen, 
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een vragenlijst in over de patiëntgerichtheid van hun ziekenhuis (PCQ-Infertility). 
Tegelijkertijd verzamelden we met een vragenlijst voor professionals de overige 
kliniekfactoren, als mogelijke voorspeller voor voortijdige uitval (bijv. de grootte 
van een kliniek of de aanwezigheid van een fertiliteitsverpleegkundige). We 
vervolgden de patiënten één jaar, waarna zij een vragenlijst ontvingen over hun 
huidige status in de fertiliteitszorg (T1). In geval van voortijdige uitval gaven zij 
hun meest belangrijke reden daarvoor. Tijdens T1 vulden 434 vrouwen (respons 
81.3%) de vragenlijst in. Van deze vrouwen waren er 153 (35.2%) nog onder 
behandeling en 76 vrouwen (17.5%) waren voortijdig gestopt. Met binaire 
logistische regressie analyse vonden we dat zowel de patiëntgerichtheid van de zorg 
als de overige kliniekfactoren niet significant geassocieerd waren met voortijdige 
uitval. In de groep patiënten die non-invasieve behandelingen ontvingen (bijv. 
inseminaties), hadden patiënten die voortijdig uitvielen echter een significant 
lagere (slechtere) score op het domein ‘Respect voor patiëntwaarden’. Voor 
patiënten die invasieve behandelingen ondergingen (bijv. IVF) was de voortijdige 
uitval juist hoger bij een hogere (betere) score op het domein ‘Autonomie’. Deze 
resultaten suggereren dat de meeste kliniekfactoren niet gerelateerd zijn aan 
voortijdige uitval in de fertiliteitszorg en daarom geen optimale voorspellers 
lijken te zijn. Voor bepaalde patiëntgroepen zouden sommige domeinen van 
patiëntgerichte zorg wellicht wel als voorspeller gebruikt kunnen worden.
Hoofdstuk 6
In dit hoofdstuk bestudeerden we het belang van het leveren van patiëntgerichte 
zorg door de “financiële waarde” van patiëntgerichtheid vast te stellen. Dit deden 
we middels een keuze-experiment (zgn. Discrete Choice Experiment) waarbij we 
voor zowel patiënten als verzekeraars berekenden wat zij willen betalen voor meer 
patiëntgerichte zorg. Voor deze studie includeerden we 993 subfertiele patiënten 
uit tien verschillende Nederlandse ziekenhuizen en alle 84 zorginkopers van de vijf 
grote Nederlandse zorgverzekeraars. Zij ontvingen allen een vragenlijst waarin 
ze meerdere malen moesten kiezen tussen hypothetische fertiliteitsklinieken 
die van elkaar verschilden in de volgende kenmerken: zwangerschapskans, 
patiëntgerichtheid van de kliniek (informatievoorziening, autonomie van de patiënt 
en continuïteit van de zorg) en extra kosten per cyclus. Aan patiënten vroegen 
we in welke kliniek zij behandeld zouden willen worden en aan verzekeraars in 
welke kliniek zij de zorg zouden inkopen. In totaal namen 521 patiënten (52.5%) 
en 45 zorginkopers (53.6%) deel aan de studie. De resultaten van de logistische 
regressie analyse lieten zien dat alle vijf de kenmerken voor zowel patiënten als 
zorginkopers significant van belang waren bij hun keuze voor een kliniek. Voor één 
stap verbetering in patiëntgerichte zorg waren patiënten bereid €463 per cyclus 
te betalen, terwijl ze voor 1% hogere zwangerschapskans €107 over hadden. 
Voor zorgverzekeraars was dit €191 voor meer patiëntgerichte zorg en €60 
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voor 1% hogere zwangerschapskans. Deze resultaten benadrukken het belang 
van patiëntgerichtheid in de huidige gezondheidszorg en verhogen mogelijk de 
motivatie voor zorgprofessionals om de patiëntgerichtheid van hun kliniek verder 
te verbeteren. Bovendien zouden deze resultaten een aanzet kunnen zijn voor 
een eigen bijdrage voor patiëntgerichte zorg, aangezien patiënten blijkbaar een 
behoorlijk bedrag zouden willen betalen voor een kliniek die meer patiëntgericht 
werkt. 
_______________________________________________________________
DEEL II
Het tweede deel van dit proefschrift gaat over het verbeteren van patiëntgerichte 
fertiliteitszorg. Dit deel bestaat uit drie hoofdstukken.
_______________________________________________________________
Hoofdstuk 7
In de literatuur wordt naast traditionele uitkomstmaten als (kosten)effectiviteit 
en veiligheid ook patiëntgerichtheid als een belangrijke en onafhankelijke 
uitkomstmaat genoemd om kwaliteit van zorg te meten. Het is belangrijk om 
patiëntgerichte zorg te leveren, zodat patiënten zich gehoord en begrepen 
voelen in hun eigen normen en waarden. Dit geldt zeker ook voor subfertiele 
patiënten, aangezien de fertiliteitszorg zich kenmerkt door een hoge lichamelijke 
en psychische belasting en veel voortijdige uitval, zoals in de vorige hoofdstukken 
beschreven. Hoe we de patiëntgerichtheid van de fertiliteitszorg echter optimaal 
kunnen verbeteren is onbekend, alhoewel audit en feedback vaak ingezet worden 
als hulpmiddelen voor het verbeteren van de zorg. Wij voerden daarom een 
mixed-methods onderzoek uit, waarbij we het effect van audit en feedback op de 
patiëntgerichtheid van de Nederlandse fertiliteitszorg onderzochten. Daarnaast 
probeerden we te achterhalen hoe zorgprofessionals denken over het leveren 
en verbeteren van patiëntgerichte fertiliteitszorg. In het kwantitatieve deel van 
deze studie werd allereerst de mate van patiëntgerichte zorg in 15 ziekenhuizen 
gemeten met behulp van de PCQ-Infertility vragenlijst (T0). Daarna ontvingen de 
klinieken een feedback rapport met de resultaten van deze meting. Na twee jaar 
werd de mate van patiëntgerichte zorg opnieuw gemeten (T1) en vergeleken we 
met multilevel lineaire regressie analyse het verschil in patiëntgerichtheid tussen 
T0 en T1. Gedurende die twee jaar interviewden we 15 professionals uit de 
fertiliteitzorg en achterhaalden hun ideeën over het verbeteren van patiëntgerichte 
zorg. De uitkomsten van deze interviews analyseerden we met thematische 
inhoudsanalyse waarna we de uitspraken indeelden in de vier stappen voor 
gedragsverandering volgens Hibbard: bewustzijn, kennis, houding en gedrag. 
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Onze resultaten toonden geen verschil in totaalscore voor patiëntgerichte zorg 
tussen T0 en T1, wat suggereert dat audit en feedback alleen niet genoeg zijn 
om de patiëntgerichtheid van de fertiliteitszorg te verbeteren. De resultaten van 
de interviews lieten zien dat de motivatie van professionals om te verbeteren en 
de kennis om feedback om te zetten in een adequaat verbeterprogramma niet 
optimaal waren. Dit lijken dan ook de belangrijkste aanknopingspunten te zijn 
om tot een succesvol verbeterprogramma voor patiëntgerichte fertiliteitszorg te 
komen. 
Hoofdstuk 8
Het vorige hoofdstuk heeft ons belangrijke informatie opgeleverd over de 
samenstelling van een optimaal verbeterprogramma voor patiëntgerichte 
fertiliteitszorg. Gebaseerd op deze bevindingen en overige literatuur over 
patiëntgerichte zorg ontwierpen wij een studie om het effect van een 
multifaceted interventie strategie op de patiëntgerichtheid van de zorg te 
bepalen. In dit hoofdstuk beschrijven we het studie protocol van deze studie. 
In een clustergerandomiseerde studie in 32 Nederlandse ziekenhuizen zal het 
effect van de multifaceted interventie op de patiëntgerichtheid worden bepaald, 
zoals gemeten met de PCQ-Infertility vragenlijst. Ook het effect op de kwaliteit 
van leven van patiënten (FertiQoL vragenlijst) en stress (SCREENIVF vragenlijst) 
zal bepaald worden. In totaal zullen 16 klinieken gerandomiseerd worden voor 
de interventie, bestaande uit 3 onderdelen. Allereerst ontvangen deze klinieken 
een persoonlijk feedbackrapport met de resultaten van het vragenlijstonderzoek 
gepresenteerd in relatie tot de resultaten van de overige ziekenhuizen. Dit 
rapport zal vervolgens per ziekenhuis in een educatieve bijeenkomst met het 
hele fertiliteitsteam besproken worden, waaruit enkele concrete actiepunten 
ter verbetering van de patiëntgerichtheid ontstaan waar het team een jaar 
lang aan zal werken. Daarnaast worden teams aangemoedigd de communicatie 
tussen professionals en patiënten verder te optimaliseren, bijvoorbeeld door het 
organiseren van focusgroepen. De 16 klinieken in de controlegroep leveren zorg 
als voorheen. Na een jaar zal het vragenlijstonderzoek worden herhaald. We 
verwachten met de resultaten van deze studie nieuwe en belangrijke aanwijzingen 
te verzamelen over het verbeteren van de patiëntgerichtheid van de Nederlandse 
fertiliteitszorg. Bovendien kunnen deze resultaten als voorbeeld dienen voor 
vergelijkbare initiatieven in andere landen of andere specialismen.
Hoofdstuk 9
In dit hoofdstuk wordt het effect van de multifaceted interventie, zoals gepresenteerd 
in het vorige hoofdstuk, op de mate van patiëntgerichte fertiliteitszorg beschreven. 
Met behulp van multilevel multivariate lineaire regressie analyse berekenden we 
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het effect van de interventie op de totaal- en subscores van de PCQ-Infertility 
vragenlijst. Ook bepaalden we in welke mate patiëntkarakteristieken het 
effect van de interventie op de PCQ-Infertility totaalscores beïnvloedden door 
interactietermen op te nemen in de analyses. Tot slot werden de totale kosten die 
gepaard gingen met de uitvoer van de interventie bepaald. Tijdens de voormeting 
vulden 696 patiënten (respons 58.4%) uit 32 verschillende ziekenhuizen de 
vragenlijsten. Een jaar later, tijdens de nameting, hadden we de beschikking over 
data van 730 patiënten (respons 60.4%). De PCQ-Infertility totaalscores bleken 
niet significant verschillend tussen patiënten uit de interventie- en controlegroep 
in de nameting, waarbij we corrigeerden voor de resultaten uit de voormeting 
en voor meerdere relevante achtergrondkarakteristieken (bijv. leeftijd en soort 
behandeling). Op één van de zeven subschalen (continuïteit van zorg) werd 
echter wel een significant hogere en dus betere score in de interventiegroep 
behaald (B=0.20). Bovendien bleek dat de totaalscores in de interventiegroep 
significant hoger waren dan in de controlegroep als patiënten korter dan een jaar 
onder behandeling waren, jonger dan 36 jaar waren en als patiënten alternatieve 
zorg ontvingen. In totaal kostte de uitvoer van de interventie €64.628 per jaar, 
wat overeenkomt met €13 (range €2-€28) per patiënt per kliniek per jaar. 
Overige kosten (productieverlies en overige gezondheidszorgkosten) verschilden 
niet tussen de controle- en de interventiegroep. Deze resultaten laten zien 
dat feedback en educatie op basis van patiëntervaringen niet voldoende is om 
de patiëntgerichtheid van de fertiliteitszorg voor alle subfertiele patiënten te 
verbeteren. Verbetering voor bepaalde subgroepen was echter wel haalbaar. Dit 
suggereert dat toekomstig onderzoek zich op meer individuele strategieën en 
uitkomstmaten moet richten om de zorgervaringen van alle patiënten te kunnen 
verbeteren.
Hoofdstuk 10
Wanneer je het effect van complexe interventies bestudeert, is een uitgebreide 
procesevaluatie van de studie van groot belang. Procesevaluaties zijn namelijk 
niet geïnteresseerd in het (gebrek aan) succes van een studie, maar bekijken 
de interventie in meer detail om te zien wat er nu werkelijk is gebeurd om zo de 
studieresultaten beter te kunnen interpreteren. In hoofdstuk 10 beschrijven we 
de resultaten van een procesevaluatie van onze clustergerandomiseerde studie. 
Daarin evalueerden we de ervaringen van professionals en patiënten met de studie 
en bestudeerden we de relatie tussen de intensiteit waarmee de interventie werd 
uitgevoerd en de verbetering in patiëntgerichtheid scores. Tot slot analyseerden 
we de associatie tussen verschillende kliniekkarakteristieken en een toename in 
patiëntgerichtheid. We hebben verschillende vragenlijsten gebruikt om onze data 
te verzamelen en constateerden dat zowel patiënten als professionals grotendeels 
positief waren over de verschillende onderdelen van de interventie. Tijdens de 
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educatieve bijeenkomst werden er vijf actiepunten per kliniek opgesteld om hun 
patiëntgerichtheid te verbeteren (mediaan, range: 3-7). Na één jaar waren 75% 
van deze actiepunten werkelijk uitgevoerd (range: 20-100%). Zowel de interventie- 
als controleklinieken werkten echter ook aan andere, extra actiepunten tijdens 
de studie. Lineaire regressieanalyses liet zien dat het aantal verbeterprojecten 
per kliniek (actiepunten en extra verbeterprojecten) niet gerelateerd was aan 
een verbetering in patiëntgerichtheid scores. Multivariate regressie analyse 
toonde dat verbetering van patiëntgerichtheid wel geassocieerd was met een 
hogere mate van patiëntparticipatie tijdens de educatieve bijeenkomsten, een 
hogere groepscultuur score van een kliniek en de afwezigheid van wekelijkse, 
gestructureerde patiëntbesprekingen voor het fertiliteitsteam. Patiëntparticipatie, 
teamwerk en een verminderde fixatie op protocollen en richtlijnen kunnen 
daarom als belangrijke elementen worden gezien om de patiëntgerichtheid in de 
dagelijkse praktijk werkelijk te verbeteren.
_______________________________________________________________
Hoofdstuk 11
Dit hoofdstuk beschrijft de Algemene Discussie van dit proefschrift, waarin de 
belangrijkste bevinden worden samengevat en besproken. We geven antwoord 
op de acht onderzoeksvragen die in de Algemene Introductie werden gesteld en 
bespreken deze bevindingen door allereerst op het concept ‘patiëntgerichtheid’ 
in te gaan. Het bestuderen van patiëntgerichtheid van de zorg kan in onze 
ogen beschouwd worden als een zogenaamde ‘alpha’ wetenschap, aangezien 
het sterk afhankelijk is van de individuele context van de patiënt. Studies die 
zich bijvoorbeeld op de effectiviteit of veiligheid van de zorg richten kunnen 
daarentegen als ‘beta’ wetenschappen worden bestempeld; vaste uitkomstmaten 
die grotendeels onafhankelijk zijn van hun context. Door deze verschillen zou 
het meten en verbeteren van patiëntgerichte zorg op een andere manier moeten 
worden benaderd dan andere dimensies van kwaliteit van zorg. Waarschijnlijk is 
hier een belangrijk rol weggelegd voor de psychosociale situatie van de patiënt, 
vooral omdat in meerdere vakgebieden in de gezondheidszorg een relatie tussen 
patiëntgerichte zorg en de psychosociale gezondheid van de patiënt wordt gezien. 
In de fertiliteitszorg is de richting van deze relatie echter nog onduidelijk en ook 
enkel onderzocht bij de vrouw, terwijl ook partners een belangrijk onderdeel van 
het subfertiele paar zijn. Het is duidelijk dat meer onderzoek op dit gebied nodig 
is. Vervolgens wordt besproken dat patiëntgerichtheid van de zorg nog steeds 
met vragenlijsten worden gemeten die zich richten op de gemiddelde patiënt in 
plaats van op de individuele patiënt met zijn eigen verwachtingen, wensen en 
ideeën. Voor de toekomst adviseren we om de patiëntgerichtheid van de zorg 
dan ook op zowel ziekenhuis- als individueel niveau te meten en verbeteren. The 
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PCQ-Infertility vragenlijst kan hiervoor worden gebruikt om op ziekenhuisniveau 
verbeterpunten vast te stellen, die vervolgens met het gehele team besproken 
en verbeterd kunnen worden. Daarnaast is het van belang dat zorgverleners de 
normen, waarden en verwachtingen van de individuele patiënt in het oog houden 
door deze aan het begin van de behandeling te bespreken en samen te vatten 
in een behandelplan. Dit plan kan door het gehele behandeltraject als een gids 
voor zowel zorgverlener als patiënt worden gebruikt. Ten slotte benadrukken 
we dat gerandomiseerde studies nog steeds de gouden standaard zijn voor 
studies die context-onafhankelijke, ‘beta’ wetenschappen bestuderen. Voor 
‘alpha’ wetenschappen zoals patiëntgerichtheid zouden mixed-method studies, 
kwalitatieve of meer pragmatische studies wellicht meer van bruikbaar zijn. 
We eindigen onze Algemene Discussie met onze aanbevelingen voor patiënten, 
zorgverleners, beleidsmakers en toekomstig onderzoek.
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Patient-Centredness Questionnaire-Infertility
PCQ-Infertility
Questionnaire on Couples’ Experiences with Fertility Care
This questionnaire is intended for patients receiving treatment for fertility 
problems.
This questionnaire was developed by the research team Reproductive 
Medicine of theRadboud University Nijmegen Medical Centre in cooperation 
with the Erasmus MedicalCentre in Rotterdam and the Isala Clinics in 
Zwolle.
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Information about the questionnaire
This 51-item questionnaire includes 4 background questions and 47 
‘experience’questions. These questions concern the way you and your spouse 
have experiencedthe fertility care in your hospital during the past twelve 
months.
There are no “right” or “wrong” answers. Your views and experiences are what 
matters.Please do not think too long before answering each question. Your first 
answer usuallyis the best answer.
Explanation of differences in terminology
“The physician” indicates only gynaecologists and/or fertility specialists who 
aretreating you or who have treated you.
“Caregivers” include physicians as well as nurses.
“Staff” includes all staff members you saw at the department, ranging from 
physicians and nurses to laboratory workers and personnel at the reception.
“The treatment period” indicates the entire period of time including both the 
diagnostic and treatment phase.
Explanation of possible answers
If a question can be answered as indicated below, the answer has the following 
meaning:
‘never’  = the situation in question never occurred or did not occur in 9  
  out of 10 cases
‘sometimes’ = the situation in question occurred in about 1 out of 3 cases
‘usually’  = the situation in question occurred in about 3 out of 4 cases
‘always’  = the situation in question occurred always or in 9 out of 10  
  cases.
Certain questions may not apply, or you may not have experienced certain 
aspects of the treatment. In that case, please answer the question with “does 
not apply”. If possible, please answer the questions together with your spouse.
Although some questions may appear to be similar to each other, it is important 
for the improvement of fertility care that you fill in the questionnaire completely 
and that you do not omit any questions.
Please answer the questions by marking them with an X in the little square that 
is printed at the left of your answer.
It will take you 10-15 minutes to complete the questionnaire.
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Background questions
The questions below are about you and your treatment
1.  About which hospital are you filling in this questionnaire?
.....................................................................................
2.  What is the highest level of education you completed?
❑  None
❑  Primary or lower vocational education
❑  Secondary or intermediate vocational education
❑  Higher professional education or University
❑  Other .................................
3.  What treatment are you receiving or did you receive recently?
Only one answer possible
❑  No treatment has been initiated yet
❑  Ovulation induction (stimulating ovulation with hormones)
❑  Intrauterine insemination (either with or without any hormone
  stimulation
❑  IVF or ICSI (test-tube fertilization)
❑  Other .................................
4.  Are you pregnant at this moment?
❑ No
❑  Yes
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Accessibility
The questions below are about the attainableness of your treating team (by 
telephone)
1.  How often have you been able to speak to someone immediately  
 when you called the Fertility Department?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
2.  Was it a problem for you to contact staff (by telephone or   
 e-mail) if you had any questions?
❑  A great problem
❑  A minor problem
❑  No problem
❑  Does not apply; I never tried to contact any staff
Information and explanation
The questions below are about the information and explanation you received 
during your treatment
3.  Did you receive contact numbers for urgent questions or   
 problems at nights or weekends?
❑  No
❑  Yes
4.  Did you also receive written information apart from verbal   
 information?
❑  No
❑  Yes, but insufficient information
❑  Yes, absolutely 
5.  Was the information about the investigations you would undergo 
comprehensive?
❑  No, not at all
❑  Somewhat
❑  For the most part
❑  Yes, absolutely
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6.  Were different treatment options discussed with you?
❑  No
❑  Yes, but insufficiently
❑  Yes, absolutely
7.  Was the information about the treatment you would receive 
comprehensive?
❑  No, not at all
❑  Somewhat
❑  For the most part
❑  Yes, absolutely
8.  Did you receive an overview of your treatment plan with a time  
 schedule?
❑  No
❑  Yes
9.  Were you informed of any possible side-effects of the medication  
 prescribed to you?
❑  No
❑  Yes, but insufficiently
❑  Yes, absolutely
❑  Does not apply; no medication was prescribed to me
10.  Were the instructions on how to inject your hormones   
 comprehensive?
❑  No, not at all
❑  Somewhat
❑  For the most part
❑  Yes, absolutely
❑  Does not apply
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11.  Did the staff inform you how to get support from a social worker  
 or a psychologist?
❑  No
❑  Yes, but insufficiently
❑  Yes, absolutely
12.  Did you miss any instructions from a nurse? If so, when?
More than one answer possible
❑  During the first consultation (intake)
❑  With new medication
❑  After you received a treatment plan
❑  Before or after a punction
❑  Before or after an embryo transfer
❑  Before or after a pregnancy test
❑  I did not miss any instructions
13.  Were there any periodical evaluations to overlook your   
 treatment period?
❑  No
❑  Yes, but insufficient talks
❑  Yes, absolutely
❑  I have only just begun treatment or did not begin any treatment  
  yet
Staff’s communication skills
The questions below are about how the team communicated with you
14.  Were caregivers honest and clear about what to expect from the  
 fertility care service?
e.g. about your success rates and possibilities
❑  No, not at all
❑  Somewhat
❑  For the most part
❑  Yes, absolutely
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15.  Were the results of the investigations discussed with you?
❑  No
❑  Yes, but insufficiently
❑  Yes, absolutely
16.  How often did the physician listen to you carefully?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
17.  How often did the physician take you seriously?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
18.  How often did the physician take the time for you?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
19.  How often did you have the impression that staff was talking  
 “about” you instead of talking to you?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
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20.  Was staff willing to talk to you about errors or incidents?
❑  No
❑  Yes
❑  Does not apply; nothing went wrong
Involvement in your treatment
The questions below are about the extent of your involvement in treatment
21.  How often was your physician open to your opinion and ideas  
 about treatment?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
22.  How often were you given the opportunity to ask your physician 
 questions?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
23.  Was decision-making shared with you, if you preferred?
❑  No, not at all
❑  Somewhat
❑  For the most part
❑  Yes, absolutely
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Respect for your values and needs
The questions below are about how you were cared for during your 
treatment and whether te team showed an interest in you
24.  Did you have access to your own medical record during the   
 treatment period?
❑  No, none at all
❑  Yes, but insufficient access
❑  Yes, absolutely
❑  I do not know
25.  How often did your physician show an interest in your personal  
 situation?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
26.  How often did your physician have empathy for your emotions  
 and your current situation?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
27.  Did nurses show understanding for your situation?
❑  No, none at all
❑  Some
❑  Much
❑  Yes, absolutely
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28.  Did staff also involve your partner?
❑  No, none at all
❑  Some
❑  Much
❑  Yes, absolutely
❑  No, my partner never accompanied me
29. How often did you receive any personal attention and support  
 from nurses during your treatment?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
30.  Did staff pay attention to any possible emotional impact of   
 fertility problems?
❑  No, none at all
❑  Some
❑  Much
❑  Yes, absolutely
❑  Does not apply / I do not know
Continuity and transition during your treatment
The questions below are about uniformity within your care and cooperation 
between care givers
31.  Was one staff member assigned to you to contact any time you  
 had any questions or problems (e.g. a nurse)?
❑  No
❑  Yes
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32.  How many different physicians are or were involved in your   
 treatment at your present hospital?
❑  1 or 2
❑  3 or 4
❑  5 or more
33.  Did you have one lead physician (a physician for moments of  
 evaluation and decision-making)?
❑  No lead physician was assigned to me
❑  Yes, but I saw him or her too little
❑  Yes, absolutely
34.  How often did you have an appointment with the same physi- 
 cian?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
35.  How often did you have to repeat the same story to different  
 physicians?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
36.  How often did you get contradictory information or advice?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
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37.  Did caregivers contradict each other in policy (one says one  
 thing, the other says something else)?
❑  No, not at all
❑  Somewhat
❑  For the most part
❑  Yes, absolutely
Staff’s competence
The questions below are about how skilled and competent the staff appeared to 
you
38.  How often did staff use difficult words without explaining them  
 to you?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
39.  How often was your physician well prepared for an appointment?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
40.  Did the physician(s) seem competent to you?
❑  No, not at all
❑  Somewhat
❑  For the most part
❑  Yes, absolutely
41.  How often did staff work disorderly?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
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42.  How often were logistics smooth at the Fertility Department?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
43.  How long did you usually have to wait in the waiting room?
❑  More than 1 hour
❑  30 to 60 minutes
❑  15 to 30 minutes
❑  Less than 15 minutes
Care organisation
The questions below are about how much time it took you to finish your 
treatment
44.  How often did you have to wait more than 3 weeks if you wanted  
 to make an appointment with the physician?
❑  Never
❑  Sometimes
❑  Usually
❑  Always
45.  How much time passed between your first hospital visit and the  
 moment you received your treatment plan?
❑  More than 6 months
❑  4 to 6 months
❑  2 to 4 months
❑  Less than 2 months
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46.  How long on average did you have to wait ‘unnecessarily’ before  
 being able to start with a next treatment?
For example due to a waiting list or a summer break.
❑  More than 2 months
❑  2 months
❑  1 month
❑  I always was able to start directly with the next treatment
❑  Does not apply
In conclusion
47.  What mark do you give the total fertility care at your hospital?
0 means extremely bad. 10 means excellent.
❑  0  Extremely bad care
❑  1
❑  2
❑  3
❑  4
❑  5
❑  6
❑  7
❑  8
❑  9
❑  10  Excellent care
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Room for additional remarks.
You have reached the end of the questionnaire.
If you have any remarks or comments you want to make about the care 
you received or about this questionnaire, please write them down below.
These data will be processed anonymously.
End of this questionnaire
Thank you very much for completing the questionnaire
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MANUAL Patient-Centredness Questionnaire-Infertility
This section provides information on some practical issues when applying the
PCQ for measuring the level of patient-centredness of your clinic.
How to convert item responses for scoring purposes:
4-answer categories:
- Never = 0; Sometimes = 1; Usually = 2; Always = 3
- No, not at all = 0; Somewhat = 1; For the most part = 2; Yes, absolutely = 3
- No, none at all = 0; Little = 1; Much = 2; Yes, absolutely = 3
- More than 1 hour = 0; 30 to 60 min = 1; 15 to 30 min = 2; less than 15 min = 3
- More than 6 months = 0; 4 to 6 months = 1; 2 to 4 months = 2; Less than 2 months = 3
- More than 2 months = 0; 2 months = 1; 1 month = 2; Start directly = 3
3-answer categories:
- A great problem = 0; A minor problem = 1; No problem = 3
- No = 0; Yes, but insufficiently = 1; Yes, absolutely = 3
- 1 or 2 = 3; 3 or 4 = 1 . ; 5 or more = 0
- No = 0; Yes, but I saw him too little = 1; Yes, absolutely = 3
2-answer categories:
- No = 0; Yes = 3
Pay special attention to:
- Item 12:  Instructions are missed for at least 1 answer category=0. 
No instructions missed=3
- Items 19, 35, 36, 37, 38, 41 and 44 need to be mirrored before scoring the question
The 7 dimensions of the PCQ-Infertility with accompanying items
Accessibility: 1 and 2          
Information: 3 through 13       
Communication: 14 through 20        
Patient involvement: 21 through 23       
Respect for patient’s values: 24 through 30       
Continuity and transition: 31 through 37     
Competence: 38 through 43
The answer category “is not applicable” cannot be used when calculating means
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Calculating ‘mean dimension score’ of patient-centredness
For calculating a mean dimension score, a participant’s responses to the 
individual items within a dimension need to be summed up and divided the 
number of items filled in. To calculate a reliable score, more than half of the 
items within a dimension need to be completed.
10
Quality Improvement scores (QI scores)
To calculate QI-scores you can add per experience item an extra question to 
reveal the patient’s importance regarding that specific care aspect.
For example:
Experience item:  How often did the physician take you seriously?
Importance item:  How important did you find it that the physician takes 
you seriously?
Answer categories: Extremely important = 3; Important = 2; fairly important = 
1; not important = 0
To compute an improvement score per item the following formula can be used: 
QI = I x (3 – E)
I = mean importance score of your patients on this item
E = mean experience score of your patients on this item
Case-mix factors
When the PCQ-Infertility is used to benchmark clinics on patient-centredness, 
adjustment for (e.g. by using GLM in SPSS) or stratification on 3 significant 
background characteristics is recommended: (1) women’s level of education, 
(2) current treatment, and (3) actual pregnancy. These characteristics appeared 
significantly associated with one or more subscales of patient-centredness. 
However, when more socio-demographic information is preferred, users are free 
to add more background questions to the questionnaire.
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PhD theses Human Reproduction NCEBP (2000 – 2013)
2000
1. 07-02-2000  Els van der Molen
Disturbed homocysteine metabolism endothelial dysfunction and placental    
     vasculopathy
2. 29-06-2000  Willianne Nelen
Risk factors for recurrent early pregnancy loss. Hyperhomocysteinaemia, 
thrombophilia and impaired detoxification
3. 05-09-2000  Ina Beerendonk
Sodium and ovarian hyperstimulation. Some clinical and psychological as 
     pects
4. 04-12-2000  Anne-Marie van Cappellen van Walsum
Cerebral metabolism of hypoxic fetal sheep by NMR spectroscopy
5. 18-12-2000  Friso Delemarre
Vascular aspects of human pregnancy. Clinical studies on sodium restriction    
     and angiotensin infusion
2001
6. 10-01-2001  Way Yee Wong
Male factor subfertility. The impact of lifestyle and nutritional factors
7. 05-06-2001  Petra Zusterzeel
Biotransformation enzymes and oxidative stress in preeclampsia
8. 05-10-2001  Cathelijne van Heteren
Development of habituation and memory in the human fetus
9. 10-10-2001  Michael Gaytant
Cytomegalovirus and herpes simplex virus infections in pregnancy
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2002
10. 25-01-2002  Ron van Golde
Male subfertility and genetics
11. 21-05-2002  Tanja de Galan-Roosen
Perinatal Mortality
2003
12. 08-01-2003  Maarten Raijmakers
Oxidative stress and detoxification in reproduction with emphasis on gluta 
     thione and preeclampsia
13. 18-2-2003  Sabine de Weerd
Preconception counselling. Screening & periconceptional health
14. 22-4-2003  Iris van Rooij
Etiology of orofacial clefts. Gene-environment interactions and folate
15. 17-12-2003  Chris Verhaak
Emotional impact of unsuccessful fertility treatment in women
2004
16. 14-01-2004 Liliana Ramos
The quality of epididymal sperm in azoospermia
17. 04-10-2004  Pascal Groenen
Nutritional and environmental factors in human spina bifida. An emphasis    
     on myo-inositol
18. 24-11-2004  Tanya Bisseling
Placental function in maternal disease. Ex vivo assessment of foetoplacental  
     vascular function and transport in diabetes and preeclampsia
19. 15-12-2004  Eva Maria Roes
Oxidant-antioxidant balance and maternal health in preeclampsia and HELLP 
     syndrome
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2005
20. 01-06-2005  Marieke Rijnsaardt-Lukassen
Single Embryo Transfer: clinical and immunological aspects
21. 10-11-2005  Ingrid Krapels
The etiology of orofacial clefts. An emphasis on lifestyle and nutrition other 
than folate
2006
22. 14-06-2006  Reini Bretveld
Fertility among greenhouse workers
23. 09-11-2006  Jesper Smeenk
Stress and IVF. Clinical consequences
2007
24. 08-02-2007  Inge Ebisch
Human subfertility: explorative studies on some pathophysiologic factors in  
     semen and follicular fluid
25. 01-11-2007  Alwin Derijck
The transmission of chromatin and DNA lesions by sperm and their fate in 
de zygote (1)
26. 01-11-2007  Godfried van der Heijden
The transmission of chromatin and DNA lesions by sperm and their fate in 
de zygote (2)
27. 03-12-2007  Kirsten Kluivers
On the measurement of recovery following hysterectomy
28. 10-12-2007  Rene Kok
Proton Magnetic Resonance Spectroscopy of Human fetal brain
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2008
29. 10-12-2008  Trudie Gerrits
Clinical encounters: Dynamics of patient-centred practices in a Dutch fertilty  
     clinic
30. 12-12-2008  Wouter Tuil
IVF and Internet
2009
31. 06-03-2009  Ineke Krabbendam
Venous reserve capacity & autonomic function in formerly preeclamtic     
     women
32. 03-09-2009  Arno van Peperstraten
Implementation of single embryo transfer
33. 07-10-2009 Wilson Farid Abdo
Parkinsonism: possible solutions to a diagnostic challenge
2010
34. 10-03-2010  Suzan Broekhuis 
Dynamic MR imaging in female pelvic floor disorders
35. 12-03-2010  Bea Lintsen
IVF in the Netherlands: success rates, lifestyle, psychological factors and   
     costs
36. 21-04-2010  Selma Mourad
Improving fertility care: the role of guidelines, quality indicators and      
     patients
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2011
37. 24-02-2011  Monique Brandes
Observational studies in reproductive medicine
38. 04-04-2011 Marijn Brouwers
Why foetal development of the male reproductive structures sometimes 
fails. An epidemiologic study on hypospadias and undescended testis with a 
focus on endocrine disruptors. 
39. 22-06-2011  Marian Spath
Risk estimate for fragile X-associated primary ovarian insufficiency: Genetic, 
environmental and reproductive factors
40. 30-06-2011  Inge van Empel
Patient-centredness in fertility care
41. 18-11-2011  Gwendolyn Woldringh
ICSI children. Follow-up after ICSI with ejaculated or non-ejaculated sperm
42. 17-06-2011 Tiny de Boer
Aspects of surgery for pelvic organ prolapse and its relation to overactive 
bladder symptoms
2012
43. 20-01-2012  Esther Haagen
Guidelines in IUI care. Implications for quality improvement
44. 17-02-2012  Loes van der Zanden
Aetiology of hypospadias. From genes to environment and back
45. 11-04-2012  Reda Z Mahfouz
Oxidative stress and apoptotic biomarkers in human semen
46. 06-06-2012 Marleen van Gelder
The role of medical and illicit drug use in the etiology of birth defects. 
Epidemiological studies and methodological considerations.
47. 12-09-2012  Annemijn Aarts
Personalized fertility care in the Internet era
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48. 17-09-2012 Eline Dancet
Bridging the gap between evidence based and patient-centred infertility and 
endometriosis care in Europe
49. 09-10-2012 Berto Nieboer
Minimally invasive surgery: patients and doctors perspectives.
50. 25-10-2012 Sanne van Leijsen
The value of urodynamics prior to surgery for stress urinary incontinence
51. 21-12-2012 Marieke de Vries
A cytological exploration of human spermatogenesis in non-obstructive 
azoospermia patients: an analysis of variation
2013
52. 16-01-2013 Jacqueline Pieters
Incidental Findings of Sex Chromosomal Aneuploidies in Routine Prenatal 
Diagnostic Procedures
53. 04-09-2013 Ellen Lensen
Surgery for pelvic organs prolapse with emphasis on the anterior   
     compartment
54. 16-12-2013 Renne Gerritse
Cryopreservation of an intact ovary
2014
55. 23-01-2014 Dana Huppelschoten
Improving patient-centredness of fertility care
AAPPENDICES 293
Bibliography
Publications - this thesis
Aarts JW, Huppelschoten AG, van Empel IW, Boivin J, Verhaak CM, Kremer JA, 
Nelen WL. How does patient-centred care relate to patients’ quality of life and 
distress: a study in 427 women experiencing infertility. Human Reproduction 
2012; 27: 488 – 495.
Huppelschoten AG, van Duijnhoven NTL, Hermens RPMG, Verhaak C, Kremer 
JAM, Nelen WLDM. Improving patient-centeredness of fertility care using a 
multifaceted approach: study protocol for a randomized controlled trial. Trials 
2012; 13: 175 – 182.
Huppelschoten AG, van Duijnhoven NTL, van Bommel PFJ, Kremer JAM, Nelen 
WLDM. Do infertile women and their partners have equal experiences with fertility 
care? Fertility and Sterility 2013; 99: 832 – 838.
Huppelschoten AG, Aarts JWM, van Empel IWH, Cohlen BJ, Kremer JAM, Nelen 
WLDM. Feedback to professionals on patient-centered fertility care is insufficient 
for improvement: a mixed method study. Fertility and Sterility 2013; 99: 1419 
– 1427.
Huppelschoten AG, van Dongen AJCM, Verhaak CM, Smeenk JMJ, Kremer JAM, 
Nelen WLDM. Differences in quality of life and emotional status between infertile 
women and their partners. Human Reproduction 2013; 28: 2168 – 2176.
Huppelschoten AG, van Dongen AJCM, Philipse ICP, Hamilton CJCM, Verhaak CM, 
Nelen WLDM, Kremer JAM. Predicting dropout in fertility care: a longitudinal study 
on patient-centredness. Human Reproduction 2013; 28: 2177 – 2186.
Huppelschoten AG, Verkerk EW, Groenewoud H, Adang EMM, Appleby J, Nelen 
WLDM, Kremer JAM. The monetary value of ‘patient-centred’ care: results from a 
discrete choice experiment in Dutch fertility care. Submitted.
Huppelschoten AG, Nelen WLDM, van Golde RJT, Adang EMM, Kremer JAM. 
Improving patient-centredness by a multifaceted intervention with feedback and 
education by patients: a cluster-randomized trial in fertility care. Submitted.
Huppelschoten AG, Nap AW, Perquin DA, Nelen WLDM, Kremer JAM. Improving 
patient-centredness of fertility care: a process evaluation study. Submitted.
APPENDICES294
Publications – other
van Empel IW, Aarts JW, Cohlen BJ, Huppelschoten AG, Laven JS, Nelen WL, 
Kremer JA. Measuring patient-centredness, the neglected outcome in fertility 
care: a random multicentre validation study. Human Reproduction 2010; 25: 
2516 – 2526.
Huppelschoten AG, Sykora D, de Bruin JP. Myoomextirpatie bij patiënte met het 
mayer-rokitansky-kuster-hauser syndroom. Nederlands Tijdschrift voor Obstetrie 
& Gynaecologie 2011; 124: 193 – 196. 
Huppelschoten AG, van Ginderen JC, van den Broek KC, Bouwma AE, Oosterbaan 
HP. Different ways of subcutaneous tissue and skin closure at cesarean section: a 
randomized clinical trial on the long-term cosmetic outcome. Acta Obstetricia et 
Gynecologica Scandinavica 2013; 92: 916 – 924.
Oral presentations
Evaluation of patient satisfaction in fertility care, how patient-centred are we? 
‘Our first 5000 children’ Symposium, Department for Reproductive medicine, 
University Medical Centre Maribor, Slovenia, March 2012.
The role of clinical guidelines in quality of care. 28th Annual Meeting of European 
Society of Human Reproduction and Embryology (ESHRE), Istanbul, Turkey, July 
2012. 
Improving patient-centred fertility care; the first results. 2nd NCEBP PhD Retreat, 
Wageningen, the Netherlands, September 2012.
Respect voor communicatie in de zorg. Jaarlijkse training van de Samenwerkende 
GezondheidsFondsen, Amsterdam, March 2013.
Implementatie van kwaliteitsbeleid. Symposium NVOG-werkgroep Endometriose 
‘Kwaliteit van leven – onze zorg’, Veldhoven, April 2013.
Participatory research in fertility care. Jaarlijkse wetenschapsdag NCEBP 
‘Personalized healthcare’, Nijmegen, the Netherlands, June 2013.
The relation between dropout and patient-centredness in fertility care. 29th Annual 
Meeting of European Society of Human Reproduction and Embryology (ESHRE), 
London, United Kingdom, July 2013.
AAPPENDICES 295
Poster presentations
Huppelschoten AG, Aarts JW, van Empel IW, Nelen WL, Kremer, JA. Effects of a 
multifaceted approach on improvement of patient centredness in fertility care, a 
study protocol. 27th Annual Meeting of European Society of Human Reproduction 
and Embryology (ESHRE), Stockholm, Sweden, July 2011.
Huppelschoten AG, Aarts JW, van Empel IW, Nelen WL, Kremer, JA. Effects of a 
multifaceted approach on improvement of patient centredness in fertility care, a 
study protocol. 1st NCEBP PhD Retreat, Wageningen, September 2011.
Huppelschoten AG, van Duijnhoven NT, Hermens RP, Verhaak C, Kremer JA, Nelen 
WL. Improving patient-centred fertility care; the first results. International Forum 
on Quality and Safety in Healthcare, Paris, France, April 2012.
Huppelschoten AG, Kremer JAM, van Empel IWH, Adang EMM, Groenewoud H, 
Nelen WLDM. Willingness-to-pay for patient-centred and effective fertility care; 
preferences of patients and healthcare insurers. 29th Annual Meeting of European 
Society of Human Reproduction and Embryology (ESHRE), London, United 
Kingdom, July 2013.
Huppelschoten AG, Nelen WLDM, Verkerk EW, Adang EMM, Kremer JAM. Towards 
more patient-centred fertility care: what does it cost? 29th Annual Meeting of 
European Society of Human Reproduction and Embryology (ESHRE), London, 
United Kingdom, July 2013.
Van Dongen AJCM, Huppelschoten AG, Kremer JAM, Nelen WLDM, Verhaak CM. 
Psychosocial predictors of dropout in in vitro fertilization. 29th Annual Meeting 
of European Society of Human Reproduction and Embryology (ESHRE), London, 
United Kingdom, July 2013.
APPENDICES296
Dankwoord
Ik ben ontzettend trots op dit proefschrift waar ik afgelopen paar jaren mijn ziel 
en zaligheid in heb gestopt. Nog trotser ben ik echter op het feit dat ik dit traject 
met zoveel slimme, kritische, maar vooral leuke mensen heb mogen doorlopen. 
Een aantal van hen wil ik hier graag in het bijzonder bedanken.
Het dankwoord van een proefschrift over patiëntgerichtheid kan uiteraard enkel 
starten met het danken van alle patiënten die hun steentje hebben bijgedragen. 
Daarbij noem ik de paar duizend patiënten die al mijn verschillende vragenlijsten 
hebben ingevuld, maar ook de (oud)-patiënten die zo dapper waren om de 
groepsbijeenkomsten bij te wonen en hun mening over (het verbeteren van) de 
patiëntgerichtheid van hun eigen fertiliteitsafdeling te geven. Ook de prachtige 
bijdrage van Ingrid aan dit proefschrift, het schrijven van de proloog, mag niet 
onbenoemd blijven. Mijn proefschrift had niet mooier kunnen beginnen, dank 
daarvoor!
Prof. dr. J.A.M. Kremer, beste Jan, een meer inspirerende promotor had ik me 
niet kunnen wensen. Ik vond de eerste gesprekken met jou erg spannend, maar 
ik ontdekte al snel dat deze meetings bedoeld waren om me een bredere kijk 
op de gezondheidszorg te geven en me aan te moedigen om weer voortvarend 
aan de slag te gaan. Ik kreeg veel vrijheid, maar kon ook altijd bij je terecht als 
ik het spoor even bijster was. Dank daarvoor, maar ook voor je onuitputtelijke 
positiviteit en vertrouwen in ons promotietraject.                                                                     
Dr. W.L.D.M. Nelen, beste Willianne, als mijn enige co-promotor maakte je 
het team compleet en wat was ik blij met jou! Niet alleen je kritische houding, 
praktische en inhoudelijke kennis en je zeer nauwkeurige revisies waren van 
onschatbare waarde. Ook je gezelligheid bij de verschillende etentjes, uitjes en 
congressen heb ik zeer gewaardeerd. Dank voor al je hulp in de afgelopen jaren!
Ook alle medeauteurs van de verschillende artikelen wil ik danken voor hun 
bijdrage. Chris Verhaak en Angelique van Dongen, jullie hulp bij de meer 
psychologisch ingestoken artikelen was van grote waarde. Hetzelfde geldt voor 
de artikelen op het economische vlak, waar ik zonder de visie van Eddy Adang en 
de geniale statistiekuurtjes met Hans Groenewoud nooit uit was gekomen.
Uiteraard wil ik ook veel dank uitspreken naar de 32 fertiliteitsteams die met veel 
enthousiasme deelnamen aan mijn studie. Mijn dank gaat uit naar de gynaecologen 
en fertiliteitsartsen die de kar trokken in de verschillende klinieken, maar ook 
naar de verpleegkundigen, doktersassistenten, secretaresses, psychologen en 
kwaliteitsfunctionarissen die keer op keer weer met nieuwe plannen kwamen hoe 
we de patiëntgerichtheid in hun kliniek nog verder konden verbeteren. Zonder 
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jullie inzet had deze studie nooit kunnen bestaan!
Beste Eva, jouw enorme hulp als student verdiend zonder meer een benoeming in 
mijn dankwoord. Hoe leuk was het om samen naar Londen te gaan om over ‘ons’ 
artikel te spreken en als uitsmijter mocht ik je enkele maanden geleden zelfs 
toespreken bij je afstuderen. Ik wens je alle succes voor de toekomst!
Beste (oud)-onderzoekers uit de kantoortuin, dank voor alle gezellige, 
ontspannende momenten die voor een fijne afwisseling zorgden tussen het harde 
werken door. Tom, wat fijn dat jij voor wat mannelijke input in ‘onze vpg-hoek’ 
zorgde, al was je er maar enkele dagen per week. Het is een ontzettende eer 
dat ik in februari jouw paranimf mag zijn! Inge en Annemijn, jullie hebben de 
tuin allang verlaten, maar toch wil ik jullie hier extra bedanken omdat jullie mij 
wegwijs hebben gemaakt in de wereld van de patiëntgerichte fertiliteitszorg. Ik 
vind het erg leuk dat ik nu jullie AIOS-collega mag zijn!
Ook wil ik dank uitspreken naar mijn oud-collega’s uit het Jeroen Bosch 
Ziekenhuis in Den Bosch. De liefde voor de gynaecologie is bij jullie gestart en 
ik heb twee enorm fijne jaren bij jullie als ANIOS beleefd. Gelukkig mocht ik na 
mijn promotietraject het klinisch werk voortzetten in het Brabantse Land; in het 
Catharina ziekenhuis in Eindhoven voelde ik mij in oktober direct zeer welkom 
en ik weet zeker dat ik hier een ontzettend leerzame en gezellige opleidingstijd 
ga beleven. 
Dan mijn vriendinnetjes: Eva, Marjan, Lisanne, Lucie en natuurlijk alle ‘heidies’, 
het is top om zulke goede vriendinnen te hebben! Ik vond het erg fijn dat jullie zo 
geïnteresseerd waren in mijn onderzoek en de hoogtepunten met mij meevierden! 
En ja Eva, nu gaan we weer ‘echt’ aan het werk, ik ben alleen wel bang dat het 
ten koste zal gaan van onze tennisuurtjes  ;-)
Lieve Marloes, het was direct duidelijk dat jij mijn paranimf moest zijn: mijn beste 
vriendin-collegaatje (en dan ook vooral in die volgorde!). Het klikte meteen toen 
jij in Den Bosch kwamen werken en ik maakte dan ook een vreugdedansje toen 
ik hoorde dat jij even later ook naar het Radboud kwam! Het ultieme doel is nu 
als opleidingsmaatjes verder, maar met jouw harde werken en mooie onderzoek 
moet dat helemaal goed komen. Dankjewel dat je tijdens mijn promotie naast 
me wil staan! 
Lieve Fleur, ik ben ook heel blij dat jij mijn paranimf wilt zijn. De uitspraak: ‘Beter 
een goede buur dan een verre vriend’ is op ons wel van toepassing. Een betere 
en gezelligere ‘overbuuf’ had ik me namelijk niet kunnen wensen tijdens mijn 
laatste jaartjes in de kantoortuin. En dan bleek je ook nog eens met regelmaat 
in mijn straat in Den Bosch rond te hangen, aangezien mijn buurvrouw jouw 
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beste vriendin is! Ik wens ook jou heel veel succes met de laatste loodjes van 
je onderzoek en hoop dat we het Bourgondische leven in Den Bosch samen nog 
vaak in stand mogen houden!
Ook wil ik dank uitspreken naar mijn (schoon)familie voor wie het vaak maar 
abracadabra was waar Dana nou ook alweer mee bezig was. Toch waren jullie 
allemaal even geïnteresseerd als ik op een familiefeestje weer eens probeerde uit 
te leggen waar mijn onderzoek over ging.
Wilco, jij kreeg volgens mij pas echt besef van de omvang van een promotietraject 
toen je de uitdaging aanging om de cover en lay-out van mijn proefschrift te 
verzorgen. Maar wat heb je dat goed gedaan. Als dit een voorbode is voor je 
verdere werk dan gaat mijn ‘kleine broertje’ echt een goede architect worden! 
Erica, ik ben ontzettend benieuwd wat jij van mijn proefschrift vindt, want aan 
jouw manier van schrijven kan ik natuurlijk niet tippen. Ik ben heel blij dat je 
het zo naar je zin hebt op je huidige werk en ik hoop dat je al je schrijf- en 
onderwijstalent in de komende jaren maximaal kunt inzetten.
Papa en Elly, jullie ook bedankt voor jullie morele steun tijdens mij 
promotieonderzoek. Wat fijn dat jullie speciaal voor deze gelegenheid terugkomen 
naar Nederland.
En dan mijn lieve mama, een grotere fan kan ik me niet wensen. De link naar 
Pubmed staat in je ‘Favorieten’ en mijn gepubliceerde artikelen hangen uitgeprint 
boven je bureau! Je bent de beste moeder die ik me kan wensen en ik weet zeker 
dat je apentrots op de eerste rij zit tijdens mijn verdediging! Ik ben je ontzettend 
dankbaar dat je mij alle kansen om te studeren en promoveren hebt kunnen en 
willen geven!!
Last but not least, mijn lieve Laurens, zonder jou had ik dit allemaal niet gekund. 
Al twaalf jaar mijn lief, maar ook mijn allerbeste maatje. Jij kent mij als geen 
ander en geeft mij alle ruimte om mijn droom om gynaecoloog te worden te 
verwezenlijken. Met jouw relativeringsvermogen en humor help je mij door mijn 
moeilijke momenten heen, waar ik je ontzettend dankbaar voor ben. Ik kijk 
enorm uit naar de rest van ons fijne leven samen!
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Curriculum Vitae
Dana Huppelschoten werd op 10 augustus 1984 als oudste van drie kinderen 
geboren in het dorpje Hooglanderveen. Op 6-jarige leeftijd verhuisde zij met 
haar familie naar de polder, waar ze in Dronten en Kampen de basisschool en 
middelbare school doorliep. Dana wist al vroeg dat ze arts wilde worden. Gelukkig 
kon ze in 2002, na het behalen van haar VWO-diploma, direct starten met de 
opleiding Geneeskunde in Nijmegen.
Naast haar studie Geneeskunde volgde Dana vanaf 2003 een tweejarig traject 
aan de Radboud Honours Academy, een initiatief van de Radboud Universiteit 
om over de grenzen van de eigen studie te kijken. Ook was Dana actief binnen 
een commissie van de Medische Faculteit Vereniging Nijmegen (MFVN) en was zij 
bestuurslid van het Nijmeegse Studentenkoor Alphons Diepenbrock (NSKAD) in 
het jaar 2005-2006.
Tijdens het doorlopen van haar coschappen in 2007 en 2008 werd het Dana 
meer dan duidelijk dat ze gynaecoloog wilde worden. Om verder te komen 
in dit mooie specialisme volgde zij een keuze coschap binnen het vak en liep 
haar wetenschappelijke stage op de afdeling Voortplantingsgeneeskunde van 
het UMC St Radboud in Nijmegen. Tijdens deze stage werkte zij mee aan het 
promotieonderzoek van dr. Inge van Empel naar de ontwikkeling van de Patient-
Centredness Questionnaire-Infertility, onder leiding van prof. dr. Jan Kremer.
Nadat Dana in 2009 haar artsenexamen behaalde, werkte zij twee jaar vol 
enthousiasme als ANIOS Gynaecologie in het Jeroen Bosch ziekenhuis te 
‘s-Hertogenbosch. Tijdens haar eerdere stage was echter ook de nieuwsgierigheid 
naar het doen van wetenschappelijk onderzoek gewekt. Toen zich in 2011 de 
mogelijkheid aandiende om een promotieonderzoek te starten onder leiding van 
prof. dr. Jan Kremer en dr. Willianne Nelen, greep zij dit dan ook met twee handen 
aan, hetgeen binnen drie jaar resulteerde in dit proefschrift.
Dana is op 1 oktober 2013 gestart met haar opleiding tot gynaecoloog in het 
Catharina ziekenhuis te Eindhoven, bij opleider dr. Simone Kuppens.
Sinds 2001 heeft Dana een relatie met Laurens Schouten met wie ze sinds 2007 
samenwoont in ’s-Hertogenbosch.


